Andalay Solar S-1 1 Jul 15 IPO registration Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2015	May. 13, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Andalay Solar, Inc.
Document Type	S1
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		402,586,240
Entity Public Float			$ 4,300,000
Amendment Flag	false
Entity Central Index Key	1,347,452
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2013
Series C Preferred Stock [Member]
Current liabilities:
Convertible redeemable preferred stock	$ 163,998
Series D Preferred Stock [Member]
Current liabilities:
Convertible redeemable preferred stock	858,565
Series B Preferred Stock [Member]
Stockholders’ deficit:
Series B convertible redeemable preferred stock, $0.001 par value; 0 and 467 shares issued and outstanding as of December 31, 2014 and 2013, respectively	146,224
Cash	150,081
Accounts receivable, net	567,523
Other receivables	21,378
Inventory	786,636
Prepaid expenses and other current assets	317,510
Total current assets	1,843,128
Property and equipment, net	13,854
Patents, net	1,244,712
Other assets, net	363,711
Total assets	3,465,405
Accounts payable	4,199,511
Accrued liabilities	89,730
Accrued warranty	1,312,918
Credit facility	500,000
Capital lease obligations – current portion	299
Derivative liability – embedded conversion feature	177,927
Note payable – short-term	129,839
Convertible notes – short-term	60,000
Total current liabilities	6,470,224
Convertible notes	382,084
Total liabilities	6,852,308
Commitments and contingencies (Note 17)	0
Common stock, $0.001 par value; 500,000,000 shares authorized; 279,475,332 and 116,339,293 shares issued and outstanding as of December 31, 2014 and 2013, respectively	116,339
Additional paid-in capital	78,717,997
Accumulated deficit	(83,390,026)
Total stockholders’ deficit	(4,409,466)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit	$ 3,465,405

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2014	Dec. 31, 2013
Series C Preferred Stock [Member]
Convertible redeemable preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible redeemable preferred stock, shares issued	0	87
Convertible redeemable preferred stock, shares outstanding	0	87
Series D Preferred Stock [Member]
Convertible redeemable preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible redeemable preferred stock, shares issued	0	860
Convertible redeemable preferred stock, shares outstanding	0	860
Series B Preferred Stock [Member]
Series B convertible redeemable preferred stock par value (in Dollars per share)	$ 0.001	$ 0.001
Series B convertible redeemable preferred stock shares issued	0	467
Series B convertible redeemable preferred stock shares outstanding	0	467
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	279,475,332	116,339,293
Common stock, shares outstanding	279,475,332	116,339,293

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Net revenue	$ 1,288,985	$ 1,124,836
Cost of goods sold	1,191,390	1,121,612
Gross profit	97,595	3,224
Operating Expenses
Sales and marketing	366,543	887,305
General and administrative	2,263,086	2,377,703
Total operating expenses	2,629,629	3,265,008
Loss from operations	(2,532,034)	(3,261,784)
Other Income (Expense)
Interest income (expense), net	(362,955)	(65,031)
Adjustment to the fair value of embedded derivatives	(50,809)	65,962
Adjustment to the fair value of common stock warrants		9
Settlement of prior debt owed	769,148	420,000
Total other income, net	355,384	420,940
Loss before provision for income taxes	(2,176,650)	(2,840,844)
Provision for income taxes	0	0
Net loss from continuing operations	(2,176,650)	(2,840,844)
Gain from discontinued operations	324,349	10,797
Net loss	(1,852,301)	(2,830,047)
Preferred stock dividend	(18,927)	(153,305)
Preferred deemed dividend		(875,304)
Net loss attributable to common stockholders	$ (1,871,228)	$ (3,858,656)
Net loss per common and common equivalent share (basic and diluted) attributable to common shareholders (in Dollars per share)	$ (0.01)	$ (0.06)
Weighted average shares used in computing loss per common share: (basic and diluted) (in Shares)	203,814,897	69,170,957

Consolidated Statements of Chan

Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)	Series C Preferred Stock [Member]Preferred Stock [Member]	Series C Preferred Stock [Member]Common Stock [Member]	Series C Preferred Stock [Member]Additional Paid-in Capital [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]Preferred Stock [Member]	Series D Preferred Stock [Member]Common Stock [Member]	Series D Preferred Stock [Member]Additional Paid-in Capital [Member]	Series D Preferred Stock [Member]Retained Earnings [Member]	Series D Preferred Stock [Member]	Series B Preferred Stock [Member]Preferred Stock [Member]	Preferred Class B [Member]Common Stock [Member]	Preferred Class B [Member]Additional Paid-in Capital [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012	$ 983,747									$ 741,171			$ 26,919	$ 76,455,045	$ (79,611,493)	$ (2,388,343)
Balance (in Shares) at Dec. 31, 2012	800									2,243			26,924,643
Issuance of Series C convertible redeemable preferred stock for cash	$ 75,000				$ 475,000
Issuance of Series C convertible redeemable preferred stock for cash, Shares (in Shares)	75				950
Return of Series D convertible redeemable preferred stock					$ (80,123)			$ 80,123	$ 80,123
Return of Series D convertible redeemable preferred stock (in Shares)					(200)
Issuance of Series D convertible redeemable preferred stock for payment of financial advisor fees					$ 230,000
Issuance of Series D convertible redeemable preferred stock for payment of financial advisor fees (in Shares)					230
Preferred deemed dividend	$ 410,227				$ 465,077										(875,304)	(875,304)
Conversion of Convertible Redeemable preferred stock to common stock	$ (1,304,976)	$ 18,478	$ 1,286,498	$ 1,304,976	$ (180,010)	$ 6,000	$ 174,010		180,010	$ (594,947)	$ 58,278	$ 536,669
Conversion of Convertible Redeemable preferred stock to common stock, Shares (in Shares)	(788)	18,477,766			(120)	6,000,000				(1,776)	58,277,813
Convertible Redeemable Preferred Stock dividends paid in common stock													$ 4,313	148,992	(153,305)
Convertible Redeemable Preferred Stock dividends paid in common stock, Shares (in Shares)													4,310,661
Grant of warrant on issuance of convertible note														53,623		53,623
Placement agent and registration fees and other direct costs					$ (51,379)									(40,602)		(40,602)
Grants of restricted stock, net of forfeitures and repurchases for employee taxes													$ 2,354	(6,456)		(4,102)
Grants of restricted stock, net of forfeitures and repurchases for employee taxes, Shares (in Shares)													2,348,410
Stock-based compensation														110,200		110,200
Net loss															(2,830,047)	(2,830,047)
Balance at Dec. 31, 2013	$ 163,998				$ 858,565					$ 146,224			$ 116,339	78,717,997	(83,390,026)	(4,409,466)
Balance (in Shares) at Dec. 31, 2013	87				860					467			116,339,293
Issuance of Series C convertible redeemable preferred stock for cash													$ 44,080	882,510		926,590
Issuance of Series C convertible redeemable preferred stock for cash, Shares (in Shares)													44,079,800
Conversion of Convertible Redeemable preferred stock to common stock	$ (163,998)	$ 4,333	$ 159,665	$ 163,998	$ (858,565)	$ 43,000	$ 815,565		$ 858,565	$ (146,224)	$ 21,020	$ 125,204	$ 50,439	957,880		1,008,319
Conversion of Convertible Redeemable preferred stock to common stock, Shares (in Shares)	(87)	4,333,350			(860)	43,000,000				(467)	21,020,015		50,439,751
Convertible Redeemable Preferred Stock dividends paid in common stock													$ 644	18,283	(18,927)
Convertible Redeemable Preferred Stock dividends paid in common stock, Shares (in Shares)													643,520
Grant of warrant on issuance of convertible note														170,767		170,767
Placement agent and registration fees and other direct costs														(36,618)		(36,618)
Grants of restricted stock, net of forfeitures and repurchases for employee taxes													$ (380)	(8,312)		(8,692)
Grants of restricted stock, net of forfeitures and repurchases for employee taxes, Shares (in Shares)													(380,397)
Stock-based compensation														224,011		224,011
Net loss															(1,852,301)	(1,852,301)
Balance at Dec. 31, 2014													$ 279,475	82,026,952	(85,261,254)	(2,954,827)
Balance (in Shares) at Dec. 31, 2014													279,475,332
Issuance of Series C convertible redeemable preferred stock for cash													$ 58,214	777,634		835,848
Issuance of Series C convertible redeemable preferred stock for cash, Shares (in Shares)													58,213,490
Conversion of Convertible Redeemable preferred stock to common stock													$ 34,565	443,829		478,394
Conversion of Convertible Redeemable preferred stock to common stock, Shares (in Shares)													34,565,577
Stock-based compensation														68,600		68,600
Net loss															(825,176)	(825,176)
Balance at Mar. 31, 2015													$ 372,254	$ 83,592,015	$ (86,086,430)	$ (2,122,161)
Balance (in Shares) at Mar. 31, 2015													372,254,399

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Prepaid Expenses and Other Current Assets [Member]
Supplemental disclosure of non-cash financing activity:
Note issued	$ 121,100	$ 144,071
Financial Advisory Services Fees [Member]
Supplemental disclosure of non-cash financing activity:
Note issued	160,000	60,000
To Settle Claim [Member]
Supplemental disclosure of non-cash financing activity:
Common stock issued to settle claim	250,000
Net loss	(1,852,301)	(2,830,047)
Depreciation	13,155	33,023
Amortization of patents	113,385	113,071
Bad debt expense	36,763	92,224
Adjustment to the fair value of embedded derivatives	50,809	(65,962)
Accretion of interest on convertible notes	168,708	21,889
Unrealized gain on fair value adjustment of common stock warrants		(9)
Stock-based compensation expense	224,011	110,200
Non-cash settlement of prior debt owed	(769,148)
Accounts receivable	412,304	(293,902)
Other receivables	21,378	100,612
Inventory	58,264	209,077
Prepaid expenses and other current assets	158,544	246,669
Other assets	123,233	1,706
Accounts payable	324,998	1,159,974
Accrued liabilities and accrued warranty	(276,657)	(461,100)
Deferred revenue	15,450
Net cash used in operating activities	(1,177,104)	(1,562,575)
Borrowing on long-term debt	600,000	650,000
Repayment of notes payable	(142,416)	(14,232)
Borrowing on line of credit, net		500,000
Repayments on capital lease obligations	(299)	(4,414)
Proceeds from securities purchase agreement	676,590	550,000
Payment of placement agent and registration fees and other direct costs	(36,618)	(91,981)
Employee taxes paid for vesting of restricted stock	(8,692)	(4,102)
Net cash provided by financing activities	1,088,565	1,585,271
Net (decrease) increase in cash	(88,539)	22,696
Beginning of period	150,081	127,385
End of period	61,542	150,081
Cash paid during the period for interest	57,580	6,759
Embedded derivatives on convertible note issuances	122,630	243,889
Grant of warrant on issuance of convertible note	170,767	53,623
Preferred deemed dividend		875,304
Conversion of preferred stock to common stock	1,168,787	2,079,933
Conversion of convertible note to common stock	786,551
Preferred stock dividends paid in common stock	18,927	153,305
Return of Series D convertible preferred stock		80,123
Embedded derivative converted to equity	$ 221,768
Preferred stock issued for payment of financial advisor fees		$ 230,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash	$ 135,377	$ 61,542
Accounts receivable, net	62,386	118,456
Inventory	701,945	728,372
Prepaid expenses and other current assets	315,377	280,066
Total current assets	1,215,085	1,188,436
Property and equipment, net	350	699
Patents, net	1,144,342	1,131,327
Other assets, net	199,005	240,478
Total assets	2,558,782	2,560,940
Current liabilities:
Accounts payable	3,220,948	3,345,361
Accrued liabilities	204,793	104,229
Accrued warranty	934,088	938,466
Deferred revenue		15,450
Derivative liability – embedded conversion feature		129,598
Line of credit		500,000
Note payable – short-term	73,129	109,164
Convertible note and beneficial conversion feature – short-term	247,985	30,000
Total current liabilities	4,680,943	5,172,268
Convertible notes, less current portion (net of discount)		343,499
Total liabilities	4,680,943	5,515,767
Commitments and contingencies (Note 17)	0	0
Stockholders’ deficit:
Common stock, $0.001 par value; 500,000,000 shares authorized; 372,254,399 and 279,475,332 shares issued and outstanding as of March 31, 2015 and December 31, 2014, respectively	372,254	279,475
Additional paid-in capital	83,592,015	82,026,952
Accumulated deficit	(86,086,430)	(85,261,254)
Total stockholders’ deficit	(2,122,161)	(2,954,827)
Total liabilities and stockholders’ deficit	$ 2,558,782	$ 2,560,940

Condensed Consolidated Balance8

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Apr. 13, 2011	Aug. 11, 2006	Aug. 10, 2006
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001	$ 0.001		$ 0.001	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common stock, shares issued	372,254,399	279,475,332	116,339,293
Common stock, shares outstanding	372,254,399	279,475,332	116,339,293

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Net revenue	$ 274,641	$ 142,482	$ 1,288,985	$ 1,124,836
Cost of goods sold	286,382	135,388	1,191,390	1,121,612
Gross profit (loss)	(11,741)	7,094	97,595	3,224
Operating expenses
Sales and marketing	71,129	63,384	366,543	887,305
General and administrative	721,358	604,164	2,263,086	2,377,703
Total operating expenses	792,487	667,548	2,629,629	3,265,008
Loss from continuing operations	(804,228)	(660,454)	(2,176,650)	(2,840,844)
Other income (expense)
Interest income (expense), net	(62,213)	(77,085)	(362,955)	(65,031)
Adjustment to the fair value of embedded derivatives	41,265	(101,551)		9
Settlement of prior debt owed		769,148	769,148	420,000
Total other income (expense), net	(20,948)	590,512	355,384	420,940
Loss before provision for income taxes	(825,176)	(69,942)	(2,176,650)	(2,840,844)
Provision for income taxes	0	0	0	0
Net loss	(825,176)	(69,942)	(1,852,301)	(2,830,047)
Preferred stock dividend		(14,454)		(875,304)
Net loss attributable to common stockholders	$ (825,176)	$ (84,396)	$ (1,871,228)	$ (3,858,656)
Net loss attributable to common stockholders per common share (basic and diluted) (in Dollars per share)	$ 0	$ 0	$ (0.01)	$ (0.06)
Weighted-average shares used in computing loss per common share: (in Shares)	327,997,747	131,428,001	203,814,897	69,170,957

Condensed Consolidated Statem10

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012	$ 26,919	$ 76,455,045	$ (79,611,493)	$ (2,388,343)
Balance (in Shares) at Dec. 31, 2012	26,924,643
Stock-based compensation		110,200		110,200
Net loss			(2,830,047)	(2,830,047)
Balance at Dec. 31, 2013	$ 116,339	78,717,997	(83,390,026)	(4,409,466)
Balance (in Shares) at Dec. 31, 2013	116,339,293
Issuance of common stock pursuant to equity purchase agreement	$ 44,080	882,510		926,590
Issuance of common stock pursuant to equity purchase agreement (in Shares)	44,079,800
Issuance of common stock upon conversion of note payable	$ 50,439	957,880		1,008,319
Issuance of common stock upon conversion of note payable (in Shares)	50,439,751
Stock-based compensation		224,011		224,011
Net loss			(1,852,301)	(1,852,301)
Balance at Dec. 31, 2014	$ 279,475	82,026,952	(85,261,254)	(2,954,827)
Balance (in Shares) at Dec. 31, 2014	279,475,332
Issuance of common stock pursuant to equity purchase agreement	$ 58,214	777,634		835,848
Issuance of common stock pursuant to equity purchase agreement (in Shares)	58,213,490
Beneficial conversion feature on issuance of convertible note		275,000		275,000
Issuance of common stock upon conversion of note payable	$ 34,565	443,829		478,394
Issuance of common stock upon conversion of note payable (in Shares)	34,565,577
Stock-based compensation		68,600		68,600
Net loss			(825,176)	(825,176)
Balance at Mar. 31, 2015	$ 372,254	$ 83,592,015	$ (86,086,430)	$ (2,122,161)
Balance (in Shares) at Mar. 31, 2015	372,254,399

Condensed Consolidated Statem11

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Financial Advisory Services Fees [Member]
Supplemental cash flows disclosures:
Convertible note issued to financial advisor in exchange for service		$ 90,000
Net loss	$ (825,176)	(69,942)
Depreciation	349	4,920
Amortization	29,358	28,347
Bad debt expense	(2,909)	4,492
Unrealized (gain) loss on fair value of embedded derivatives	(41,265)	101,551
Accretion of interest on convertible note	6,345	25,964
Accretion of interest on debt discount	22,985
Non-cash stock-based compensation expense	68,600	75,822
Non-cash settlement of prior debt owed		(769,148)
Accrued interest payable	13,730	15,987
Accounts receivable	68,036	34,263
Other receivables		(178,624)
Inventory	26,427	(153,547)
Prepaid expenses and other current assets	19,966	86,391
Other assets	41,473	6,755
Accounts payable	(124,413)	96,524
Accrued liabilities and accrued warranty	84,079	(18,317)
Deferred revenue	(15,450)
Net cash used in operating activities	(627,865)	(708,562)
Acquisition of patents	(42,373)
Net cash used in investing activities	(42,373)
Borrowing on convertible notes payable		600,000
Repayment notes payable	(36,035)	(42,929)
Proceeds from issuance of common stock	780,108
Borrowing on line of credit		300,000
Repayments on capital lease obligations		(299)
Payment of placement agent and registration fees and other direct costs		(36,616)
Employee taxes paid for vesting of restricted stock		(2,714)
Net cash provided by financing activities	744,073	817,442
Net increase in cash	73,835	108,880
Beginning of period	61,542	150,081
End of period	135,377	258,961
Cash paid during the period for interest	939	20,254
Embedded derivative on convertible note issued	176,771	122,630
Embedded derivative converted to equity	88,333	221,768
Receivable for issuance of common stock	55,277
Grant of warrants on issue of convertible note		170,767
Refinance of line of credit to convertible note payable	500,000
Preferred stock dividend		14,454
Common stock issued for equity purchase agreement fees	12,107
Conversion of preferred stock to common stock		$ 465,053
Conversion of convertible note to common stock	570,531
Beneficial conversion feature on note refinance	$ 275,000

Note 1 - Description of Busines

Note 1 - Description of Business	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure Text Block [Abstract]
Business Description and Basis of Presentation [Text Block]	1. Basis of Presentation and Description of Business Basis of Presentation — Interim Financial Information The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial information. They should be read in conjunction with the consolidated financial statements and related notes to the consolidated financial statements of Andalay Solar, Inc. (“we”, “us”, “our” or the “Company”), formerly Westinghouse Solar, Inc. and Akeena Solar, Inc., for the years ended December 31, 2014 and 2013 appearing in our Form 10-K. The March 31, 2015 unaudited interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements filed with our Annual Report on Form 10-K have been condensed or omitted as permitted by those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring accruals, necessary for a fair statement of the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the entire year. Description of Business Andalay Solar, Inc. and its subsidiaries (Andalay Solar, the Company, we, us or our) is a designer and manufacturer of integrated solar power systems and solar panels with integrated microinverters (which we call AC solar panels). We design, market and sell these solar power systems to solar installers and do-it-yourself customers in the United States, Canada, the Caribbean and South America through distribution partnerships, our dealer network and retail outlets. Our products are designed for use in solar power systems for residential and commercial rooftop customers. Prior to September 2010, we were also in the solar power installation business, but decided to exit that business. During the fourth quarter 2014, we re-entered the solar power installation business. Additionally, we are engaging in a new strategy of licensing our patented products to large module manufacturers and entering into distribution agreements with these manufacturers and large national distributors/installers. This new strategy is less capital intensive and aligns us with companies that have proven track records in the residential solar industry. We were incorporated in February 2001 as Akeena Solar, Inc. in the State of California and elected at that time to be taxed as an S corporation. During June 2006, we reincorporated in the State of Delaware and became a C corporation. On August 11, 2006, we entered into a reverse merger transaction with Fairview Energy Corporation, Inc. (“Fairview”). Pursuant to the merger, our stockholders received one share of Fairview common stock for each issued and outstanding share of our common stock. Our common shares were also adjusted from $0.01 par value to $0.001 par value at the time of the Merger. On May 17, 2010, we entered into an exclusive worldwide license agreement with Westinghouse, Inc, which permitted us to manufacture, distribute and market solar panels under the Westinghouse name and in connection therewith, on April 6, 2011, we changed our name to Westinghouse Solar, Inc. On April 13, 2011, we effected a reverse split of our common stock at a ratio of 1 – for – 4. On August 23, 2013, the license agreement with Westinghouse, Inc. was terminated and on September 19, 2013, we changed our name to our current name, Andalay Solar, Inc. and increased our number of authorized shares of common stock to 500,000,000. Our Corporate headquarters is located at 48900 Milmont Drive, Fremont, CA 94538. Our telephone number is (408) 402-9400. Additional information about Andalay Solar is available on our website at http://www.andalaysolar.com .	1. Description of Business Andalay Solar, Inc. and its subsidiaries (Andalay Solar, the Company, we, us or our) is a designer and manufacturer of integrated solar power systems and solar panels with integrated microinverters (which we call AC solar panels). We design, market and sell these solar power systems to solar installers and do-it-yourself customers in the United States, Canada, the Caribbean and South America through distribution partnerships, our dealer network and retail outlets. Our products are designed for use in solar power systems for residential and commercial rooftop customers. Prior to September 2010, we were also in the solar power installation business, but decided to exit that business. Recently we have re-entered the solar power installation business. In September 2007, we introduced our “plug and play” solar panel technology (under the brand name “Andalay”), which we believe significantly reduces the installation time and costs, and provides superior reliability and aesthetics, when compared to other solar panel mounting products and technology. Our panel technology offers the following features: (i) mounts closer to the roof with less space in between panels; (ii) no unsightly racks underneath or beside panels; (iii) built-in wiring connections; (iv) approximately 70% fewer roof-assembled parts and approximately 50% less roof-top labor required; (v) approximately 25% fewer roof attachment points; (vi) complete compliance with the National Electric Code and UL wiring and grounding requirements. We have seven U.S. patents (Patent No. 7,406,800, Patent No. 7,832,157, Patent No. 7,866,098, Patent No. 7,987,641, Patent No. 8,505,248, Patent No. 8,813,460, and Patent No. 8,938,919) that cover key aspects of our Andalay solar panel technology, as well as U.S. Trademark No. 348565 3 for registration of the mark “Andalay Solar.” In addition to these U.S. patents, we have eight foreign patents. Currently, we have 15 issued patents and nine other pending U.S. and foreign patent applications that cover the Andalay technology working their way through the United States Patent and Trademark Office (“USPTO”) and foreign patent offices. In February 2009, we began our strategic relationship with Enphase, a leading manufacturer of microinverters, to develop and market solar panel systems with ordinary AC house current output instead of high voltage DC output. We introduced Andalay AC panel products and began offering them to our customers in the second quarter of 2009. Andalay AC panels cost less to install, are safer, and generally provide higher energy output than ordinary DC panels. Andalay AC panels deliver 5-25% more energy compared to ordinary panels, produce safe household AC power, and have built-in panel level monitoring, racking, wiring, grounding and microinverters. With 80% fewer parts and 5 – 25% better performance than ordinary DC panels, we believe Andalay AC panels are an ideal solution for solar installers and do-it-yourself customers. On May 7, 2012, we announced the execution of an agreement and plan of merger with CBD Energy Limited, an Australian corporation (CBD), which contemplated a merger in which CBD would become our parent company. The targeted completion of the merger was repeatedly delayed and on July 18, 2013 we terminated the merger. During such merger delays, our supply relationships had been disrupted, leading to a significant decline in our revenue and the implementation of significant cost reductions, including the lay-off of employees during the time we pursued the merger. Since the termination of the merger, we have been committed to focus our attention on rebuilding our core business, expanding our current product offering and exploring strategic opportunities. In September 2013, we entered into a supply agreement for assembly of our proprietary modules with Tianwei New Energy Co, Ltd., (Tianwei) a panel supplier located in China. We began receiving initial shipments from Tianwei in February 2014 but ended our relationship in June 2014. On July 16, 2014, we entered into an agreement for supply of solar photovoltaic (“PV”) modules with Auxin Solar Inc. These modules are assembled in the United States and we began distributing these panels from our new supplier in December 2014. Prior to September 2010, we were also in the solar power system installation business and we had completed over 4,300 solar power installations for customers in California, New York, New Jersey, Pennsylvania, Colorado and Connecticut since the commencement of our operations in 2001. In early 2009, we closed our non-California offices on the east coast and in Colorado and began distributing our solar power systems to customers outside of California. In September 2010, we made the strategic decision to exit our California solar panel installation business and expand our solar panel distribution network to dealers and other installers in California, by far the largest solar market in the United States. However, we recently made the decision to re-enter the solar panel installation business on a limited basis. Our business is now focused on design and manufacturing activities, and sales of our solar power systems to solar installers, trade workers and retailers through distribution partnerships, our dealer network and retail home improvement outlets as well as installation of our panels. We were incorporated in February 2001 as Akeena Solar, Inc. in the State of California and elected at that time to be taxed as an S corporation. During June 2006, we reincorporated in the State of Delaware and became a C corporation. On August 11, 2006, we entered into a reverse merger transaction with Fairview Energy Corporation, Inc. (“Fairview”). Pursuant to the merger, our stockholders received one share of Fairview common stock for each issued and outstanding share of our common stock. Our common shares were also adjusted from $0.01 par value to $0.001 par value at the time of the Merger. On May 17, 2010, we entered into an exclusive worldwide license agreement with Westinghouse, Inc, which permitted us to manufacture, distribute and market solar panels under the Westinghouse name and in connection therewith, on April 6, 2011, we changed our name to Westinghouse Solar, Inc. On April 13, 2011, we effected a reverse split of our common stock at a ratio of 1 – for – 4. On August 23, 2013, the license agreement with Westinghouse, Inc. was terminated and on September 19, 2013, we changed our name to our current name, Andalay Solar, Inc. and increased our number of authorized shares of common stock to 500,000,000.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies Liquidity and Financial Position We currently face challenges meeting the working capital needs of our business. Our primary requirements for working capital are to fund purchases for solar panels and microinverters, and to cover our payroll and lease expenses. We have incurred net losses and negative cash flows from operations for the three months ended March 31, 2015 and for each of the years ended December 31, 2014 and 2013. During recent years, we have undertaken several equity and debt financing transactions to provide the capital needed to sustain our business. We have dramatically reduced our headcount and other variable expenses. As of March 31, 2015, we had approximately $135,000 in cash on hand. We intend to address ongoing working capital needs through sales of remaining inventory, along with raising additional debt and equity financing. Our revenue levels remain difficult to predict, and as we anticipate we will continue to sustain losses in the near term, we cannot assure investors that we will be successful in reaching break-even. In September 2013, we entered into a supply agreement for assembly of our proprietary modules with Tianwei New Energy Co, Ltd., a panel supplier located in China. We began receiving product from Tianwei in February 2014 and stopped as of June 2014. In July 2014, we entered into a supply agreement for assembly of our proprietary modules with Auxin Solar, Inc., a panel supplier located in the United States. In December 2014, we began distributing panels from our new supplier. Although we believe we can find alternative suppliers for solar panels manufactured to our specifications, our operations would be disrupted unless we are able to rapidly secure alternative sources of supply, our inventory and revenue could diminish significantly, causing disruption to our operations. The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern. Our significant operating losses, negative cash flow from operations, and challenges in rapidly securing alternative sources of supply for solar panels, raise substantial uncertainty about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty, and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. There can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all. There is uncertainty to our anticipated revenue levels and to the timing of cash receipts, which are needed to support our operations. It also worsens the market conditions for seeking equity and debt financing. We currently anticipate that we will retain all of our earnings, if any, for development of our business and do not anticipate paying any cash dividends on common stock in the foreseeable future. Securities Purchase Agreement Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to the embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the three months ended March 31, 2015 of approximately $41,000 on a total of three convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. Equity Purchase Agreement On January 23, 2014, we entered into an Equity Purchase Agreement with Southridge Partners II, LP (“Southridge”), that superseded our prior Equity Purchase Agreement with Southridge that was entered into on November 25, 2013 (the “Prior Equity Purchase Agreement”). The terms of the new Equity Purchase Agreement are identical to those of the Prior Equity Purchase Agreement other than that the New Equity Purchase Agreement provides that the Agreement may not be amended by either party. Pursuant to the New Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the New Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the New Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. On March 11, 2014, we filed a Registration Statement on Form S-1/A to register 35 million shares of common stock related to our Equity Purchase Agreement with Southridge and on March 21, 2014, the Securities and Exchange Commission declared the Registration Statement effective. On March 26, 2014, we submitted an initial take-down request of $300,000 to Southridge pursuant to the terms of the Equity Purchase Agreement of which partial proceeds of $100,000 was received on March 31, 2014 and $200,000 on April 16, 2014. On June 4, 2014, June 18, 2014 and July 8, 2014, we submitted additional take-down requests for $100,000, $100,000 and $125,000, respectively, pursuant to the terms of the Equity Purchase Agreement. On December 10, 2014, we entered into the December Equity Purchase Agreement with Southridge, that superseded our Prior Equity Purchase Agreement with Southridge that was entered into on January 23, 2014. The terms of the December Equity Purchase Agreement are substantially similar to those of the Prior Equity Purchase Agreement. Pursuant to the December Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the December Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. We submitted various take-down requests during the first quarter of 2015 pursuant to the terms of the December Equity Purchase Agreement. As of May 12, 2015, 67,813,489 shares had been sold at an average price of $0.0137 per share, resulting in total proceeds of approximately $929,000. Pursuant to the terms of the December Equity Purchase Agreement we agreed to pay Southridge a commitment fee of 1,000,000 shares of our common stock, of which 500,000 shares of our common stock were due to Southridge on January 16, 2015, the date that the registration statement was declared effective and the remaining 500,000 shares of common stock were due on January 20, 2015, the date that we delivered our first Draw Down Notice to Southridge. We valued the issuance of these shares based on the closing price of the stock as of January 16, 2015, $0.0169 for 500,000, and as of January 20, 2015, $0.0161 for 500,000, and we recorded $16,500 as a reduction in “Additional Paid In Capital” on our condensed consolidated balance sheets. On December 10, 2014, we also entered into a Registration Rights Agreement with Southridge pursuant to which we agreed to register shares of the common stock to be issued to Southridge in connection with the December Equity Purchase Agreement. Settlement of Potential Claims Agreement On January 22, 2014, we entered into a Settlement of Potential Claims Agreement with ASC Recap LLC (“ASCR”). Pursuant to the Agreement, ASCR has offered to purchase (and in one (1) case has already purchased) approximately $3.7 million of our prior debt owed to four creditors (“Creditors”) for past due services at a substantial discount to face value to which we have agreed to issue to ASCR certain shares of our common stock in a §3(a)(10) 1933 Act proceeding. The shares of our common stock that we have agreed to issue to ASCR in full payment for, and as a release of any debt it purchases from the Creditors, is anticipated to have, upon issuance, a market value equal to approximately 25% of the principal amount of our outstanding debt. In the case of the debt ASCR already purchased from one (1) Creditor, we entered into a Settlement Agreement and Stipulation on February 26, 2014 that was filed with the Circuit Court of the Second Judicial Circuit, Leon County, Florida pursuant to which we agreed, subject to court approval, to issue shares of our common stock that generate proceeds in the amount of $250,000 in full settlement of the claim in the amount of $1,027,705 that ASCR acquired from one Creditor (the value of the stock that we have agreed to issue was two hundred and fifty percent (250%) of the discounted purchase price ASCR paid to purchase the debt from the Creditor, and approximately 25% of the original amount we owed to the Creditor), resulting in a gain on settlement of $769,148, net of expenses. On March 24, 2014, the Circuit Court of the Second Judicial Circuit, Leon County, Florida, approved the §3(a)(10) 1933 Act proceeding and Settlement Agreement and Stipulation and in April 2014, we issued 8,079,800 shares of common stock at an average price of $0.031 for the full settlement of the agreement with ASCR. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer. Revenue from installation of a system is recognized when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sales price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. In general, we recognize revenue upon completion of a system installation for residential installations and we recognize revenue under the percentage-of-completion method for commercial installations. Revenue recognition methods for revenue streams that fall under other categories are determined based on facts and circumstances. Cash and Cash Equivalents We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. We maintain cash and cash equivalents which consist principally of demand deposits with high credit quality financial institutions. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments and, as of March 31, 2015 and December 31, 2014, we had no cash equivalents. Accounts Receivable Accounts receivable consist of trade receivables. We regularly evaluate the collectibility of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses, and such losses have historically been minimal and within our expectations. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information. Manufacturer and Installation Warranties The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $366,000 as of March 31, 2015 and $345,000 at December 31, 2014, is included within “Accrued warranty” in the accompanying consolidated balance sheets. The liability for our manufacturing warranty consists of the following: March 31, 2015 December 31, 2014 Beginning accrued warranty balance $ 938,466 $ 1,312,918 Reduction for labor payments and claims made under the warranty (13,998 ) (75,966 ) Adjustment to warranty liability for discontinued operations (324,349 ) Accruals related to warranties issued during the period 9,620 25,863 Ending accrued warranty balance $ 934,088 $ 938,466 Patent Costs We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 9.75 years as of March 31, 2015, are reasonable. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time. Significant Accounting Policies and Estimates There have been no material developments or changes to the significant accounting policies discussed in our 2014 Annual Report on Form 10-K or accounting pronouncements issued or adopted, except as described below. Segment Reporting We are engaged in two business segments, (i) we sell our AC solar panels to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets and (ii) we market, sell, design and install systems for residential and commercial customers. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. During the fourth quarter 2014, we re-entered the solar power installation business. See Note 3 for financial information on our business segments. Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (“FASB”) issued, Accounting Standards Update (“ASU”) ASU 2015-03 Interests — Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs In February 2015, the FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis In January 2015, ASU 2015-01 Income Statement — Extraordinary and Unusual Items (Subtopic 225-20) Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), to provide guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Since ASU 2014-15 only impacts financial statement disclosure requirements regarding whether there is substantial doubt about an entity’s ability to continue as a going concern, we do not expect its adoption to have an impact on our consolidated financial statements. In November 2014, the FASB issued ASU No. 2014-16, Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.	2. Summary of Significant Accounting Policies Liquidity and Financial Position We currently face challenges meeting the working capital needs of our business. Our primary requirements for working capital are to fund purchases for solar panels and microinverters, and to cover our payroll and lease expenses. We have incurred net losses and negative cash flows from operations for each of the years ended December 31, 2014 and 2013. During recent years, we have undertaken several equity and debt financing transactions to provide the capital needed to sustain our business. We have dramatically reduced our headcount and other variable expenses. As of December 31, 2014, we had approximately $62,000 in cash on hand. We intend to address ongoing working capital needs through sales of remaining inventory, along with raising additional debt and equity financing. In January 2013, our board of directors approved actions to dramatically reduce our variable operating costs, including a 12 person employee headcount reduction effective January 15, 2013, for the period through the anticipated merger closing with CBD, which was terminated in July 2013. No restructuring charges or severance payments were incurred. Our revenue levels remain difficult to predict, and as we anticipate we will continue to sustain losses in the near term, we cannot assure investors that we will be successful in reaching break-even. During 2012, because of our cash position and liquidity constraints, we were late in making payments to both of our former panel suppliers, Suntech and Lightway. We currently have no unshipped orders from these suppliers. In September 2013, we entered into a supply agreement for assembly of our proprietary modules with Tianwei New Energy Co, Ltd., a panel supplier located in China. We began receiving product from Tianwei in February 2014 and stopped as of June 2014. In July 2014, we entered into a supply agreement for assembly of our proprietary modules with Auxin Solar, Inc., a panel supplier located in the United States. In December 2014, we began distributing panels from our new supplier. Although we believe we can find alternative suppliers for solar panels manufactured to our specifications, our operations would be disrupted unless we are able to rapidly secure alternative sources of supply, our inventory and revenue could diminish significantly, causing disruption to our operations. The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern. Our significant operating losses, negative cash flow from operations, and challenges in rapidly securing alternative sources of supply for solar panels, raise substantial uncertainty about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty, and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. There can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all. There is uncertainty to our anticipated revenue levels and to the timing of cash receipts, which are needed to support our operations. It also worsens the market conditions for seeking equity and debt financing. We currently anticipate that we will retain all of our earnings, if any, for development of our business and do not anticipate paying any cash dividends on common stock in the foreseeable future. Convertible Note s payable On August 30, 2013, we entered into a securities purchase agreement with Alpha Capital Anstalt (“Alpha Capital”) relating to the sale and issuance of a convertible note in the principal amount of $200,000 that matures August 29, 2015 (the "Convertible Note"). Subsequently, on November 25, 2013 and December 19, 2013, we entered into additional securities purchase agreements with Alpha Capital relating to the sale and issuance of convertible notes in the principal amount of $200,000 and $250,000, respectively, which mature on November 25, 2015 and December 19, 2015. On January 27, 2014, we issued a convertible note in the principal amount of $100,000 that matures on January 27, 2016 under the Securities Purchase Agreement we entered into with Alpha Capital on December 19, 2013. In connection with the issuance of the December 19, 2013 convertible note, we also issued 6,250,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On February 25, 2014, we entered into a Securities Purchase Agreement with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $200,000 that matures on February 25, 2016. In connection with the issuance of the February 25, 2014 convertible note, we issued 5,000,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On March 18, 2014, we entered into a Securities Purchase Agreement with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $300,000 that matures on March 18, 2016. In connection with the March 18, 2014 convertible note, we issued a five–year warrant to purchase 7,500,000 shares of our common stock at an exercise price of $.02 per share. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. Subject to our fulfilling certain conditions, including beneficial ownership limits, the convertible notes are subject to a mandatory conversion if the closing price of our common stock for any 20 consecutive days commencing six months after the issue date of the convertible notes equal or exceeds $0.04 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. We have the option of repaying the outstanding principal amount of the convertible notes, in whole or in part, by paying the purchaser a sum of money equal to one hundred and twenty percent (120%) of the principal together with accrued but unpaid interest upon 30 days’ notice, subject to certain beneficial ownership limits. For so long as we have any obligation under the convertible notes, we have agreed to certain restrictions regarding, among other things, incurrence of additional debt, liens, amendments to charter documents, repurchase of stock, payment of cash dividends, affiliated transactions. We are also prohibited from entering into certain variable priced agreements until the convertible notes are repaid in full. Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to the embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the year ended December 31, 2014 of $51,000 on a total of six convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. During 2014, convertible notes in the principal amount of approximately $940,000, along with accrued interest of $68,319, were converted into 50,439,751 shares of our common stock. Line of credit On September 30, 2013, we entered into a loan and security agreement with Alpha Capital Anstalt and Collateral Services, LLC to provide financing, on a discretionary basis, for one year, against our accounts receivable and inventory. The maximum amount that can be borrowed under the Agreement is $500,000. We have the right to borrow up to 80% of our eligible accounts receivable, not in excess of $200,000, 50% of the value of our raw materials in inventory, 65% of our finished goods inventory and 95% of cash, but not in the aggregate amount in excess of $300,000. The advances are secured by a lien on all of our assets. All advances under the agreement bear interest at a per annum rate of 12% and monthly interest shall be a minimum of $500. At the time of initial funding we paid a loan fee of 50 shares of our Series D Preferred Shares to the lender, in addition to other payments for legal fees. In addition, we paid the collateral agent an initial fee of $5,000 and have agreed to pay an administrative fee to the collateral agent of 0.5% per month of the daily balance during the preceding month or $500 whichever is less. In the event that of a prepayment, we are obligated to pay a prepayment fee in an amount equal to one-half of one percent (0.5%) of $500,000. On September 30, 2013, we requested and received an initial borrowing under the Agreement totaling $350,000. Subsequently, on October 21, 2013, we requested and received an additional $100,000 and on November 20, 2013, we requested and received an additional $50,000. As of December 31, 2014, the balance outstanding under our line of credit was $500,000. On February 27, 2015, we agreed to extend the term of the agreement for one year, and to exchange the $500,000 plus interest owing under the agreement for a one year, 8%, convertible note. We are no longer able to make borrowings under the line of credit agreement. Cash and Cash Equivalents We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments. As of December 31, 2014 and 2013, we had no cash equivalents. Accounts Receivable Accounts receivable consist of trade receivables. We regularly evaluate the collectability of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information. Inventory Inventory is stated at the lower of cost (on an average basis) or market value. We determine cost based on the weighted-average purchase price and include both the costs of acquisition and the shipping costs in inventory. We regularly review the cost of inventory against its estimated market value and record a lower of cost or market write-down to cost of goods sold, if any inventory has a cost in excess of estimated market value. Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided for using the straight-line method over the estimated useful lives of the respective assets. Estimated useful lives are as follows: Category Useful Lives (years) Office Equipment 2 - 5 Vehicles 3 - 5 Leasehold Improvements 2 Maintenance and repairs are expensed as incurred. Expenditures for significant renewals or betterments are capitalized. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in current operations. Long-Lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of a long-lived asset may not be recoverable. We periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful lives of our long-lived assets or whether the remaining balance of long-lived assets should be evaluated for possible impairment. We do not believe that there were any indicators of impairment that would require an adjustment to such assets or their estimated periods of recovery at December 31, 2014 and 2013. Patent Costs We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 10 years as of December 31, 2014, are reasonable. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time. Costs associated with patents currently held are approximately $1.1 million, net of approximately $314,000 of accumulated amortization, are included in patents, net as of December 31, 2014, and are being amortized over the estimated useful life, which was determined to be seventeen years. Amortization expense of patents was approximately $113,000 in each of the years ended December 31, 2014 and 2013. Estimated amortization expense of patents for the five years subsequent to December 31, 2013, is approximately $113,000 per year. Capitalized filing fees associated with obtaining new patents not yet issued and defense of existing patents (not yet resolved) of approximately $141,000 are included in other assets as December 31, 2014. Discontinued Operations Discontinued operations are presented and accounted for in accordance with Accounting Standards Codification (ASC) 360, “ Impairment or Disposal of Long-Lived Assets,” On September 10, 2010, we announced that we were exiting the solar panel installation business. The exit from the installation business was essentially completed at the end of the fourth quarter of 2010. The exit from the installation business was therefore classified as discontinued operations for all periods presented under the requirements of ASC 360. We re-entered the residential and commercial installation business in the fourth quarter 2014. As a result of re-entering the installation business, we reclassified our discontinued operations into continuing operations. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Manufacturer and Installation Warranties The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $371,000 as of December 31, 2014 and $345,000 as of December 31, 2013, is included within “Accrued warranty” in the accompanying consolidated balance sheets. The liability for our manufacturing warranty consists of the following: Years Ended 2014 2013 Beginning accrued warranty balance $ 1,312,918 $ 1,372,342 Reduction for labor payments and claims made under the warranty (75,966 ) (79,134 ) Accruals related to warranties issued during the period 25,863 19,710 Adjustment to warranty liability for discontinued operations (324,349 ) — Ending accrued warranty balance $ 938,466 $ 1,312,918 We previously recorded a provision for warranty liability related to our discontinued installation operations. We provided for a 5-year or a 10-year warranty on the installation of a system and all equipment and incidental supplies other than solar panels and inverters that are covered under the manufacturer warranty. During the year ended December 31, 2014, we re-evaluated our warranty liability related to our discontinued installation operations right before and in conjunction with re-entering the installation operations, we reduced the liability by approximately $324,000. This reduction to the liabilities for discontinued operations was recorded as a gain from operations of discontinued operations. The remaining warranty liability related to our previously discontinued operations was reclassified into current liabilities and has been included in “Accrued warranty.” Defective solar panels or inverters are covered under the manufacturer warranty. In the event that a panel or inverter needs to be replaced, we will replace the defective item within the manufacturer’s warranty period (between 5-25 years). Fair Value of Financial Instruments The carrying values reported for cash equivalents, accounts receivable, accounts payable, accrued liabilities and the outstanding credit facility approximated their respective fair values at each balance sheet date due to the short-term maturity of these financial instruments. Revenue Recognition Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer. Revenue from installation of a system is recognized when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sales price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. In general, we recognize revenue upon completion of a system installation for residential installations and we recognize revenue under the percentage-of-completion method for commercial installations. Revenue recognition methods for revenue streams that fall under other categories are determined based on facts and circumstances. Stock-based Compensation We apply the fair value method under Accounting Standards Codification (ASC) 718 in accounting for our 2001 Stock Option Plan and our 2006 Stock Incentive Plan. Under ASC 718, compensation cost is measured at the grant date based on the fair value of the equity instruments awarded and is recognized over the period during which an employee is required to provide service in exchange for the award, or the requisite service period, which is usually the vesting period. The fair value of the equity award granted is estimated on the date of the grant. Advertising We expense advertising costs as incurred. Advertising expense, included in “Sales and marketing expenses,” for the years ended December 31, 2014 and 2013, was approximately $15,000 and $16,000, respectively. Research and Development Costs Research and development expenses, which include the cost of activities that are useful in developing new products, processes or techniques, as well as expenses for activities that may significantly improve existing products or processes are expensed as incurred. In the years ended December 31, 2014 and 2013, we expensed approximately $178,000 and $243,000, respectively, in costs related to research and development activities that are included under general and administrative expenses on the consolidated statements of operations. Shipping and Handling Costs Shipping and handling costs associated with inbound freight are included in cost of inventory and expensed as cost of goods sold when the related inventory is sold. Income Taxes Deferred income taxes arise from timing differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. A deferred tax asset valuation allowance is recorded when it is more likely than not that deferred tax assets will not be realized. Utilization of net operating loss carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carryforwards before utilization. We apply the provisions of ASC 740, formerly FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” Earnings Per Share We follow Accounting Standards Codification (ASC) 260 (ASC 260), “ Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities ” In accordance with the Staff Position, basic net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the weighted average number of shares outstanding less the weighted average unvested restricted shares outstanding. Diluted net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the denominator for basic net income (loss) per share and any dilutive effects of stock options, restricted stock, convertible notes and warrants. The following table sets forth the computation of basic and diluted net loss per share: Year Ended December 31, 2014 2013 Basic: Numerator: Net loss $ (1,852,301 ) $ (2,830,047 ) Preferred deemed dividend and preferred stock dividend (18,927 ) (1,028,609 ) Less: Net loss allocated to participating securities 6,005 12,503 $ (1,865,223 ) $ (3,846,153 ) Denominator: Weighted-average shares outstanding 204,471,018 69,477,915 Weighted-average unvested restricted shares outstanding (656,121 ) (306,958 ) Denominator for basic net loss per share 203,814,897 69,170,957 Basic net loss per share attributable to common stockholders $ (0.01 ) $ (0.06 ) The following table sets forth potential shares of common stock at the end of each period presented that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive: December 31, 2014 December 31, 2013 Stock options outstanding 37,034,483 5,368,233 Unvested restricted stock 7,186 1,890,952 Warrants to purchase common stock 22,148,045 9,648,045 Preferred stock convertible into common stock — 68,353,582 Segment Reporting Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. We are engaged in two business segments; (i) we sell our AC solar panels to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets, and (ii) we market, sell, design and install systems for residential and commercial customers. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. We re-entered the residential and commercial installation business in the fourth quarter 2014, and we do not report separate segment information because these sales are not material for the year ended December 31, 2014. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Andalay Solar and Fairview, pursuant to the Merger as described in Note 1. We also have two wholly-owned subsidiaries as of December 31, 2014 and 2013. Akeena Corp. is a wholly-owned subsidiaries of Andalay Solar, Inc. All inter-company accounts have been eliminated in consolidation. Recent Accounting Pronouncements In April 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" (ASU 2014-08). ASU 2014-08 changes the criteria for reporting discontinued operations by requiring that in order for a disposal to qualify as a discontinued operation, the disposal must represent a strategic shift that has (or will have) a major effect on the entity's operations and financial results. ASU 2014-08 also requires additional disclosures both for discontinued operations and individually significant components of an entity that do not qualify as discontinued operations. ASU 2014-08 is effective for annual and interim periods beginning on or after December 15, 2014, with early adoption permitted. We adopted the provisions of ASU 2014-08 and such adoption did not have a material impact on our consolidated financial statements. In May 2014, as part of its ongoing efforts to assist in the convergence of U.S. GAAP and International Financial Reporting Standards (“IFRS”), the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” The new guidance sets forth a new five-step revenue recognition model which replaces the prior revenue recognition guidance in its entirety and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the new standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance. The ASU provides alternative methods of initial adoption and is effective for annual and interim periods beginning after December 15, 2016. We are currently evaluating the impact that this standard will have on our consolidated financial statements. In June 2014, the FASB issued ASU No. 2014-12, "Compensation – Stock Compensation: Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved After a Requisite Service Period" ("ASU 2014-12") Companies commonly issue share-based payment awards that require a specific performance target to be achieved in order for employees to become eligible to vest in the awards. ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period should be treated as a performance condition. The performance target should not be reflected in estimating the grant date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 will be effective for the Company's fiscal years beginning fiscal 2016 and interim reporting periods within that year, using either the retrospective or prospective transition method. Early adoption is permitted. We are currently evaluating the effect of the adoption of this guidance on the condensed consolidated financial statements. In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" ("ASU 2014-15"), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Since ASU 2014-15 only impacts financial statement disclosure requirements regarding whether there is substantial doubt about an entity's ability to continue as a going concern, we do not expect its adoption to have an impact on our consolidated financial statements.

Note 3 - Discontinued Operation

Note 3 - Discontinued Operations	12 Months Ended
	Dec. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	3. Discontinued Operations On September 10, 2010, we announced that we were exiting the solar panel installation business and we were expanding our distribution business to include sales of our Andalay Solar Power Systems directly to dealers in California. The exit from the installation business was essentially completed by the end of 2010. As a result of the decision to exit the California installation business we recorded a restructuring charge totaling approximately $3.0 million for the year ended December 31, 2010, the majority of which were non-cash charges. This restructuring charge was comprised primarily of (i) one-time severance costs of $765,000 related to headcount reductions paid primarily in shares of our common stock, (ii) inventory write downs of $948,000, (iii) lease accelerations and the write off of leasehold improvements of $307,000, (iv) goodwill impairment of $299,000, (v) vehicle, furniture and fixtures and computer equipment write downs of $290,000 and (vi) other prepaid costs write-downs of $367,000. During the year ended December 31, 2010, we recorded a loss from discontinued operations of $6.5 million. During the year ended December 31, 2014, we re-evaluated our warranty liability related to our discontinued installation operations right before and in conjunction with re-entering the installation operations, and reduced the liability by approximately $324,000. This reduction to the liabilities for discontinued operations was recorded as a gain from operations of discontinued operations. The remaining warranty liability related to our previously discontinued operations was reclassified into current liabilities and has been included in “Accrued warranty.” We entered into a Supply and Warranty Agreement and Master Assignment Agreement with Real Goods Solar, Inc. (Real Goods), pursuant to which Real Goods has agreed to perform certain warranty work. The terms of the agreement provide that an escrow account be established as a source of funds from which to satisfy our obligation to pay Real Goods for its fees and reimburse it for its expenses for this warranty work. In March 2011, we entered into an Escrow Agreement with Real Goods and deposited $200,000 into an escrow account. The amount is reflected in other assets in the consolidated balance sheets. The escrow deposit will be released to us in the amount of $40,000, or one-fifth of the remaining escrow funds, per year after each of the fifth through the ninth anniversary of the escrow agreement. In December 2014, $110,000 of the funds in escrow were returned by Real Goods.

Note 4 - Accounts Receivable

Note 4 - Accounts Receivable	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	5 . Accounts Receivable Accounts receivable consists of the following: March 31, 2015 December 31, 2014 Trade accounts $ 104,005 $ 154,172 Less: Allowance for bad debts (21,972 ) (24,882 ) Less: Allowance for returns (19,647 ) (10,834 ) $ 62,386 $ 118,456 The following table summarizes the allowance for doubtful accounts as of March 31, 2015 and December 31, 2014: Balance as of Beginning of Period Provisions, net Write-Off/ Recovery Balance as of End of Period Three months ended March 31, 2015 $ 24,882 $ 2,909 $ 5,819 $ 21,972 Year ended December 31, 2014 $ 2,899 $ 36,763 $ (14,780 ) $ 24,882	4. Accounts Receivable Accounts receivable consists of the following: December 31, 2014 December 31, 2013 Trade accounts $ 154,172 $ 575,375 Less: Allowance for bad debts (24,882 ) (2,899 ) Less: Allowance for returns (10,834 ) (4,953 ) $ 118,456 $ 567,523 The following table summarizes the allowance for doubtful accounts as of December 31, 2014 and 2013: Balance as of Beginning of Period Provisions, net Write-Off Balance as of End of Period Year ended December 31, 2014 $ 2,899 $ 36,763 $ (14,780 ) $ 24,882 Year ended December 31, 2013 $ 108,750 $ 92,224 $ (198,075 ) $ 2,899

Note 5 - Inventory

Note 5 - Inventory	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	6 . Inventory Inventory consists of the following: March 31, 2015 December 31, 2014 Finished goods $ 631,616 $ 669,706 Work in process 70,329 58,666 $ 701,945 $ 728,372 Inventory is stated at the lower of cost (on an average basis) or market value. We determine cost based on our weighted-average purchase price and include both the costs of acquisition and the shipping costs in our inventory. We regularly review the cost of inventory against its estimated market value and record a lower of cost or market write-down to cost of goods sold, if any inventory has a cost in excess of estimated market value. We did not record a write-down of inventory during the three months ended March 31, 2015.	5. Inventory Inventory consists of the following: December 31, 2014 December 31, 2013 Finished goods $ 669,706 $ 654,970 Work in process 58,666 131,666 $ 728,372 $ 786,636

Note 6 - Prepaid Expenses and O

Note 6 - Prepaid Expenses and Other Current Assets	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Other Current Assets [Text Block]	4. Other Assets We entered into a Supply and Warranty Agreement and Master Assignment Agreement with Real Goods Solar, Inc. (“Real Goods”), pursuant to which Real Goods has agreed to perform certain warranty work. The terms of the agreement provide that an escrow account be established as a source of funds from which to satisfy our obligation to pay Real Goods for its fees and reimburse it for its expenses for this warranty work. In March 2011, we entered into an Escrow Agreement with Real Goods and deposited $200,000 into an escrow account. In accordance to the Escrow Agreement, the escrow deposit will be released to us in the amount of $40,000, or one-fifth of the remaining escrow funds, per year after each of the fifth through the ninth anniversary of the escrow agreement, although we believe that the amount may be redeemed earlier. In December 2014, $110,000 of the funds in escrow were returned by Real Goods. As of March 31, 2015, there was $90,000 remaining in escrow, which is included under “Other assets, net” in our condensed consolidated balance sheets.	6. Prepaid expenses and other current assets Prepaid expenses and other current assets consist of the following: December 31, 2014 December 31, 2013 Prepaid insurance $ 116,243 $ 152,812 Prepaid - other 46,471 68,906 Vendor deposits 117,352 95,792 $ 280,066 $ 317,510

Note 7 - Property and Equipment

Note 7 - Property and Equipment, Net	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	7 . Property and Equipment, Net Property and equipment, net consist of the following: March 31, 2015 December 31, 2014 Office equipment $ 436,051 $ 436,051 Leasehold improvements 123,278 123,278 Vehicles 17,992 17,992 577,321 577,321 Less: Accumulated depreciation and amortization (576,971 ) (576,622 ) $ 350 $ 699 Depreciation expense for the three months ended March 31, 2015 and 2014 was $ and $4,920, respectively.	7 . Property and Equipment, Net Property and equipment, net consist of the following: December 31, 2014 December 31, 2013 Office equipment $ 436,051 $ 436,051 Leasehold improvements 123,278 123,278 Vehicles 17,992 17,992 577,321 577,321 Less: Accumulated depreciation and amortization (576,622 ) (563,467 ) $ 699 $ 13,854 Depreciation expense for the years ended December 31, 2014 and 2013 was approximately $13,155 and $33,000, respectively. Depreciation expense related to leasehold improvements and equipment in our warehouse is allocated to cost of goods sold. All other depreciation is included in general and administrative expense.

Note 8 - Accrued Liabilities

Note 8 - Accrued Liabilities	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	8 . Accrued Liabilities Accrued liabilities consist of the following: March 31, 2015 December 31, 2014 Accrued salaries, wages, benefits and bonus $ 63,876 $ 45,586 Sales tax payable 3,646 662 Accrued accounting and legal fees 61,050 — Customer deposit payable 33,604 41,265 Accrued interest 22,256 5,683 Other accrued liabilities 20,361 11,033 $ 204,793 $ 104,229	8 . Accrued Liabilities Accrued liabilities consist of the following: December 31, 2014 December 31, 2013 Accrued salaries, wages, benefits and bonus $ 45,586 $ 45,456 Sales tax payable 662 4,409 Customer deposit payable 41,265 580 Accrued interest 5,683 6,288 Other accrued liabilities 11,033 32,997 $ 104,229 $ 89,730

Note 9 - Convertible Notes Paya

Note 9 - Convertible Notes Payable and Credit Facility	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	9 . Convertible Note s Payable and Credit Facility Convertible Note s P ayable On August 30, 2013, we entered into a securities purchase agreement with Alpha Capital Anstalt (“Alpha Capital”) relating to the sale and issuance of a convertible note in the principal amount of $200,000 that matures August 29, 2015 (the "Convertible Note"). Subsequently, on November 25, 2013 and December 19, 2013, we entered into additional securities purchase agreements with Alpha Capital relating to the sale and issuance of convertible notes in the principal amount of $200,000 and $250,000, respectively, which mature on November 25, 2015 and December 19, 2015. On January 27, 2014, we issued a convertible note in the principal amount of $100,000 that matures on January 27, 2016 under the Securities Purchase Agreement we entered into with Alpha Capital on December 19, 2013. In connection with the issuance of the December 19, 2013 convertible note, we also issued 6,250,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On February 25, 2014, we entered into a securities purchase agreement with a certain institutional accredited investor relating to the sale and issuance of a (i) convertible note in the principal amount of $200,000 that matures February 25, 2016 and (ii) five-year warrant (with a cashless exercise feature under certain circumstances) to purchase 5,000,000 shares of our common stock at an exercise price of $0.02 per share, subject to adjustment under certain circumstances. On March 18, 2014, we issued under the Securities Purchase Agreement we entered into with the institutional investor on February 25, 2014 a (i) convertible note in the principal amount of $300,000 that matures March 18, 2016 and (ii) five–year warrant (with a cashless exercise feature under certain circumstances) to purchase 7,500,000 shares of our common stock at an exercise price of $0.02 per share, subject to adjustment under certain circumstances. The convertible notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. During the three months ended March 31, 2015, the remaining outstanding convertible notes in the principal amount of approximately $520,000, along with accrued interest of $47,134, net of unamortized discount at date of conversion, were converted into 34,565,577 shares of our common stock. Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to the embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the three months ended March 31, 2015 of approximately $41,000 on a total of three convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. Line of C redit On September 30, 2013, we entered into a loan and security agreement (the “Loan Agreement”) with Alpha Capital Anstalt (“Alpha Capital”) and Collateral Services, LLC to provide financing, on a discretionary basis, for one year, against our accounts receivable and inventory. The maximum amount that could be borrowed under the Loan Agreement was $500,000. We had the right to borrow up to 80% of our eligible accounts receivable, not in excess of $200,000, 50% of the value of our raw materials in inventory, 65% of our finished goods inventory and 95% of cash, but not in the aggregate amount in excess of $300,000. The advances were secured by a lien on all of our assets. All advances under the Loan Agreement bear interest at a per annum rate of 12% and monthly interest shall be a minimum of $500. At the time of initial funding we paid a loan fee of 50 shares of our Series D Preferred Shares to the lender, in addition to other payments for legal fees. In addition, we paid the collateral agent an initial fee of $5,000 and have agreed to pay an administrative fee to the collateral agent of 0.5% per month of the daily balance during the preceding month or $500 whichever is less. In the event that of a prepayment, we are obligated to pay a prepayment fee in an amount equal to one-half of one percent (0.5%) of $500,000. On September 30, 2013, we requested and received an initial borrowing under the Loan Agreement totaling $350,000. Subsequently, on October 21, 2013, we requested and received an additional $100,000 and on November 20, 2013, we requested and received an additional $50,000. As of December 31, 2014, the balance outstanding under our line of credit was $500,000. On February 27, 2015, we agreed to extend the term of the Loan Agreement for one year, and to exchange the $500,000 plus interest owing under the Loan Agreement for a one year, 8%, convertible note. As of March 31, 2015, a $500,000 convertible note, along with $10,000 in accrued interest, was outstanding. We are no longer able to make borrowings under the Loan Agreement. The convertible note is convertible at $0.01 per share of common stock. On the date we issued the convertible note to Alpha Capital, our stock price was $0.0155 per share of common stock. As a result of the difference between the stock price at the time of issuance and the conversion price, we recorded a beneficial conversion feature in the amount of $275,000 as a reduction to the Convertible Note and an increase in additional paid in capital on our condensed consolidated balance sheets. The beneficial conversion feature is being amortized over the 12 month term of the Note. We recorded additional interest expense of approximately $23,000 during the three months ended March 31, 2015 related to the beneficial conversion feature.	9 . Convertible Note s Payable and Credit Facility Convertible Note s payable On August 30, 2013, we entered into a securities purchase agreement with Alpha Capital Anstalt (“Alpha Capital”) relating to the sale and issuance of a convertible note in the principal amount of $200,000 that matures August 29, 2015 (the "Convertible Note"). Subsequently, on November 25, 2013 and December 19, 2013, we entered into additional securities purchase agreements with Alpha Capital relating to the sale and issuance of convertible notes in the principal amount of $200,000 and $250,000, respectively, which mature on November 25, 2015 and December 19, 2015. On January 27, 2014, we issued a convertible note in the principal amount of $100,000 that matures January 27, 2016 under the Securities Purchase Agreement we entered into with Alpha Capital on December 19, 2013. In connection with the issuance of the December 19, 2013 convertible note, we also issued 6,250,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On February 25, 2014, we entered into a Securities Purchase Agreement with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $200,000 that matures February 25, 2016. In connection with the issuance of the February 25, 2014 convertible note, we issued 5,000,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On March 18, 2014, we entered into a Securities Purchase Agreement we entered into with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $300,000 that matures March 18, 2016. In connection with the March 18, 2014 convertible note, we issued a five–year warrant to purchase 7,500,000 shares of our common stock at an exercise price of $0.02 per share. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. Subject to our fulfilling certain conditions, including beneficial ownership limits, the convertible notes are subject to a mandatory conversion if the closing price of our common stock for any 20 consecutive days commencing six months after the issue date of the convertible notes equal or exceeds $0.04. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. As of December 31, 2014, convertible notes in the principal amount of $940,000, along with accrued interest of $68,319, were converted into 50,439,751 shares of our common stock. We have the option of repaying the outstanding principal amount of the convertible notes, in whole or in part, by paying the purchaser a sum of money equal to one hundred and twenty percent (120%) of the principal together with accrued but unpaid interest upon 30 days’ notice, subject to certain beneficial ownership limits. For so long as we have any obligation under the convertible notes, we have agreed to certain restrictions regarding, among other things, incurrence of additional debt, liens, amendments to charter documents, repurchase of stock, payment of cash dividends, affiliated transactions. We are also prohibited from entering into certain variable priced agreements until the convertible notes are repaid in full, except for the Equity Line we have with Southridge. Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the year ended December 31, 2014 of $51,000 on a total of six convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. Below is a table showing the convertible notes payable, the derivative liability and fair value of the warrants as of December 31, 2014 and 2013: December 31, 2014 December 31, 2013 Convertible notes payable $ 520,000 $ 650,000 Convertible notes payable issued for financial advisory services 10,000 60,000 Less: Derivative liability (93,376 ) (243,889 ) Less: Relative fair value of warrants (170,767 ) (53,623 ) Accreted interest 79,358 21,889 Accrued interest 28,284 7,707 Convertible notes payable, net 373,499 442,084 Less current portion (30,000 ) (60,000 ) $ 343,499 $ 382,084 Line of credit On September 30, 2013, we entered into a loan and security agreement with Alpha Capital Anstalt and Collateral Services, LLC to provide financing, on a discretionary basis, for one year, against our accounts receivable and inventory. The maximum amount that could be borrowed under the Agreement is $500,000. We had the right to borrow up to 80% of our eligible accounts receivable, not in excess of $200,000, 50% of the value of our raw materials in inventory, 65% of our finished goods inventory and 95% of cash, but not in the aggregate amount in excess of $300,000. The advances were secured by a lien on all of our assets. All advances under the agreement bear interest at a per annum rate of 12% and monthly interest shall be a minimum of $500. At the time of initial funding we paid a loan fee of 50 shares of our Series D Preferred Shares to the lender, in addition to other payments for legal fees. In addition, we paid the collateral agent an initial fee of $5,000 and have agreed to pay an administrative fee to the collateral agent of 0.5% per month of the daily balance during the preceding month or $500 whichever is less. In the event that of a prepayment, we are obligated to pay a prepayment fee in an amount equal to one-half of one percent (0.5%) of $500,000. On September 30, 2013, we requested and received an initial borrowing under the Agreement totaling $350,000. Subsequently, on October 21, 2013, we requested and received an additional $100,000 and on November 20, 2013, we requested and received an additional $50,000. As of December 31, 2014, the balance outstanding under our line of credit was $500,000. On February 27, 2015, we agreed to extend the term of the agreement for one year, and to exchange the $500,000 plus interest owing under the agreement for a one year, 8%, convertible note. We are no longer able to make borrowings under the agreement.

Note 10 - Long-term Debt

Note 10 - Long-term Debt	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	10 . Long-term Debt Long-term debt Our long-term debt consists of three convertible notes amounting to an aggregate principal amount of $500,000, and are scheduled to mature in 2016.

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	10 . Stockholders’ Deficit We have 501,000,000 shares of capital stock authorized under our certificate of incorporation, consisting of 500,000,000 shares of common stock and 1,000,000 shares of preferred stock. As of September 30, 2014, we have authorized (i) 2,000 shares of Series A Convertible Preferred Stock, par value $0.001, (ii) 4,000 shares of Series B 4% Convertible Preferred Stock, par value $0.001, (iii) 1,175 shares of our Series C 8% Convertible Preferred Stock, par value $0.001, and (iv) 1,180 shares of our Series D 8% Convertible Preferred Stock, par value $0.001. All preferred stock has been converted or cancelled and none remain outstanding On March 11, 2014, we filed a Registration Statement on Form S-1/A to register 35 million shares of common stock related to our Equity Purchase Agreement with Southridge and on March 21, 2014, the Securities and Exchange Commission declared the Registration Statement effective. On March 26, 2014, we submitted an initial take-down request of $300,000 to Southridge pursuant to the terms of the Equity Purchase Agreement of which partial proceeds of $100,000 was received on March 31, 2014 and $200,000 on April 16, 2014. On April 17, 2014, we issued 8,079,800 shares of our common stock in a Section 3(a) (10) proceeding that generated proceeds in the amount of $250,000 in full settlement of a claim (see Note 17. Commitments and Contingencies). On June 4, 2014, June 18, 2014 and July 8, 2014, we submitted additional take-down requests for $100,000, $100,000 and $125,000, respectively, pursuant to the terms of the Equity Purchase Agreement. We issued a total of 31,760,578 shares of our common stock at an average price of $0.02 per share pursuant to the terms of the Equity Purchase Agreement. We have approximately 3.2 million shares remaining under our effective Form S-1 and available pursuant to the terms of our Equity Purchase Agreement following our take-downs through August 11, 2014. Pursuant to the terms of our Equity Purchase Agreement, a placement fee of one million shares of unregistered common stock was due to Southridge pursuant to the terms of the Equity Purchase Agreement. As of March 31, 2014, we issued 500,000 shares of unregistered common stock due upon the declaration of effectiveness of our Form S-1/A by the Securities and Exchange Commission of our Form S-1/A. In April 2014, we issued the remaining 500,000 shares of unregistered common stock to Southridge upon the completion of our initial take-down request under the Equity Purchase Agreement. The sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a) (2) of the Securities Act as transactions by an issuer not involving any public offering. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. On December 10, 2014, we entered into the December Equity Purchase Agreement with Southridge, that superseded our Prior Equity Purchase Agreement with Southridge that was entered into on January 23, 2014. The terms of the December Equity Purchase Agreement are substantially similar to those of the Prior Equity Purchase Agreement. Pursuant to the December Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the December Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. We submitted various take-down requests during the first quarter of 2015 pursuant to the terms of the December Equity Purchase Agreement. As of May 12, 2015, 67,813,489 shares had been sold at an average price of $0.0137 per share, resulting in total proceeds of approximately $929,000. Pursuant to the terms of the December Equity Purchase Agreement we agreed to pay Southridge a commitment fee of 1,000,000 shares of our common stock, of which 500,000 shares of our common stock were due to Southridge on January 16, 2015, the date that the registration statement was declared effective and the remaining 500,000 shares of common stock were due on January 20, 2015, the date that we delivered our first Draw Down Notice to Southridge. We valued the issuance of these shares based on the closing price of the stock as of January 16, 2015, $0.0169 for 500,000, and as of January 20, 2015, $0.0161 for 500,000, and we recorded $16,500 as a reduction in “Additional Paid In Capital” on our condensed consolidated balance sheets.	11. Stockholders’ Equity We have 501,000,000 shares of capital stock authorized under our certificate of incorporation, consisting of 500,000,000 shares of common stock and 1,000,000 shares of preferred stock. As of September 30, 2014, we have authorized (i) 2,000 shares of Series A Convertible Preferred Stock, par value $0.001, (ii) 4,000 shares of Series B 4% Convertible Preferred Stock, par value $0.001, (iii) 1,175 shares of our Series C 8% Convertible Preferred Stock, par value $0.001, and (iv) 1,180 shares of our Series D 8% Convertible Preferred Stock, par value $0.001. All preferred stock has been converted or cancelled and none remain outstanding On March 11, 2014, we filed a Registration Statement on Form S-1/A to register 35 million shares of common stock related to our Prior Equity Purchase Agreement with Southridge and on March 21, 2014, the Securities and Exchange Commission declared the Registration Statement effective. On March 26, 2014, we submitted an initial take-down request of $300,000 to Southridge pursuant to the terms of the Prior Equity Purchase Agreement and issued 12,541,806 shares of our common stock, of which partial proceeds of $100,000 was received on March 31, 2014 and $200,000 was received on April 16, 2014. On April 17, 2014, we issued 8,079,800 shares of our common stock in a Section 3(a) (10) proceeding that generated proceeds in the amount of $250,000 in full settlement of a claim (see Note 17. Commitments and Contingencies). On June 4, 2014, June 18, 2014, July 8, 2014, and October 25, 2014, we submitted additional take-down requests for $100,000, $100,000, $125,000, and approximately $52,000 respectively, pursuant to the terms of the Prior Equity Purchase Agreement. We issued a total of 44,079,800 shares of our common stock at an average price of $0.02 per share pursuant to the terms of the Prior Equity Purchase Agreement. Pursuant to the terms of our Equity Purchase Agreement, a placement fee of 1 million shares of unregistered common stock was due to Southridge pursuant to the terms of the Equity Purchase Agreement. During March 2014, we issued 500,000 shares of unregistered common stock due upon the declaration of effectiveness of our Form S-1/A by the Securities and Exchange Commission of our Form S-1/A. In April 2014, we issued the remaining 500,000 shares of unregistered common stock to Southridge upon the completion of our initial take-down request under the Prior Equity Purchase Agreement. On December 10, 2014, we entered into the December Equity Purchase Agreement with Southridge, that superseded our Prior Equity Purchase Agreement with Southridge that was entered into on January 23, 2014. The terms of the December Equity Purchase Agreement are substantially similar to those of the Prior Equity Purchase Agreement. Pursuant to the December Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the December Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. Pursuant to the terms of the December Equity Purchase Agreement we agreed to pay Southridge a commitment fee of 1,000,000 shares of our common stock (having a value of $17,900 based upon the closing price of our common stock on December 5, 2014), of which 500,000 shares of our common stock were issued to Southridge on the date that the registration statement was declared effective, January 16, 2015, and the remaining 500,000 shares of common stock were issued on the date that we delivered our first Draw Down Notice to Southridge. On December 10, 2014, we also entered into a Registration Rights Agreement with Southridge pursuant to which we agreed to register shares of the common stock to be issued to Southridge in connection with the December Equity Purchase Agreement. See Note 14 for a discussion of the accounting treatment of the stock warrant transactions discussed above.

Note 12 - Convertible Redeemabl

Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend	12 Months Ended
	Dec. 31, 2014
Convertible Redeemable Preferred Stock And Preferred Deemed Dividend [Abstract]
Convertible Redeemable Preferred Stock And Preferred Deemed Dividend [Text Block]	1 2 . Convertible Redeemable Preferred Stock and Preferred Deemed Dividend On January 24, 2013, we provided to the purchasers of our Series C Preferred Stock a draw down notice under the Purchase Agreement. The purchasers agreed to accept the new draw down notice and thereby extend our right to exercise a “put” to sell additional Series C Preferred beyond the securities purchase agreement’s prior expiration date of December 31, 2012. As a result of the draw down, we sold an aggregate of 75 additional shares of Series C Preferred to the purchasers for aggregate proceeds of $75,000. Based on the closing price of our common stock as reported on the OTCQB Marketplace on January 24, 2013 (which was $0.05 per share), the 75 shares of Series C Preferred to be issued pursuant to the draw down would be convertible into 1,500,000 shares of our common stock. As a result of the contingent conversion feature on the Series C Preferred, which reduced the conversion price from $0.08 to $0.05 per share on the total 720 shares of Series C Preferred Stock issued and outstanding at January 24, 2013, and which resulted in an increase in the number of common shares issuable, we recognized additional preferred deemed dividends of $270,000. As a result of the January 24, 2013 draw down notice, the conversion price of the Series C Preferred issued under the initial closing was reduced from $0.08 per share of common stock to become equal to $0.05. As a result of the May 13, 2013 draw down notice, the conversion price of the Series C Preferred was further reduced from $0.05 per share of common stock to $0.03 per share. As a result of our August 30, 2013 financing, the conversion price of the Series C Preferred was further reduced from $0.03 per share of common stock to $0.02 per share. On February 15, 2013, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale and issuance of up to 1,180 shares of our newly created Series D Preferred Stock at a price per share equal to the stated value, which is $1,000 per share, for aggregate proceeds of up to $1,000,000. At the initial closing, concurrent with entering the agreement, we issued 150 shares of Series D Preferred, for initial aggregate proceeds of $150,000. After the initial closing, the securities purchase agreement permits the purchaser to exercise a “call” right to purchase additional Series D Preferred in multiple draw downs from time to time until December 31, 2013, subject to certain limits, terms and conditions. In March 2013, the Company and investors entered into a letter agreement to the securities purchase agreement dated as of February 15, 2013, modifying the number of shares of Series D Preferred Stock to be issued upon settlement of any purchaser draw downs made on or after March 18, 2013, equal to the purchaser investment amount divided by the stated value multiplied by a number agreed upon by the Company and the purchaser, which shall not be higher than $1.67. Subsequently, on March 21, 2013, we issued 167 shares of Series D Preferred for aggregate proceeds of $100,000. On May 13, 2013, the Company and investors entered into a letter agreement amendment to the securities purchase agreement dated as of February 15, 2013, modifying the number of shares of Series D Preferred Stock that may be issued upon draw downs made on or after May 13, 2013, equal to the purchaser investment amount divided by the stated value multiplied by a number agreed upon by the Company and the purchaser, which shall not be higher than $3.34. The corresponding conversion price into underlying shares of our common stock was $0.03 per share. On May 13, 2013, we issued 583 shares of Series D Preferred to an investor for aggregate proceeds of $175,000. As a result of the contingent conversion feature on the Series C Preferred, which reduced the conversion price from $0.05 to $0.03 per share on the total 260 shares of Series C Preferred Stock issued and outstanding as of May 13, 2013, and which resulted in an increase in the number of common shares issuable, we recognized additional preferred deemed dividends of $104,000. On August 30, 2013, we entered into an agreement to sell $200,000 in convertible notes. As a result of the sale of these convertible notes and as a result of the contingent conversion feature on the Series C Preferred and Series D Preferred, which reduced the conversion price from $0.03 to $0.02 per share on the Series C and from $0.10 to $0.02 per share on the Series D on the total 147 shares and 930 shares, respectively, of Series C Preferred Stock and Series D Preferred Stock issued and outstanding as of August 30, 2013, and which resulted in an increase in the number of common shares issuable, we recognized additional preferred deemed dividends of $36,000 on the Series C Preferred Stock and $465,000 on the Series D Preferred Stock. The net loss attributable to common shareholders reflects both the net loss and the deemed dividend. As a result of the $500,000 loan and security agreement entered into on September 30, 2013, we issued to the lender 50 shares of our Series D Preferred stock for the $50,000 loan origination fee. During the year ended December 31, 2014, the remaining 467 shares of Series B Preferred Stock were converted into 21,020,015 shares of common stock, the remaining 87 shares of Series C Preferred Stock were converted into 4,333,350 shares of common stock and the remaining 860 shares of Series D Preferred Stock were converted into 43,000,000 shares of common stock. See Note 12 for a discussion of the accounting treatment of the stock warrant transactions described above.

Note 13 - Stock Option and Ince

Note 13 - Stock Option and Incentive Plan	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	1 1 . Stock Option Plan and Stock Incentive Plan On August 8, 2006, we adopted the Akeena Solar, Inc. 2006 Stock Incentive Plan (the “Stock Plan”) pursuant to which shares of common stock are available for issuance to employees, directors and consultants under the Stock Plan as restricted stock and/or options to purchase common stock. The Stock Plan allows for issuance of up to 50,000,000 shares and there were 45,593,221 shares available for issuance under the Stock Plan as of March 31, 2015. Restricted stock and options to purchase common stock may be issued under the Stock Plan. The restriction period on restricted stock grants generally expires at a rate of 25% per year over four years, unless decided otherwise by our Compensation Committee. Options to purchase common stock generally vest and become exercisable as to one-third of the total amount of shares subject to the option on each of the first, second and third anniversaries from the date of grant. Options to purchase common stock generally have a 5-year term. We use the Black-Scholes-Merton Options Pricing Model (“Black-Scholes”) to estimate fair value of our employee and our non-employee director stock-based awards. Black-Scholes requires various judgmental assumptions, including estimating stock price volatility, expected option life and forfeiture rates. If we had made different assumptions, the amount of our deferred stock-based compensation, stock-based compensation expense, gross margin, net loss and net loss per share amounts could have been significantly different. We believe that we have used reasonable methodologies, approaches and assumptions to determine the fair value of our common stock, and that our deferred stock-based compensation and related amortization were recorded properly for accounting purposes. If any of the assumptions we used change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. We measure compensation expense for non-employee stock-based compensation under ASC 505-50, “Equity-Based Payments to Non-Employees.” We recognized stock-based compensation expense of approximately $68,600 and $166,000 during the three months ended March 31, 2015 and 2014, respectively, relating to compensation expense calculated based on the fair value at the time of grant for restricted stock and based on Black-Scholes for stock options granted under the Stock Plan. Stock-based compensation expense for the three months ended March 31, 2014, included $90,000, related to the issuance of convertible notes for our financial advisor. The following table sets forth a summary of restricted stock activity for the three months ended March 31, 2015: Number of Restricted Shares Weighted-Average Grant Date Fair Value Outstanding and not vested beginning balance as of January 1, 2015 7,186 $ 2.16 Granted — $ — Forfeited/cancelled — $ — Released/vested (7,186 ) $ 2.16 Outstanding and not vested as of March 31, 2015 — $ — Restricted stock is valued at the grant date fair value of the common stock and expensed over the requisite service period or vesting period. We estimate forfeitures when recognizing stock-based compensation expense for restricted stock, and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. As of December 31, 2014, there was approximately $1,000, respectively, of unrecognized stock-based compensation expense associated with the granted of unvested restricted stock. Stock-based compensation expense relating to these restricted shares is being recognized over a weighted-average period of 0.2 years. The total fair value of shares vested during the three months ended March 31, 2015 and 2014, was approximately $23,000 and $13,000, respectively. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) are classified as financing cash flows on our consolidated statements of cash flows. During the three months ended March 31, 2015 and 2014, there were no excess tax benefits relating to restricted stock and therefore there is no impact on the accompanying consolidated statements of cash flows. The following table sets forth a summary of stock option activity for the three months ended March 31, 2015: Number of Shares Subject to Option Weighted- Average Exercise Price Outstanding as of January 1, 2015 37,034,483 $ 0.03 Granted — $ — Forfeited/cancelled/expired — $ — Exercised — $ — Outstanding as of March 31, 2015 37,034,483 $ 0.03 Exercisable as of March 31, 2015 7,321,779 $ 0.07 Stock options are valued at the estimated fair value grant date or the measurement date and expensed over the requisite service period or vesting period. The weighted-average volatility was based upon the historical volatility of our common stock price. There were no stock options granted during the three months ended March 31, 2015 and 2014. The weighted-average remaining contractual term for the stock options outstanding (vested and expected to vest) and exercisable as of March 31, 2015 and December 31, 2014, was 4.1 years and 4.4 years, respectively. The total estimated fair value of stock options vested during the three months ended March 31, 2015 and 2014 was approximately $23,000 and $13,000, respectively. The aggregate intrinsic value of stock options outstanding as of March 31, 2015 was zero. We estimate forfeitures when recognizing stock-based compensation expense for stock options and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. As of March 31, 2015 and December 31, 2014, there was approximately $479,000 and $91,000, respectively, of unrecognized stock-based compensation expense associated with stock options granted. Stock-based compensation expense relating to these stock options is being recognized over a weighted-average period of 4.3 years. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) is classified as financing cash flows on our consolidated statements of cash flows. During the three ended March 31, 2015, there were no excess tax benefits relating to stock options and therefore there is no impact on the accompanying consolidated statements of cash flows.	13. Stock Option and Incentive Plan On August 8, 2006, we adopted the Andalay Solar, Inc. 2006 Stock Incentive Plan (the “Stock Plan”) pursuant to which shares of common stock are available for issuance to employees, directors and consultants under the Stock Plan as restricted stock and/or options to purchase common stock. At our Annual Meeting of Stockholders held on September 19, 2013, our stockholders approved and adopted an amendment to our 2006 Incentive Stock Plan, increasing the number of shares of our common stock reserved for issuance under the Plan from 3,000,000 to 50,000,000. Restricted stock and options to purchase common stock may be issued under the Stock Plan. The restriction period on restricted stock grants generally expire at a rate of 25% per quarter over one year or 25% per year over four years, unless decided otherwise by our Compensation Committee. Options to purchase common stock generally vest and become exercisable at a rate of 25% per quarter over one year or as to one-third of the total amount of shares subject to the option on each of the first, second and third anniversaries from the date of grant. Options to purchase common stock generally have a 5-year term. We use the Black-Scholes-Merton Option Pricing Model (Black-Scholes) to estimate fair value of our employee and our non-employee director stock-based awards. Black-Scholes requires various judgmental assumptions, including estimating stock price volatility, expected option life and forfeiture rates. If we had made different assumptions, the amount of our deferred stock-based compensation, stock-based compensation expense, gross margin, net loss and net loss per share amounts could have been significantly different. We believe that we have used reasonable methodologies, approaches and assumptions to determine the fair value of our common stock, and that our deferred stock-based compensation and related amortization were recorded properly for accounting purposes. If any of the assumptions we used change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. We measure compensation expense for non-employee stock-based compensation under ASC 505-50, “Equity-Based Payments to Non-Employees.” We recognized stock-based compensation expense of approximately $224,000 and $110,000 during the years ended December 31, 2014 and 2013, respectively, relating to compensation expense calculated based on the fair value at the time of grant for restricted stock and based on Black-Scholes for stock options granted under the Stock Plan. The following table sets forth a summary of restricted stock activity for the years ended December 31, 2014 and 2013: Number of Restricted Shares Weighted-Average Grant Date Fair Value Outstanding and not vested beginning balance as of January 1, 2013 48,073 $ 2.50 Granted 2,500,000 $ 0.03 Forfeited/cancelled (21,798 ) $ 2.46 Released/vested (635,323 ) $ 0.08 Outstanding and not vested beginning balance as of January 1, 2014 1,890,952 $ 0.05 Granted — $ — Forfeited/cancelled — $ — Released/vested (1,883,766 ) $ 0.04 Outstanding and not vested as of December 31, 2014 7,186 $ 2.16 Restricted stock is valued at the grant date fair value of the common stock and expensed over the requisite service period or vesting period. We estimate forfeitures when recognizing stock-based compensation expense for restricted stock, and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. As of December 31, 2014, there was approximately $1,000 of unrecognized stock-based compensation expense associated with the granted but unvested restricted stock. Stock-based compensation expense relating to these restricted shares is being recognized over a weighted-average period of 0.2 years. The total fair value of shares vested during the years ended December 31, 2014 and 2013, was approximately $64,000 and $19,000, respectively. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) are classified as financing cash flows on our consolidated statements of cash flows. During the years ended December 31, 2014 and 2013, there were no excess tax benefits relating to restricted stock and therefore there is no impact on the accompanying consolidated statements of cash flows. The following table sets forth a summary of stock option activity for the years ended December 31, 2014 and 2013: Number of Shares Subject To Option 2014 Weighted- Average Exercise Price Number of Shares Subject To Option 20 13 Weighted-Average Exercise Price Outstanding beginning balance 6,618,233 $ 0.11 679,744 $ 2.82 Granted during the year 30,456,250 0.02 6,400,000 0.03 Forfeited/cancelled/expired during the year (40,000 ) 5.15 (461,511 ) 3.29 Exercised during the year — — — — Outstanding at end of year 37,034,483 $ 0.03 6,618,233 $ 0.11 Exercisable at end of year 5,934,303 $ 0.09 2,330,650 $ 0.28 Outstanding and expected to vest 36,916,502 $ 0.03 6 191,212 $ 0.11 Stock options are valued at the estimated fair value on the grant date or the measurement date and expensed over the requisite service period or vesting period. The weighted-average volatility was based upon the historical volatility of our common stock price. The fair value of stock option grants during the years ended December 31, 2014 and 2013 was estimated using the Black-Scholes option-pricing model with the following assumptions: Years Ended December 31 , 201 4 201 3 Weighted-average volatility 185.0 % 105.5 % Expected dividends 0.0 % 0.0 % Expected life (in years) 3.5 2.0 Weighted-average risk-free interest rate 1.1 % 0.30 % The weighted-average fair value per share of the stock options as determined on the date of grant was $0.02 for the stock options to purchase 30,456,250 shares of common stock granted during the years ended December 31, 2014 and $0.02 for the stock options to purchase 6,400,000 share of common stock granted during the years ended December 31, 2013. The weighted-average remaining contractual term for the stock options outstanding (vested and expected to vest) and exercisable as of December 31, 2014 and 2013, was 4.4 and 4.7 years, respectively. The total estimated fair value of stock options vested during the years ended December 31, 2014 and 2013 was approximately $91,000 and $81,000, respectively. The aggregate intrinsic value of stock options outstanding as of December 31, 2014 and 2013 was zero. We estimate forfeitures when recognizing stock-based compensation expense for stock options and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. As of December 31, 2014 there was approximately $514,000 of unrecognized stock-based compensation expense associated with stock options granted. Stock-based compensation expense relating to these stock options is being recognized over a weighted-average period of 0.7 years and 1.0, respectively. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) is classified as financing cash flows on our consolidated statements of cash flows. During the years ended December 31, 2014 and 2013, there were no excess tax benefits relating to stock options and therefore there is no impact on the accompanying consolidated statements of cash flows. Non-Vested Stock Options Weighted-Average Grant Date Fair Value Outstanding as of January 1, 2014 4,287,583 $ 0.02 Granted 30,456,250 $ 0.02 Forfeited/cancelled (40,000 ) $ 3.04 Released/vested (3,637,403 ) $ 0.02 Outstanding as of December 31, 2014 31,066,430 $ 0.02 Options outstanding as of December 31, 2014 are summarized as follows: Options Outstanding Vested Options Number Weighted- Weighted- Number Weighted- Average $0.0192 12,450,000 4.6 $ 0.02 358,320 $ 0.02 $0.020 - $0.023 18,000,000 4.6 $ 0.02 1,125,000 $ 0.02 $0.0296 6,400,000 3.8 $ 0.0296 4,266,500 $ 0.0296 $0.11 - $5.32 184,483 1.3 $ 1.95 184,483 $ 1.95 $0.0192 - $5.32 37,034,483 4.4 $ 0.03 5,934,303 $ 0.09

Note 14 - Stock Warrants and Wa

Note 14 - Stock Warrants and Warrant Liability	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure Text Block [Abstract]
Derivatives and Fair Value [Text Block]	1 2 . Stock Warrants and Warrant Liability On December 19, 2013 and February 25, 2014, we entered into securities purchase agreements with certain institutional accredited investors relating to the sale and issuance of a (i) convertible notes in the principal amount of $250,000, $200,000 and $300,000 that mature on December 19, 2015, February 25, 2016 and March 19, 2016, respectively and (ii) five- year warrants (with a cashless exercise feature under certain circumstances) to purchase 6,250,000, 5,000,000 and 7,500,000 shares, respectively, of our common stock at an exercise price of $0.02 per share, subject to adjustment under certain circumstances. See Note 8 for further discussion of the issuance of the convertible note. The following table summarizes the Warrant activity for the three months ended March 31, 2015: Warrants for Number of S hares Weighted-Average Exercise Price Outstanding at January 1, 2015 22,148,045 $ 0.23 Issued — — Exercised — — Cancelled/expired — — Outstanding at March 31, 2015 22,148,045 $ 0.23 The majority of our warrants outstanding are not exercisable for nine months from the date of issuance and are exercisable for either 4.5 years or 5 years thereafter. Our outstanding warrants expire on various dates between December 2015 and March 2019.	1 4 . Stock Warrants and Warrant Liability During March 2009, in connection with an equity financing, we issued Series E Warrants to purchase 334,822 shares of common stock at an exercise price of $5.36 per share. The fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 2.69%, an expected life of five years; an expected volatility factor of 112% and a dividend yield of 0.0%. The value assigned to these warrants was approximately $1.0 million, of which $1.0 million was reflected as common stock warrant liability with an offset to additional paid-in capital as of the offering close date. The fair value of the warrants decreased to zero as of December 31, 2013. On December 19, 2013 and February 25, 2014, we entered into securities purchase agreements with Alpha Capital Anstalt relating to the sale and issuance of a (i) convertible notes in the principal amount of $250,000, $200,000 and $300,000 that mature on December 19, 2015, February 25, 2016 and March 19, 2016, respectively and (ii) five- year warrants (with a cashless exercise feature under certain circumstances) to purchase 6,250,000, 5,000,000 and 7,500,000 shares, respectively, of our common stock at an exercise price of $0.02 per share, subject to adjustment under certain circumstances. See Note 9 for further discussion of the issuance of the convertible note. The following table summarizes the Warrant activity for the year ended December 31, 2014: Warrants for Number of Shares Weighted-Average Exercise Price Outstanding as of December 31, 2013 9,648,045 $ 0.49 Issued 12,500,000 0.02 Exercised — — Cancelled/expired — — Outstanding as of December, 2014 22,148,045 $ 0.23 The majority of our warrants outstanding are not exercisable for nine months from the date of issuance and are exercisable for either 4.5 years or 5 years thereafter. Our outstanding warrants expire on various dates between December 2015 and March 2019.

Note 15 - Fair Value Measuremen

Note 15 - Fair Value Measurement	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	1 5 . Fair Value Measurement We use a fair-value approach to value certain assets and liabilities. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We use a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels: • Level one — Quoted market prices in active markets for identical assets or liabilities; • Level two — Inputs other than level one inputs that are either directly or indirectly observable; and • Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter. Assets and liabilities measured at fair value on a recurring basis are summarized as follows: Liabilities Level 1 Level 2 Level 3 December 31, 201 4 Fair value of derivative liability – embedded conversion feature $ — $ — $ 129,598 $ 129,598 Total $ — $ — $ 129,598 $ 129,598 On August 30, 2013, November 25, 2013 and December 19, 2013, we entered into securities purchase agreements relating to the sale and issuance of convertible notes in the principal amounts of $200,000, $200,000 and $250,000. Each of the Convertible Notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. Subject to our fulfilling certain conditions, including beneficial ownership limits, the convertible notes are subject to a mandatory conversion if the closing price of our common stock for any 20 consecutive days commencing six months after the issue date of the convertible notes equal or exceeds $0.04 per share. The terms of the convertible notes meet the criteria for the bifurcation of an embedded derivative. Therefore, we recorded the fair value of the embedded derivative liability as of the issuance date for each of the convertible notes for an aggregate fair value of $243,889. We use a model based on Monte Carlo simulation to value the embedded conversion feature of our notes payable that are subject to fair value liability accounting. The determination of the fair value as of the reporting date is affected by our stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the security and risk-free interest rate. In addition, the model uses multiple Monte Carlo simulations requiring the input of an expected life for the securities for which we have estimated and expectations of the timing and amount of future financing we may require. The fair value of the embedded conversion feature liability is revalued each balance sheet date utilizing our Monte Carlo simulation-based model computations with the decrease or increase in fair value being reported in the statement of comprehensive loss as other income or expense, respectively. The primary factors affecting the fair value of the embedded conversion feature liability are our stock price and volatility. In addition, the use of a Monte Carlo simulation-based model requires the input of highly subjective assumptions, and other reasonable assumptions could provide differing results. During the quarter ended March 31, 2015, the Monte Carlo simulation-based model was used to calculate the fair value of the embedded conversion feature based on a stock price of between $0.011 and $0.036 and a volatility of between 94.4% and 99.7%. The following table shows the changes in Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2015: Derivative Liability – Embedded Conversion Feature Total Level 3 Beginning balance – January 1, 2015 $ 129,598 $ 129,598 Issuances — — Conversions (88,333 ) (88,333 ) Total realized and unrealized gains or losses (41,265 ) (41,265 ) Ending balance – March 31, 2015 $ — $ —	15. Fair Value Measurement We use a fair-value approach to value certain assets and liabilities. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We use a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels: • Level one — Quoted market prices in active markets for identical assets or liabilities; • Level two — Inputs other than level one inputs that are either directly or indirectly observable; and • Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter. Assets and liabilities measured at fair value on a recurring basis are summarized as follows: Liabilities Level 1 Level 2 Level 3 December 31, 2014 Fair value of embedded derivatives — — $ 129,598 $ 129,598 Total $ — $ — $ 129,598 $ 129,598 Liabilities Level 1 Level 2 Level 3 December 31, 201 3 Fair value of embedded derivatives $ — $ — $ 177,927 $ 177,927 Total $ — $ — $ 177,927 $ 177,927 On August 30, 2013, November 25, 2013 and December 19, 2013, we entered into securities purchase agreements relating to the sale and issuance of convertible notes in the principal amounts of $200,000, $200,000 and $250,000. Each of the Convertible Notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. Subject to our fulfilling certain conditions, including beneficial ownership limits, the convertible notes are subject to a mandatory conversion if the closing price of our common stock for any 20 consecutive days commencing six months after the issue date of the convertible notes equal or exceeds $0.04 per share. The terms of the convertible notes meet the criteria for the bifurcation of an embedded derivative. Therefore, we recorded the fair value of the embedded derivative liability as of the issuance date for each of the convertible notes for an aggregate fair value of $243,889. We use a model based on Monte Carlo simulation to value the embedded conversion feature of our notes payable that are subject to fair value liability accounting. The determination of the fair value as of the reporting date is affected by our stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the security and risk-free interest rate. In addition, the model uses multiple Monte Carlo simulations requiring the input of an expected life for the securities for which we have estimated and expectations of the timing and amount of future financing we may require. The fair value of the embedded conversion feature liability is revalued each balance sheet date utilizing our Monte Carlo simulation-based model computations with the decrease or increase in fair value being reported in the statement of comprehensive loss as other income or expense, respectively. The primary factors affecting the fair value of the embedded conversion feature liability are our stock price and volatility. In addition, the use of a Monte Carlo simulation-based model requires the input of highly subjective assumptions, and other reasonable assumptions could provide differing results. Our reported net loss was approximately $1.9 million for the year ended December 31, 2014. If the closing stock price of our common stock had been 10% lower, our net loss would have been approximately $15,000 lower. If the closing stock price of our common stock had been 10% higher, our net loss would have been approximately $26,000 higher. If our volatility assumption on December 31, 2014 had been 10% lower, our net loss would have been approximately $7,000 lower and if our volatility assumption had been 10% higher, our net loss would have been approximately $13,000 higher. The following table shows the changes in Level 3 liabilities measured at fair value on a recurring basis for the years ended December 31, 2013: Embedded Derivative on Convertible Notes Total Level 3 Beginning balance – January 1, 2014 $ 177,927 $ 177,927 Issuances 122,630 122,630 Total realized and unrealized gains or losses (50,809 ) (50,809 ) Transfers out of level 3 upon exercise or conversion (221,768 ) (221,768 ) Ending balance – December 31, 2014 $ 129,598 $ 129,598

Note 16 - Income Taxes

Note 16 - Income Taxes	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	1 6 . Income Taxes Deferred income taxes arise from timing differences resulting from income and expense items reported for financial account and tax purposes in different periods. A deferred tax asset valuation allowance is recorded when it is more likely than not that deferred tax assets will not be realized. During the three months ended March 31, 2015, there was no income tax expense or benefit for federal and state income taxes in the accompanying condensed consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax asset. Our deferred tax asset has a 100% valuation allowance.	16. Income Taxes During the years ended December 31, 2014, and 2013, respectively, there was no income tax expense or benefit for federal and state income taxes in the accompanying consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax assets. The actual tax expense differs from the “expected” tax expense for the years ended December 31, 2014 and 2013 (computed by applying the U.S. Federal Corporate tax rate of 34% to income before taxes) as follows: December 31, December 31, 2014 2013 Tax at federal statutory rate $ (740,000 ) $ (967,000 ) State taxes, net of federal benefit (117,000 ) (160,000 ) Research and development credits — (12,000 ) Fair market value of warrants & derivatives 17,000 (22,000 ) Stock-based compensation 51,000 29,000 Other permanent items 10,000 1,000 Valuation allowance 779,000 1,131,000 Income tax provision $ — $ — The tax effects of temporary differences that give rise to significant portions of deferred tax assets and liabilities as of December 31, 2014 and 2013 are as follows: December 31, December 31, 2014 2013 Deferred tax assets: Net operating loss and credit carryforwards $ 30,227,000 $ 29,431,000 Stock-based compensation 1,199,000 1,193,000 Stock-based compensation 422,000 558,000 Basis difference for fixed assets and intangibles 158,000 174,000 Total gross deferred tax assets 32,006,000 31,356,000 Valuation allowance (32,006,000 ) (31,356,000 ) Net deferred tax assets $ — $ — A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized. We established a 100% valuation allowance due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. At December 31, 2014, we had useable net operating loss carryforwards of approximately $75.2 million for federal and $73.1 million for state income tax purposes available to offset future taxable income expiring through 2033 for both federal and California. At December 31, 2014, we had useable R & D credits of approximately $361,000 for federal and $231,000 for California. The federal credits expire through 2032 and the state credits have no expiration. The net change in the valuation allowance during the years ended December 31, 2014 and 2013 was an increase of approximately $650,000 and $1.1 million, respectively, primarily due to current year losses. Internal Revenue Code Section 382 places a limitation (the "Section 382 Limitation") on the amount of taxable income, which can be offset by net operating loss carryforwards after a change in control (generally greater than a 50% change in ownership) of a loss corporation. Generally, after a control change, a loss corporation cannot deduct operating loss carryforwards in excess of the Section 382 Limitation. Due to these "change in ownership" provisions, utilization of the net operating loss and tax credit carryforwards may be subject to an annual limitation regarding their utilization against taxable income in future periods. The company has not concluded its analysis of Section 382 through December 31, 2014 but believes that these provisions will not limit the availability of losses to offset future income. On January 1, 2007, the Company adopted ASC Topic 740—Income Taxes (“ASC 740”) FASB ASC 740, Income Taxes—an interpretation of FASB Statement No. 109 (“FIN 48”). Due to net operating loss and research credit carryforwards, substantially all of the Company’s tax years remain open to U.S. federal and state tax examinations. The Company classifies interest and penalties recognized pursuant to Interpretation 48 as part of income tax expense. No interest or penalties related to unrecognized tax benefits have been accrued for the year ended December 31, 2014. The aggregate changes in the balance of gross unrecognized tax benefits were as follows (in thousands): 2014 2013 Balance, beginning of year $ 147,000 $ 140,000 Additions based on tax positions related to the current year — — Additions for tax positions related to prior years — 7,000 Reductions for tax positions related to prior years — — Balance, end of year $ 147,000 $ 147,000 In the event that any unrecognized tax benefits are recognized, the effective tax rate will be affected. Approximately $128,000 and $128,000 as of December 31, 2014 and 2013 respectively, of unrecognized tax benefits would impact the effective rate, if recognized.

Note 17 - Commitments and Conti

Note 17 - Commitments and Contingencies	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	1 7 . Commitments and Contingencies Litigation On February 9, 2015, the law firm of Snell & Wilmer LLP filed suit against us in California Superior Court, County of Orange. The complaint alleges that we have failed to pay Snell & Wilmer fees due to that firm in connection with prior patent prosecution litigation, in an amount of no less than $808,202, plus interest. We are still evaluating the merits of the claim but intend to defend against it vigorously. We are also involved in other litigation from time to time in the ordinary course of business. In the opinion of management, the outcome of such proceedings will not materially affect our financial position, results of operations or cash flows.	17. Commitments and Contingencies Westinghouse License On May 17, 2010, we entered into an exclusive worldwide agreement that permits us to manufacture, distribute and market our solar panels under the Westinghouse name. On August 23, 2013, the license agreement with Westinghouse, Inc. was terminated. Operating Leases Our principal executive offices and warehouse premises are located at 2071 Ringwood Ave., Unit C, San Jose, CA 95128. On or around May 1, 2015, our corporate headquarters is relocating to 48900 Milmont Drive, Fremont, CA 94538. Commencing March 1, 2014, the monthly rent for our warehouse has been $10,500. The monthly rent during 2013 and in January and February 2014 was $7,800. We consolidated our executive offices with our warehouse premises effective January 1, 2014. Our warehouse lease agreement expired on February 28, 2015 and we are on a month-to-month rental agreement. Litigation We are also involved in other litigation from time to time in the ordinary course of business. In the opinion of management, the outcome of such proceedings will not materially affect our financial position, results of operations or cash flows.

Note 18 - Concentration of Risk

Note 18 - Concentration of Risk in Customer and Supplier Relationships	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	1 4 . Concentration of Risk Supplier Relationships We began receiving product from Tianwei in February 2014 and stopped as of June 2014. In July 2014, we entered into a supply agreement for assembly of our proprietary modules with Auxin Solar, Inc., a panel supplier located in the United States. We began receiving product from Auxin in December 2014. Although we believe we can find alternative suppliers for solar panels manufactured to our specifications, our operations would be disrupted unless we are able to rapidly secure alternative sources of supply, our inventory and revenue could diminish significantly, causing disruption to our operations. Historically, we obtained virtually all of our solar panels from Suntech and Lightway. During 2012, because of our cash position and liquidity constraints, we were late in making payments to both of these suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. At the time of issuance, the shares were valued at $1,045,000. On May 1, 2012, Suntech filed a complaint for breach of contract, goods sold and delivered, account stated and open account against us in the Superior Court of the State of California, County of San Francisco. Suntech alleged that it delivered products and did not receive full payment from us. On July 31, 2012, we and Suntech entered into a settlement of this dispute. Because of our inability to make scheduled settlement payments, on March 15, 2013, Suntech entered a judgment against us in the amount of $946,438. As of March 31, 2015, Suntech has not sought to enforce its judgment. As of March 31, 2015, we have included in accounts payable in our consolidated balance sheets a balance due to Suntech America of $946,438. We currently have no unshipped orders from Suntech or Lightway. Customer Relationships The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter. During the three months ended March 31, 2015, three customers have accounted for significant revenues, varying by period, to our company: Smart Energy Today (“Smart Energy”), which specializes in helping home owners and business owners become more energy efficient, Helco Electrics (“Helco”) a full-service provider of electrical services in southern Oregon, Verengo Solar (“Verengo”), a solar installer based in Southern California, Sustainable Environmental Enterprises (“SEE”), a leading provider of renewable energy and development projects located in New Orleans, Louisiana, and Shoreline Electric (“Shoreline”) a provider of residential and commercial electrical services in Southern California. For the three months ended March 31, 2015 and 2014, the percentages of sales of our top five customers are as follows: Three Months Ended March 31 , 2015 2014 Smart Energy Today 34.9 % — Helco Electric 12.7 % 22.9 % Verengo Solar 13.9 % — Sustainable Environmental Enterprises — 11.7 % Shoreline Electric — 31.9 % The percentage of our gross accounts receivable for our top accounts receivable balance as of March 31, 2015 and December 31, 2014, are as follows: March 31, 2015 December 31, 2014 WDC Solar, Inc. 62.4 % 40.1 % Lowe’s Retail 11.6 % 16.8 % Greg Teegarden 11.4 % — Smart Energy — 6.5 % We maintain reserves for potential credit losses and such losses, in the aggregate, have generally not exceeded management’s estimates. Our top three vendors accounted for approximately 30% and 39% of purchases as of March 31, 2015 and December 31, 2014, respectively. As of March 31, 2015 and December 31, 2014, accounts payable included amounts owed to our top three suppliers of approximately $68,000 and $0, respectively.	18. Concentration of Risk in Customer and Supplier Relationships Supplier Relationships In September 2013, we entered into a supply agreement for assembly of our proprietary modules with Tianwei New Energy Co, Ltd. (“Tianwei”), a panel supplier located in China. We began receiving product from Tianwei in February 2014 and stopped as of June 2014. In July 2014, we entered into a supply agreement for assembly of our proprietary modules with Auxin Solar, Inc., a panel supplier located in the United States. We began receiving product from Auxin in December 2014. Although we believe we can find alternative suppliers for solar panels manufactured to our specifications, our operations would be disrupted unless we are able to rapidly secure alternative sources of supply, our inventory and revenue could diminish significantly, causing disruption to our operations. Historically, we obtained virtually all of our solar panels from Suntech and Lightway. During 2012, because of our cash position and liquidity constraints, we were late in making payments to both of these suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. At the time of issuance, the shares were valued at $1,045,000. On May 1, 2012, Suntech filed a complaint for breach of contract, goods sold and delivered, account stated and open account against us in the Superior Court of the State of California, County of San Francisco. Suntech alleged that it delivered products and did not receive full payment from us. On July 31, 2012, we and Suntech entered into a settlement of this dispute. Because of our inability to make scheduled settlement payments, on March 15, 2013, Suntech entered a judgment against us in the amount of $946,438. As of December 31, 2014, Suntech has not sought to enforce its judgment. As of December 31, 2014, we have included in accounts payable in our consolidated balance sheets a balance due to Suntech America of $946,438. We currently have no unshipped orders from Suntech or Lightway. Customer Relationships The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter. During the year ended December 31, 2014, five customers have accounted for significant revenues, varying by period, to our company: Smart Energy Today (“Smart Energy”), which specializes in helping home owners and business owners become more energy efficient, WDC Solar, Inc. (“WDC”), a leading construction, integration and installation of commercial, residential and utility scale solar installations in the Washington D.C. area, JCF Wholesale (“JCF”) a provider of residential and commercial electrical services in Southern California, Lowe’s Companies, Inc. (Lowe’s), a nationwide home improvement retail chain, and Sustainable Environmental Enterprises (“SEE”), a leading provider of renewable energy and development projects located in New Orleans, Louisiana. For the year ended December 31, 2014 and 2013, the percentages of sales of our top five customers are as follows: Years Ended December 31 , 2014 2013 Smart Energy Today 13.3 % 13.5 % WDC Solar, Inc. 12.0 % 14.7 % JCF Wholesale 8.7 % 10.6 % Lowe’s 5.9 % 6.9 % Sustainable Environmental Enterprises 1.3 % 52.8 % The percentage of our gross accounts receivable for our top customers as of December 31, 2014 and 2013, are as follows: December 31 , 2014 2013 WDC Solar, Inc. 40.1 % — Lowe’s 16.8 % — Sustainable Environmental Enterprises — % 86.7 % Smart Energy Today 6.5 % — We maintain reserves for potential credit losses and such losses, in the aggregate, have generally not exceeded management’s estimates. Our top three vendors accounted for approximately 39% and 25% of purchases as of December 31, 2014 and 2013, respectively. As of December 31, 2014 and 2013, accounts payable included amounts owed to these top three suppliers of approximately $0 and $1.0 million, respectively.

Note 19 - Employee Benefit Plan

Note 19 - Employee Benefit Plan	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	19. Employee Benefit Plan On December 14, 2007, the Board of Directors approved the 401(k) profit sharing plan (the “401(k) Plan”) effective January 1, 2008. Employees began deferring a portion of their compensation into the 401(k) Plan commencing on January 1, 2008. In 2011, we began making matching contributions equal to 10% of the employee contribution. For the years ended December 31, 2014 and 2013, there was no accrual relating to this matching contribution.

Note 20 - Subsequent Events

Note 20 - Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	18. Subsequent Events On April 6 and April 20, 2015, we received proceed of approximately $55,000 and $94,000 related to the sale of approximately 14 million shares under our Equity Purchase Agreement. On April 1, 2015, we issued 24 million shares of our common stock pursuant to a put notice under the Equity Purchase Agreement. On April 17, 2015, we entered into a sublease for 1,500 square feet of office space and 2,000 square feet of warehouse storage space at 48900 Milmont Drive, Fremont, California, for $4,250 per month. The lease began when we initially occupied the new facilities on May 8, 2015 and the term will run for 12 months, expiring on May 30, 2016, after which it will be month-to-month.	20. Subsequent Events On February 9, 2015, the law firm of Snell & Wilmer LLP filed suit against us in California Superior Court, County of Orange. The complaint alleges that we have failed to pay Snell & Wilmer fees due to that firm in connection with prior patent prosecution litigation, in an amount of no less than $808,202, plus interest. We are still evaluating the merits of the claim. As of December 31, 2014, we have included in accounts payable in our Consolidated Balance Sheets a balance due to Snell & Wilmer of $808,202. On December 10, 2014, we entered into an Equity Purchase Agreement (the “December Equity Purchase Agreement”) with Southridge Partners II, LP (“Southridge”), that superseded our prior Equity Purchase Agreement with Southridge that was entered into on January 23, 2014 (the “Prior Equity Purchase Agreement”). The terms of the December Equity Purchase Agreement are substantially similar to those of the Prior Equity Purchase Agreement. Pursuant to the December Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the December Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the December Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. We submitted various take-down requests during the first quarter of 2015 pursuant to the terms of the December Equity Purchase Agreement. As of April 10, 2015, 53,781,201 shares had been sold at an average price of $0.013 per share, resulting in total proceeds of approximately $780,000.

Note 3 - Segment Reporting

Note 3 - Segment Reporting	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	3 . Segment Reporting We are engaged in two business segments, (i) we market, sell, design and install systems for residential and commercial customers and (ii) we sell our AC solar panels to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. An analysis of our revenue, operating profit and total assets are as follows (unaudited): Three Months Ended March 31, Revenue 2015 2014 Distribution $ 166,136 $ 142,482 Installation 108,505 — $ 274,641 $ 142,482 Three Months Ended March 31, Gross profit (loss) 2015 2014 Distribution $ (9,975 ) $ 7,094 Installation (1,766 ) — $ (11,741 ) $ 7,094 Assets March 31, 2015 December 31, 2014 Distribution $ 2,482,508 $ 2,560,940 Installation 20,997 — $ 2,503,505 $ 2,560,940 We do not allocate operating expenses or other income (expense) to any of these segments for internal reporting purposes, as we do not believe that allocating these expenses is beneficial in evaluating segment performance. Installation assets include only accounts receivable assets. Other than accounts receivable, we do not allocate assets to segments for internal reporting purposes as we do not manage our segments by such metrics.

Note 13 - Earnings Per Share

Note 13 - Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	1 3 . Earnings Per Share On January 1, 2009, we adopted Accounting Standards Codification 260 (formerly Financial Accounting Standards Board Staff Position (“FSP”) Emerging Issues Task Force (“EITF 03-6-1”) (“ASC 260”), Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities Earnings Per Share In accordance with the ASC 260, basic net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the weighted average number of shares outstanding less the weighted average unvested restricted shares outstanding. Diluted net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the denominator for basic net income (loss) per share and any dilutive effects of stock options, restricted stock, convertible notes and warrants. Three Months Ended March 31 , 2015 2014 Basic: Numerator: Net loss $ (825,176 ) $ (84,396 ) Preferred deemed dividend and preferred stock dividend Less: Net loss allocated to participating securities 8 960 $ (825,168 ) $ (83,436 ) Denominator: Weighted-average shares outstanding 328,001,069 132,940,312 Weighted-average unvested restricted shares outstanding (3,322 ) (1,512,311 ) Denominator for basic net loss per share 327,997,747 131,428,001 Basic net loss per share attributable to common stockholders $ (0.00 ) $ (0.00 ) The following table sets forth potential shares of common stock at the end of each period presented that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive: March 31, 2015 December 31, 201 4 Stock options outstanding 37,034,483 37,034,483 Unvested restricted stock — 7,186 Warrants to purchase common stock 22,148,045 22,148,045

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Debt, Policy [Policy Text Block]	Securities Purchase Agreement Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to the embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the three months ended March 31, 2015 of approximately $41,000 on a total of three convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. Equity Purchase Agreement On January 23, 2014, we entered into an Equity Purchase Agreement with Southridge Partners II, LP (“Southridge”), that superseded our prior Equity Purchase Agreement with Southridge that was entered into on November 25, 2013 (the “Prior Equity Purchase Agreement”). The terms of the new Equity Purchase Agreement are identical to those of the Prior Equity Purchase Agreement other than that the New Equity Purchase Agreement provides that the Agreement may not be amended by either party. Pursuant to the New Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the New Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the New Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. On March 11, 2014, we filed a Registration Statement on Form S-1/A to register 35 million shares of common stock related to our Equity Purchase Agreement with Southridge and on March 21, 2014, the Securities and Exchange Commission declared the Registration Statement effective. On March 26, 2014, we submitted an initial take-down request of $300,000 to Southridge pursuant to the terms of the Equity Purchase Agreement of which partial proceeds of $100,000 was received on March 31, 2014 and $200,000 on April 16, 2014. On June 4, 2014, June 18, 2014 and July 8, 2014, we submitted additional take-down requests for $100,000, $100,000 and $125,000, respectively, pursuant to the terms of the Equity Purchase Agreement. On December 10, 2014, we entered into the December Equity Purchase Agreement with Southridge, that superseded our Prior Equity Purchase Agreement with Southridge that was entered into on January 23, 2014. The terms of the December Equity Purchase Agreement are substantially similar to those of the Prior Equity Purchase Agreement. Pursuant to the December Equity Purchase Agreement and as provided in the Prior Equity Purchase Agreement, Southridge has committed to purchase up to $5,000,000 worth of our common stock, over a period of time terminating on the earlier of: (i) 18 months from the effective date of the registration statement to be filed by us for the Equity Purchase Agreement; or (ii) the date on which Southridge has purchased an aggregate maximum purchase price of $5,000,000 pursuant to the December Equity Purchase Agreement; Southridge’s commitment to purchase our common stock is subject to various conditions, including, but not limited to, limitations based on the trading volume of our common stock. We submitted various take-down requests during the first quarter of 2015 pursuant to the terms of the December Equity Purchase Agreement. As of May 12, 2015, 67,813,489 shares had been sold at an average price of $0.0137 per share, resulting in total proceeds of approximately $929,000. Pursuant to the terms of the December Equity Purchase Agreement we agreed to pay Southridge a commitment fee of 1,000,000 shares of our common stock, of which 500,000 shares of our common stock were due to Southridge on January 16, 2015, the date that the registration statement was declared effective and the remaining 500,000 shares of common stock were due on January 20, 2015, the date that we delivered our first Draw Down Notice to Southridge. We valued the issuance of these shares based on the closing price of the stock as of January 16, 2015, $0.0169 for 500,000, and as of January 20, 2015, $0.0161 for 500,000, and we recorded $16,500 as a reduction in “Additional Paid In Capital” on our condensed consolidated balance sheets. On December 10, 2014, we also entered into a Registration Rights Agreement with Southridge pursuant to which we agreed to register shares of the common stock to be issued to Southridge in connection with the December Equity Purchase Agreement. Settlement of Potential Claims Agreement On January 22, 2014, we entered into a Settlement of Potential Claims Agreement with ASC Recap LLC (“ASCR”). Pursuant to the Agreement, ASCR has offered to purchase (and in one (1) case has already purchased) approximately $3.7 million of our prior debt owed to four creditors (“Creditors”) for past due services at a substantial discount to face value to which we have agreed to issue to ASCR certain shares of our common stock in a §3(a)(10) 1933 Act proceeding. The shares of our common stock that we have agreed to issue to ASCR in full payment for, and as a release of any debt it purchases from the Creditors, is anticipated to have, upon issuance, a market value equal to approximately 25% of the principal amount of our outstanding debt. In the case of the debt ASCR already purchased from one (1) Creditor, we entered into a Settlement Agreement and Stipulation on February 26, 2014 that was filed with the Circuit Court of the Second Judicial Circuit, Leon County, Florida pursuant to which we agreed, subject to court approval, to issue shares of our common stock that generate proceeds in the amount of $250,000 in full settlement of the claim in the amount of $1,027,705 that ASCR acquired from one Creditor (the value of the stock that we have agreed to issue was two hundred and fifty percent (250%) of the discounted purchase price ASCR paid to purchase the debt from the Creditor, and approximately 25% of the original amount we owed to the Creditor), resulting in a gain on settlement of $769,148, net of expenses. On March 24, 2014, the Circuit Court of the Second Judicial Circuit, Leon County, Florida, approved the §3(a)(10) 1933 Act proceeding and Settlement Agreement and Stipulation and in April 2014, we issued 8,079,800 shares of common stock at an average price of $0.031 for the full settlement of the agreement with ASCR.	Convertible Note s payable On August 30, 2013, we entered into a securities purchase agreement with Alpha Capital Anstalt (“Alpha Capital”) relating to the sale and issuance of a convertible note in the principal amount of $200,000 that matures August 29, 2015 (the "Convertible Note"). Subsequently, on November 25, 2013 and December 19, 2013, we entered into additional securities purchase agreements with Alpha Capital relating to the sale and issuance of convertible notes in the principal amount of $200,000 and $250,000, respectively, which mature on November 25, 2015 and December 19, 2015. On January 27, 2014, we issued a convertible note in the principal amount of $100,000 that matures on January 27, 2016 under the Securities Purchase Agreement we entered into with Alpha Capital on December 19, 2013. In connection with the issuance of the December 19, 2013 convertible note, we also issued 6,250,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On February 25, 2014, we entered into a Securities Purchase Agreement with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $200,000 that matures on February 25, 2016. In connection with the issuance of the February 25, 2014 convertible note, we issued 5,000,000 warrants to purchase shares of our common stock at a price of $0.02 per share. On March 18, 2014, we entered into a Securities Purchase Agreement with the Alpha Capital related to the sale and issuance of a convertible note in the principal amount of $300,000 that matures on March 18, 2016. In connection with the March 18, 2014 convertible note, we issued a five–year warrant to purchase 7,500,000 shares of our common stock at an exercise price of $.02 per share. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share, subject to adjustment upon the happening of certain events, including stock dividends, stock splits and the issuance of common stock equivalents at a price below the conversion price. Subject to our fulfilling certain conditions, including beneficial ownership limits, the convertible notes are subject to a mandatory conversion if the closing price of our common stock for any 20 consecutive days commencing six months after the issue date of the convertible notes equal or exceeds $0.04 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. We have the option of repaying the outstanding principal amount of the convertible notes, in whole or in part, by paying the purchaser a sum of money equal to one hundred and twenty percent (120%) of the principal together with accrued but unpaid interest upon 30 days’ notice, subject to certain beneficial ownership limits. For so long as we have any obligation under the convertible notes, we have agreed to certain restrictions regarding, among other things, incurrence of additional debt, liens, amendments to charter documents, repurchase of stock, payment of cash dividends, affiliated transactions. We are also prohibited from entering into certain variable priced agreements until the convertible notes are repaid in full. Because of certain down-round protection in the conversion rate of the convertible notes, we determined that the derivative liability related to the embedded conversion feature met the criteria for bifurcation. Accordingly, we recognized an aggregate liability of $123,000 on the three issuance dates during the year ended December 31, 2014. This was in addition to the carrying value of the derivative liability on three previously recorded derivatives of $178,000. The derivative liability is carried at fair value with changes in the fair value reflected in the “Adjustment to the fair value of embedded derivatives” line item of our condensed consolidated statements of operations. We recognized a non-cash benefit for the year ended December 31, 2014 of $51,000 on a total of six convertible notes. In addition, the relative fair value of the warrants issued in the December 2013 convertible note issuance of $250,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 149.1%, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $109,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the February 2014 convertible note issuance of $200,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 169.1, a risk free interest rate of 0.7% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $101,000 is being accreted to interest using the effective interest method. The relative fair value of the warrants issued in the March 2014 convertible note issuance of $300,000, were allocated to additional paid-in capital. Such value was determined assuming volatility of 168.8%, a risk free interest rate of 0.8% and an expected term of 4.1 years. The resulting debt discount from the derivative liability and warrant issuance of $154,000 is being accreted to interest using the effective interest method. On November 1 and December 1, 2013, and on January 1, February 1 and March 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $30,000 each for a total of $150,000, which mature on October 31, November 30 and December 31, 2014, and on January 31 and February 28, 2015, respectively. On April 1, May 1 and June 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $20,000 each, for a total of $60,000, which mature on March 31, April 30 and May 31, 2015, respectively. On July 1, 2014, we issued convertible notes to our financial advisory firm in the principal amount of $10,000, which matures on June 30, 2015. Each of the Convertible Notes bear interest at the rate of 8% per annum compounded annually, are payable at maturity and the principal and interest outstanding under the convertible notes are convertible into shares of our common stock, at any time after issuance, at the option of the purchaser, at a conversion price equal to $0.02 per share. Unless waived in writing by the purchaser, no conversion of the convertible notes can be effected to the extent that as a result of such conversion the purchaser would beneficially own more than 9.99% in the aggregate of our issued and outstanding common stock immediately after giving effect to the issuance of common stock upon conversion. During 2014, convertible notes in the principal amount of approximately $940,000, along with accrued interest of $68,319, were converted into 50,439,751 shares of our common stock. Line of credit On September 30, 2013, we entered into a loan and security agreement with Alpha Capital Anstalt and Collateral Services, LLC to provide financing, on a discretionary basis, for one year, against our accounts receivable and inventory. The maximum amount that can be borrowed under the Agreement is $500,000. We have the right to borrow up to 80% of our eligible accounts receivable, not in excess of $200,000, 50% of the value of our raw materials in inventory, 65% of our finished goods inventory and 95% of cash, but not in the aggregate amount in excess of $300,000. The advances are secured by a lien on all of our assets. All advances under the agreement bear interest at a per annum rate of 12% and monthly interest shall be a minimum of $500. At the time of initial funding we paid a loan fee of 50 shares of our Series D Preferred Shares to the lender, in addition to other payments for legal fees. In addition, we paid the collateral agent an initial fee of $5,000 and have agreed to pay an administrative fee to the collateral agent of 0.5% per month of the daily balance during the preceding month or $500 whichever is less. In the event that of a prepayment, we are obligated to pay a prepayment fee in an amount equal to one-half of one percent (0.5%) of $500,000. On September 30, 2013, we requested and received an initial borrowing under the Agreement totaling $350,000. Subsequently, on October 21, 2013, we requested and received an additional $100,000 and on November 20, 2013, we requested and received an additional $50,000. As of December 31, 2014, the balance outstanding under our line of credit was $500,000. On February 27, 2015, we agreed to extend the term of the agreement for one year, and to exchange the $500,000 plus interest owing under the agreement for a one year, 8%, convertible note. We are no longer able to make borrowings under the line of credit agreement.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. We maintain cash and cash equivalents which consist principally of demand deposits with high credit quality financial institutions. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments and, as of March 31, 2015 and December 31, 2014, we had no cash equivalents.	Cash and Cash Equivalents We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments. As of December 31, 2014 and 2013, we had no cash equivalents.
Receivables, Policy [Policy Text Block]	Accounts Receivable Accounts receivable consist of trade receivables. We regularly evaluate the collectibility of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses, and such losses have historically been minimal and within our expectations. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information.	Accounts Receivable Accounts receivable consist of trade receivables. We regularly evaluate the collectability of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information.
Inventory, Policy [Policy Text Block]		Inventory Inventory is stated at the lower of cost (on an average basis) or market value. We determine cost based on the weighted-average purchase price and include both the costs of acquisition and the shipping costs in inventory. We regularly review the cost of inventory against its estimated market value and record a lower of cost or market write-down to cost of goods sold, if any inventory has a cost in excess of estimated market value.
Property, Plant and Equipment, Policy [Policy Text Block]		Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided for using the straight-line method over the estimated useful lives of the respective assets. Estimated useful lives are as follows: Category Useful Lives (years) Office Equipment 2 - 5 Vehicles 3 - 5 Leasehold Improvements 2 Maintenance and repairs are expensed as incurred. Expenditures for significant renewals or betterments are capitalized. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in current operations.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]		Long-Lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of a long-lived asset may not be recoverable. We periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful lives of our long-lived assets or whether the remaining balance of long-lived assets should be evaluated for possible impairment. We do not believe that there were any indicators of impairment that would require an adjustment to such assets or their estimated periods of recovery at December 31, 2014 and 2013.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Patent Costs We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 9.75 years as of March 31, 2015, are reasonable. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time.	Patent Costs We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 10 years as of December 31, 2014, are reasonable. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time. Costs associated with patents currently held are approximately $1.1 million, net of approximately $314,000 of accumulated amortization, are included in patents, net as of December 31, 2014, and are being amortized over the estimated useful life, which was determined to be seventeen years. Amortization expense of patents was approximately $113,000 in each of the years ended December 31, 2014 and 2013. Estimated amortization expense of patents for the five years subsequent to December 31, 2013, is approximately $113,000 per year. Capitalized filing fees associated with obtaining new patents not yet issued and defense of existing patents (not yet resolved) of approximately $141,000 are included in other assets as December 31, 2014.
Discontinued Operations, Policy [Policy Text Block]	Manufacturer and Installation Warranties The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $366,000 as of March 31, 2015 and $345,000 at December 31, 2014, is included within “Accrued warranty” in the accompanying consolidated balance sheets. The liability for our manufacturing warranty consists of the following: March 31, 2015 December 31, 2014 Beginning accrued warranty balance $ 938,466 $ 1,312,918 Reduction for labor payments and claims made under the warranty (13,998 ) (75,966 ) Adjustment to warranty liability for discontinued operations (324,349 ) Accruals related to warranties issued during the period 9,620 25,863 Ending accrued warranty balance $ 934,088 $ 938,466	Discontinued Operations Discontinued operations are presented and accounted for in accordance with Accounting Standards Codification (ASC) 360, “ Impairment or Disposal of Long-Lived Assets,” On September 10, 2010, we announced that we were exiting the solar panel installation business. The exit from the installation business was essentially completed at the end of the fourth quarter of 2010. The exit from the installation business was therefore classified as discontinued operations for all periods presented under the requirements of ASC 360. We re-entered the residential and commercial installation business in the fourth quarter 2014. As a result of re-entering the installation business, we reclassified our discontinued operations into continuing operations. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Manufacturer and Installation Warranties The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $371,000 as of December 31, 2014 and $345,000 as of December 31, 2013, is included within “Accrued warranty” in the accompanying consolidated balance sheets. The liability for our manufacturing warranty consists of the following: Years Ended 2014 2013 Beginning accrued warranty balance $ 1,312,918 $ 1,372,342 Reduction for labor payments and claims made under the warranty (75,966 ) (79,134 ) Accruals related to warranties issued during the period 25,863 19,710 Adjustment to warranty liability for discontinued operations (324,349 ) — Ending accrued warranty balance $ 938,466 $ 1,312,918 We previously recorded a provision for warranty liability related to our discontinued installation operations. We provided for a 5-year or a 10-year warranty on the installation of a system and all equipment and incidental supplies other than solar panels and inverters that are covered under the manufacturer warranty. During the year ended December 31, 2014, we re-evaluated our warranty liability related to our discontinued installation operations right before and in conjunction with re-entering the installation operations, we reduced the liability by approximately $324,000. This reduction to the liabilities for discontinued operations was recorded as a gain from operations of discontinued operations. The remaining warranty liability related to our previously discontinued operations was reclassified into current liabilities and has been included in “Accrued warranty.” Defective solar panels or inverters are covered under the manufacturer warranty. In the event that a panel or inverter needs to be replaced, we will replace the defective item within the manufacturer’s warranty period (between 5-25 years).
Fair Value of Financial Instruments, Policy [Policy Text Block]		Fair Value of Financial Instruments The carrying values reported for cash equivalents, accounts receivable, accounts payable, accrued liabilities and the outstanding credit facility approximated their respective fair values at each balance sheet date due to the short-term maturity of these financial instruments.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer. Revenue from installation of a system is recognized when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sales price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. In general, we recognize revenue upon completion of a system installation for residential installations and we recognize revenue under the percentage-of-completion method for commercial installations. Revenue recognition methods for revenue streams that fall under other categories are determined based on facts and circumstances.	Revenue Recognition Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer. Revenue from installation of a system is recognized when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sales price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. In general, we recognize revenue upon completion of a system installation for residential installations and we recognize revenue under the percentage-of-completion method for commercial installations. Revenue recognition methods for revenue streams that fall under other categories are determined based on facts and circumstances.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]		Stock-based Compensation We apply the fair value method under Accounting Standards Codification (ASC) 718 in accounting for our 2001 Stock Option Plan and our 2006 Stock Incentive Plan. Under ASC 718, compensation cost is measured at the grant date based on the fair value of the equity instruments awarded and is recognized over the period during which an employee is required to provide service in exchange for the award, or the requisite service period, which is usually the vesting period. The fair value of the equity award granted is estimated on the date of the grant.
Advertising Costs, Policy [Policy Text Block]		Advertising We expense advertising costs as incurred. Advertising expense, included in “Sales and marketing expenses,” for the years ended December 31, 2014 and 2013, was approximately $15,000 and $16,000, respectively.
Research and Development Expense, Policy [Policy Text Block]		Research and Development Costs Research and development expenses, which include the cost of activities that are useful in developing new products, processes or techniques, as well as expenses for activities that may significantly improve existing products or processes are expensed as incurred. In the years ended December 31, 2014 and 2013, we expensed approximately $178,000 and $243,000, respectively, in costs related to research and development activities that are included under general and administrative expenses on the consolidated statements of operations.
Shipping and Handling Cost, Policy [Policy Text Block]		Shipping and Handling Costs Shipping and handling costs associated with inbound freight are included in cost of inventory and expensed as cost of goods sold when the related inventory is sold.
Income Tax, Policy [Policy Text Block]		Income Taxes Deferred income taxes arise from timing differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. A deferred tax asset valuation allowance is recorded when it is more likely than not that deferred tax assets will not be realized. Utilization of net operating loss carryforwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carryforwards before utilization. We apply the provisions of ASC 740, formerly FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes”
Earnings Per Share, Policy [Policy Text Block]		Earnings Per Share We follow Accounting Standards Codification (ASC) 260 (ASC 260), “ Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities ” In accordance with the Staff Position, basic net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the weighted average number of shares outstanding less the weighted average unvested restricted shares outstanding. Diluted net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the denominator for basic net income (loss) per share and any dilutive effects of stock options, restricted stock, convertible notes and warrants. The following table sets forth the computation of basic and diluted net loss per share: Year Ended December 31, 2014 2013 Basic: Numerator: Net loss $ (1,852,301 ) $ (2,830,047 ) Preferred deemed dividend and preferred stock dividend (18,927 ) (1,028,609 ) Less: Net loss allocated to participating securities 6,005 12,503 $ (1,865,223 ) $ (3,846,153 ) Denominator: Weighted-average shares outstanding 204,471,018 69,477,915 Weighted-average unvested restricted shares outstanding (656,121 ) (306,958 ) Denominator for basic net loss per share 203,814,897 69,170,957 Basic net loss per share attributable to common stockholders $ (0.01 ) $ (0.06 ) The following table sets forth potential shares of common stock at the end of each period presented that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive:
Segment Reporting, Policy [Policy Text Block]	Segment Reporting We are engaged in two business segments, (i) we sell our AC solar panels to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets and (ii) we market, sell, design and install systems for residential and commercial customers. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. During the fourth quarter 2014, we re-entered the solar power installation business. See Note 3 for financial information on our business segments.	Segment Reporting Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. We are engaged in two business segments; (i) we sell our AC solar panels to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets, and (ii) we market, sell, design and install systems for residential and commercial customers. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by management in deciding how to allocate resources and in assessing performance. We re-entered the residential and commercial installation business in the fourth quarter 2014, and we do not report separate segment information because these sales are not material for the year ended December 31, 2014.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Consolidation, Policy [Policy Text Block]		Principles of Consolidation The accompanying consolidated financial statements include the accounts of Andalay Solar and Fairview, pursuant to the Merger as described in Note 1. We also have two wholly-owned subsidiaries as of December 31, 2014 and 2013. Akeena Corp. is a wholly-owned subsidiaries of Andalay Solar, Inc. All inter-company accounts have been eliminated in consolidation.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (“FASB”) issued, Accounting Standards Update (“ASU”) ASU 2015-03 Interests — Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs In February 2015, the FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis In January 2015, ASU 2015-01 Income Statement — Extraordinary and Unusual Items (Subtopic 225-20) Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), to provide guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Since ASU 2014-15 only impacts financial statement disclosure requirements regarding whether there is substantial doubt about an entity’s ability to continue as a going concern, we do not expect its adoption to have an impact on our consolidated financial statements. In November 2014, the FASB issued ASU No. 2014-16, Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity.	Recent Accounting Pronouncements In April 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" (ASU 2014-08). ASU 2014-08 changes the criteria for reporting discontinued operations by requiring that in order for a disposal to qualify as a discontinued operation, the disposal must represent a strategic shift that has (or will have) a major effect on the entity's operations and financial results. ASU 2014-08 also requires additional disclosures both for discontinued operations and individually significant components of an entity that do not qualify as discontinued operations. ASU 2014-08 is effective for annual and interim periods beginning on or after December 15, 2014, with early adoption permitted. We adopted the provisions of ASU 2014-08 and such adoption did not have a material impact on our consolidated financial statements. In May 2014, as part of its ongoing efforts to assist in the convergence of U.S. GAAP and International Financial Reporting Standards (“IFRS”), the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” The new guidance sets forth a new five-step revenue recognition model which replaces the prior revenue recognition guidance in its entirety and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the new standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance. The ASU provides alternative methods of initial adoption and is effective for annual and interim periods beginning after December 15, 2016. We are currently evaluating the impact that this standard will have on our consolidated financial statements. In June 2014, the FASB issued ASU No. 2014-12, "Compensation – Stock Compensation: Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved After a Requisite Service Period" ("ASU 2014-12") Companies commonly issue share-based payment awards that require a specific performance target to be achieved in order for employees to become eligible to vest in the awards. ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period should be treated as a performance condition. The performance target should not be reflected in estimating the grant date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 will be effective for the Company's fiscal years beginning fiscal 2016 and interim reporting periods within that year, using either the retrospective or prospective transition method. Early adoption is permitted. We are currently evaluating the effect of the adoption of this guidance on the condensed consolidated financial statements. In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" ("ASU 2014-15"), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Since ASU 2014-15 only impacts financial statement disclosure requirements regarding whether there is substantial doubt about an entity's ability to continue as a going concern, we do not expect its adoption to have an impact on our consolidated financial statements.
Significan tAccounting Policies and Estimates [Policy Text Block]	Significant Accounting Policies and Estimates There have been no material developments or changes to the significant accounting policies discussed in our 2014 Annual Report on Form 10-K or accounting pronouncements issued or adopted, except as described below.

Note 2 - Summary of Significa35

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Property Plant and Equipment Estimated Useful Lives [Table Text Block]		Category Useful Lives (years) Office Equipment 2 - 5 Vehicles 3 - 5 Leasehold Improvements 2
Schedule of Product Warranty Liability [Table Text Block]	March 31, 2015 December 31, 2014 Beginning accrued warranty balance $ 938,466 $ 1,312,918 Reduction for labor payments and claims made under the warranty (13,998 ) (75,966 ) Adjustment to warranty liability for discontinued operations (324,349 ) Accruals related to warranties issued during the period 9,620 25,863 Ending accrued warranty balance $ 934,088 $ 938,466	Years Ended 2014 2013 Beginning accrued warranty balance $ 1,312,918 $ 1,372,342 Reduction for labor payments and claims made under the warranty (75,966 ) (79,134 ) Accruals related to warranties issued during the period 25,863 19,710 Adjustment to warranty liability for discontinued operations (324,349 ) — Ending accrued warranty balance $ 938,466 $ 1,312,918
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended March 31 , 2015 2014 Basic: Numerator: Net loss $ (825,176 ) $ (84,396 ) Preferred deemed dividend and preferred stock dividend Less: Net loss allocated to participating securities 8 960 $ (825,168 ) $ (83,436 ) Denominator: Weighted-average shares outstanding 328,001,069 132,940,312 Weighted-average unvested restricted shares outstanding (3,322 ) (1,512,311 ) Denominator for basic net loss per share 327,997,747 131,428,001 Basic net loss per share attributable to common stockholders $ (0.00 ) $ (0.00 )	Year Ended December 31, 2014 2013 Basic: Numerator: Net loss $ (1,852,301 ) $ (2,830,047 ) Preferred deemed dividend and preferred stock dividend (18,927 ) (1,028,609 ) Less: Net loss allocated to participating securities 6,005 12,503 $ (1,865,223 ) $ (3,846,153 ) Denominator: Weighted-average shares outstanding 204,471,018 69,477,915 Weighted-average unvested restricted shares outstanding (656,121 ) (306,958 ) Denominator for basic net loss per share 203,814,897 69,170,957 Basic net loss per share attributable to common stockholders $ (0.01 ) $ (0.06 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	March 31, 2015 December 31, 201 4 Stock options outstanding 37,034,483 37,034,483 Unvested restricted stock — 7,186 Warrants to purchase common stock 22,148,045 22,148,045	December 31, 2014 December 31, 2013 Stock options outstanding 37,034,483 5,368,233 Unvested restricted stock 7,186 1,890,952 Warrants to purchase common stock 22,148,045 9,648,045 Preferred stock convertible into common stock — 68,353,582

Note 4 - Accounts Receivable (T

Note 4 - Accounts Receivable (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	March 31, 2015 December 31, 2014 Trade accounts $ 104,005 $ 154,172 Less: Allowance for bad debts (21,972 ) (24,882 ) Less: Allowance for returns (19,647 ) (10,834 ) $ 62,386 $ 118,456	December 31, 2014 December 31, 2013 Trade accounts $ 154,172 $ 575,375 Less: Allowance for bad debts (24,882 ) (2,899 ) Less: Allowance for returns (10,834 ) (4,953 ) $ 118,456 $ 567,523
Allowance for Credit Losses on Financing Receivables [Table Text Block]	Balance as of Beginning of Period Provisions, net Write-Off/ Recovery Balance as of End of Period Three months ended March 31, 2015 $ 24,882 $ 2,909 $ 5,819 $ 21,972 Year ended December 31, 2014 $ 2,899 $ 36,763 $ (14,780 ) $ 24,882	Balance as of Beginning of Period Provisions, net Write-Off Balance as of End of Period Year ended December 31, 2014 $ 2,899 $ 36,763 $ (14,780 ) $ 24,882 Year ended December 31, 2013 $ 108,750 $ 92,224 $ (198,075 ) $ 2,899

Note 5 - Inventory (Tables)

Note 5 - Inventory (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	March 31, 2015 December 31, 2014 Finished goods $ 631,616 $ 669,706 Work in process 70,329 58,666 $ 701,945 $ 728,372	December 31, 2014 December 31, 2013 Finished goods $ 669,706 $ 654,970 Work in process 58,666 131,666 $ 728,372 $ 786,636

Note 6 - Prepaid Expenses and38

Note 6 - Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Schedule of Other Assets [Table Text Block]	December 31, 2014 December 31, 2013 Prepaid insurance $ 116,243 $ 152,812 Prepaid - other 46,471 68,906 Vendor deposits 117,352 95,792 $ 280,066 $ 317,510

Note 7 - Property and Equipme39

Note 7 - Property and Equipment, Net (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	March 31, 2015 December 31, 2014 Office equipment $ 436,051 $ 436,051 Leasehold improvements 123,278 123,278 Vehicles 17,992 17,992 577,321 577,321 Less: Accumulated depreciation and amortization (576,971 ) (576,622 ) $ 350 $ 699	December 31, 2014 December 31, 2013 Office equipment $ 436,051 $ 436,051 Leasehold improvements 123,278 123,278 Vehicles 17,992 17,992 577,321 577,321 Less: Accumulated depreciation and amortization (576,622 ) (563,467 ) $ 699 $ 13,854

Note 8 - Accrued Liabilities (T

Note 8 - Accrued Liabilities (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	March 31, 2015 December 31, 2014 Accrued salaries, wages, benefits and bonus $ 63,876 $ 45,586 Sales tax payable 3,646 662 Accrued accounting and legal fees 61,050 — Customer deposit payable 33,604 41,265 Accrued interest 22,256 5,683 Other accrued liabilities 20,361 11,033 $ 204,793 $ 104,229	December 31, 2014 December 31, 2013 Accrued salaries, wages, benefits and bonus $ 45,586 $ 45,456 Sales tax payable 662 4,409 Customer deposit payable 41,265 580 Accrued interest 5,683 6,288 Other accrued liabilities 11,033 32,997 $ 104,229 $ 89,730

Note 9 - Convertible Notes Pa41

Note 9 - Convertible Notes Payable and Credit Facility (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Convertible Debt [Table Text Block]	December 31, 2014 December 31, 2013 Convertible notes payable $ 520,000 $ 650,000 Convertible notes payable issued for financial advisory services 10,000 60,000 Less: Derivative liability (93,376 ) (243,889 ) Less: Relative fair value of warrants (170,767 ) (53,623 ) Accreted interest 79,358 21,889 Accrued interest 28,284 7,707 Convertible notes payable, net 373,499 442,084 Less current portion (30,000 ) (60,000 ) $ 343,499 $ 382,084

Note 13 - Stock Option and In42

Note 13 - Stock Option and Incentive Plan (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	Number of Restricted Shares Weighted-Average Grant Date Fair Value Outstanding and not vested beginning balance as of January 1, 2015 7,186 $ 2.16 Granted — $ — Forfeited/cancelled — $ — Released/vested (7,186 ) $ 2.16 Outstanding and not vested as of March 31, 2015 — $ —	Number of Restricted Shares Weighted-Average Grant Date Fair Value Outstanding and not vested beginning balance as of January 1, 2013 48,073 $ 2.50 Granted 2,500,000 $ 0.03 Forfeited/cancelled (21,798 ) $ 2.46 Released/vested (635,323 ) $ 0.08 Outstanding and not vested beginning balance as of January 1, 2014 1,890,952 $ 0.05 Granted — $ — Forfeited/cancelled — $ — Released/vested (1,883,766 ) $ 0.04 Outstanding and not vested as of December 31, 2014 7,186 $ 2.16
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Shares Subject to Option Weighted- Average Exercise Price Outstanding as of January 1, 2015 37,034,483 $ 0.03 Granted — $ — Forfeited/cancelled/expired — $ — Exercised — $ — Outstanding as of March 31, 2015 37,034,483 $ 0.03 Exercisable as of March 31, 2015 7,321,779 $ 0.07	Number of Shares Subject To Option 2014 Weighted- Average Exercise Price Number of Shares Subject To Option 20 13 Weighted-Average Exercise Price Outstanding beginning balance 6,618,233 $ 0.11 679,744 $ 2.82 Granted during the year 30,456,250 0.02 6,400,000 0.03 Forfeited/cancelled/expired during the year (40,000 ) 5.15 (461,511 ) 3.29 Exercised during the year — — — — Outstanding at end of year 37,034,483 $ 0.03 6,618,233 $ 0.11 Exercisable at end of year 5,934,303 $ 0.09 2,330,650 $ 0.28 Outstanding and expected to vest 36,916,502 $ 0.03 6 191,212 $ 0.11
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]		Years Ended December 31 , 201 4 201 3 Weighted-average volatility 185.0 % 105.5 % Expected dividends 0.0 % 0.0 % Expected life (in years) 3.5 2.0 Weighted-average risk-free interest rate 1.1 % 0.30 %
Schedule of Nonvested Share Activity [Table Text Block]		Non-Vested Stock Options Weighted-Average Grant Date Fair Value Outstanding as of January 1, 2014 4,287,583 $ 0.02 Granted 30,456,250 $ 0.02 Forfeited/cancelled (40,000 ) $ 3.04 Released/vested (3,637,403 ) $ 0.02 Outstanding as of December 31, 2014 31,066,430 $ 0.02
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]		Options Outstanding Vested Options Number Weighted- Weighted- Number Weighted- Average $0.0192 12,450,000 4.6 $ 0.02 358,320 $ 0.02 $0.020 - $0.023 18,000,000 4.6 $ 0.02 1,125,000 $ 0.02 $0.0296 6,400,000 3.8 $ 0.0296 4,266,500 $ 0.0296 $0.11 - $5.32 184,483 1.3 $ 1.95 184,483 $ 1.95 $0.0192 - $5.32 37,034,483 4.4 $ 0.03 5,934,303 $ 0.09

Note 14 - Stock Warrants and 43

Note 14 - Stock Warrants and Warrant Liability (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrants for Number of S hares Weighted-Average Exercise Price Outstanding at January 1, 2015 22,148,045 $ 0.23 Issued — — Exercised — — Cancelled/expired — — Outstanding at March 31, 2015 22,148,045 $ 0.23	Warrants for Number of Shares Weighted-Average Exercise Price Outstanding as of December 31, 2013 9,648,045 $ 0.49 Issued 12,500,000 0.02 Exercised — — Cancelled/expired — — Outstanding as of December, 2014 22,148,045 $ 0.23

Note 15 - Fair Value Measurem44

Note 15 - Fair Value Measurement (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Liabilities Level 1 Level 2 Level 3 December 31, 201 4 Fair value of derivative liability – embedded conversion feature $ — $ — $ 129,598 $ 129,598 Total $ — $ — $ 129,598 $ 129,598	Liabilities Level 1 Level 2 Level 3 December 31, 2014 Fair value of embedded derivatives — — $ 129,598 $ 129,598 Total $ — $ — $ 129,598 $ 129,598 Liabilities Level 1 Level 2 Level 3 December 31, 201 3 Fair value of embedded derivatives $ — $ — $ 177,927 $ 177,927 Total $ — $ — $ 177,927 $ 177,927
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Derivative Liability – Embedded Conversion Feature Total Level 3 Beginning balance – January 1, 2015 $ 129,598 $ 129,598 Issuances — — Conversions (88,333 ) (88,333 ) Total realized and unrealized gains or losses (41,265 ) (41,265 ) Ending balance – March 31, 2015 $ — $ —	Embedded Derivative on Convertible Notes Total Level 3 Beginning balance – January 1, 2014 $ 177,927 $ 177,927 Issuances 122,630 122,630 Total realized and unrealized gains or losses (50,809 ) (50,809 ) Transfers out of level 3 upon exercise or conversion (221,768 ) (221,768 ) Ending balance – December 31, 2014 $ 129,598 $ 129,598

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	December 31, December 31, 2014 2013 Tax at federal statutory rate $ (740,000 ) $ (967,000 ) State taxes, net of federal benefit (117,000 ) (160,000 ) Research and development credits — (12,000 ) Fair market value of warrants & derivatives 17,000 (22,000 ) Stock-based compensation 51,000 29,000 Other permanent items 10,000 1,000 Valuation allowance 779,000 1,131,000 Income tax provision $ — $ —
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, December 31, 2014 2013 Deferred tax assets: Net operating loss and credit carryforwards $ 30,227,000 $ 29,431,000 Stock-based compensation 1,199,000 1,193,000 Stock-based compensation 422,000 558,000 Basis difference for fixed assets and intangibles 158,000 174,000 Total gross deferred tax assets 32,006,000 31,356,000 Valuation allowance (32,006,000 ) (31,356,000 ) Net deferred tax assets $ — $ —
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	2014 2013 Balance, beginning of year $ 147,000 $ 140,000 Additions based on tax positions related to the current year — — Additions for tax positions related to prior years — 7,000 Reductions for tax positions related to prior years — — Balance, end of year $ 147,000 $ 147,000

Note 18 - Concentration of Ri46

Note 18 - Concentration of Risk in Customer and Supplier Relationships (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Tables) [Line Items]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]		Years Ended December 31 , 2014 2013 Smart Energy Today 13.3 % 13.5 % WDC Solar, Inc. 12.0 % 14.7 % JCF Wholesale 8.7 % 10.6 % Lowe’s 5.9 % 6.9 % Sustainable Environmental Enterprises 1.3 % 52.8 %
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Tables) [Line Items]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]		December 31 , 2014 2013 WDC Solar, Inc. 40.1 % — Lowe’s 16.8 % — Sustainable Environmental Enterprises — % 86.7 % Smart Energy Today 6.5 % —
Sales Revenue, Goods, Net [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Tables) [Line Items]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended March 31 , 2015 2014 Smart Energy Today 34.9 % — Helco Electric 12.7 % 22.9 % Verengo Solar 13.9 % — Sustainable Environmental Enterprises — 11.7 % Shoreline Electric — 31.9 %
Accounts Receivable [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Tables) [Line Items]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	March 31, 2015 December 31, 2014 WDC Solar, Inc. 62.4 % 40.1 % Lowe’s Retail 11.6 % 16.8 % Greg Teegarden 11.4 % — Smart Energy — 6.5 %

Note 3 - Segment Reporting (Tab

Note 3 - Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended March 31, Revenue 2015 2014 Distribution $ 166,136 $ 142,482 Installation 108,505 — $ 274,641 $ 142,482 Three Months Ended March 31, Gross profit (loss) 2015 2014 Distribution $ (9,975 ) $ 7,094 Installation (1,766 ) — $ (11,741 ) $ 7,094 Assets March 31, 2015 December 31, 2014 Distribution $ 2,482,508 $ 2,560,940 Installation 20,997 — $ 2,503,505 $ 2,560,940

Note 13 - Earnings Per Share (T

Note 13 - Earnings Per Share (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended March 31 , 2015 2014 Basic: Numerator: Net loss $ (825,176 ) $ (84,396 ) Preferred deemed dividend and preferred stock dividend Less: Net loss allocated to participating securities 8 960 $ (825,168 ) $ (83,436 ) Denominator: Weighted-average shares outstanding 328,001,069 132,940,312 Weighted-average unvested restricted shares outstanding (3,322 ) (1,512,311 ) Denominator for basic net loss per share 327,997,747 131,428,001 Basic net loss per share attributable to common stockholders $ (0.00 ) $ (0.00 )	Year Ended December 31, 2014 2013 Basic: Numerator: Net loss $ (1,852,301 ) $ (2,830,047 ) Preferred deemed dividend and preferred stock dividend (18,927 ) (1,028,609 ) Less: Net loss allocated to participating securities 6,005 12,503 $ (1,865,223 ) $ (3,846,153 ) Denominator: Weighted-average shares outstanding 204,471,018 69,477,915 Weighted-average unvested restricted shares outstanding (656,121 ) (306,958 ) Denominator for basic net loss per share 203,814,897 69,170,957 Basic net loss per share attributable to common stockholders $ (0.01 ) $ (0.06 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	March 31, 2015 December 31, 201 4 Stock options outstanding 37,034,483 37,034,483 Unvested restricted stock — 7,186 Warrants to purchase common stock 22,148,045 22,148,045	December 31, 2014 December 31, 2013 Stock options outstanding 37,034,483 5,368,233 Unvested restricted stock 7,186 1,890,952 Warrants to purchase common stock 22,148,045 9,648,045 Preferred stock convertible into common stock — 68,353,582

Note 1 - Description of Busin49

Note 1 - Description of Business (Details)	Apr. 13, 2011shares	Mar. 31, 2015$ / sharesshares	Dec. 31, 2014$ / sharesshares	Dec. 31, 2013$ / sharesshares	Aug. 11, 2006$ / shares	Aug. 10, 2006$ / sharesshares
Reverse Stock Split [Member]
Note 1 - Description of Business (Details) [Line Items]
Stockholders' Equity Note, Stock Split, Conversion Ratio	4
Number of Shares of Target Company that Each Share of Common Stock Receives in a Merger Transaction						1
Common Stock, Par or Stated Value Per Share | $ / shares		$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.01
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000

Note 2 - Summary of Significa50

Note 2 - Summary of Significant Accounting Policies (Details)

May. 12, 2015USD ($)$ / sharesshares

Apr. 20, 2015USD ($)

Apr. 06, 2015USD ($)

Feb. 27, 2015

Jan. 20, 2015$ / sharesshares

Jan. 16, 2015$ / sharesshares

Dec. 10, 2014USD ($)shares

Mar. 31, 2014USD ($)

Mar. 26, 2014USD ($)shares

Mar. 18, 2014USD ($)$ / sharesshares

Feb. 26, 2014

Feb. 25, 2014USD ($)$ / sharesshares

Jan. 23, 2014USD ($)

Jan. 22, 2014USD ($)

Dec. 19, 2013USD ($)$ / sharesshares

Nov. 20, 2013USD ($)

Oct. 21, 2013USD ($)

Jan. 15, 2013USD ($)

Apr. 20, 2015shares

Apr. 30, 2014$ / sharesshares

Apr. 17, 2014USD ($)shares

Apr. 16, 2014USD ($)$ / shares

Apr. 16, 2014$ / sharesshares

Mar. 31, 2014USD ($)shares

Mar. 18, 2014USD ($)$ / sharesshares

Feb. 28, 2014USD ($)

Feb. 26, 2014USD ($)

Feb. 25, 2014USD ($)$ / sharesshares

Dec. 31, 2013USD ($)$ / shares

Dec. 19, 2013USD ($)$ / sharesshares

Nov. 20, 2013USD ($)

Oct. 31, 2013USD ($)

Oct. 21, 2013USD ($)

Sep. 30, 2013USD ($)shares

Mar. 31, 2015USD ($)$ / sharesshares

Mar. 31, 2014USD ($)

Apr. 10, 2015USD ($)$ / sharesshares

Dec. 31, 2014USD ($)$ / sharesshares

Dec. 31, 2013USD ($)$ / shares

Dec. 19, 2013USD ($)$ / shares

Dec. 31, 2010USD ($)

Oct. 25, 2014USD ($)

Sep. 30, 2014USD ($)

Aug. 11, 2014shares

Jul. 08, 2014USD ($)

Jul. 01, 2014USD ($)

Jun. 18, 2014USD ($)

Jun. 04, 2014USD ($)

Jun. 02, 2014USD ($)

May. 02, 2014USD ($)

Apr. 02, 2014USD ($)

Mar. 21, 2014shares

Mar. 02, 2014USD ($)

Feb. 02, 2014USD ($)

Jan. 27, 2014USD ($)

Jan. 02, 2014USD ($)

Dec. 02, 2013USD ($)

Nov. 25, 2013USD ($)

Nov. 02, 2013USD ($)

Aug. 30, 2013USD ($)shares

Convertible Notes Maturing on August 29, 2015 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

Convertible Notes Maturing on November 25, 2013 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

Convertible Notes Maturing on December 19, 2013 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 250,000

$ 250,000

$ 250,000

Convertible Notes Maturing on January 27, 2016 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 100,000

Convertible Notes Maturing on February 25, 2016 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

$ 200,000

Convertible Notes Maturing on March 18, 2016 [Member] | Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 300,000

$ 300,000

Settled [Member] | ASC Recap LLC [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.031

Stock Issued During Period, Shares, Other (in Shares) | shares

8,079,800

8,079,800

Accounts Receivable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

$ 200,000

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

80.00%

Raw Materials [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

50.00%

Finished Goods [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

65.00%

Cash [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

95.00%

Aggregate, Cash, Raw Material, and Finished Goods [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

$ 300,000

Matures October 31, 2014 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures November 30, 2014 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures December 31, 2014 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures January 31, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures February 28, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures Between October 31, 2014 And February 28, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 150,000

Matures March 31, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures April 30, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures May 31, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures Between March 31, 2015 and May 31, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 60,000

Matures June 30, 2015 [Member] | Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Face Amount

$ 10,000

Convertible Note Payable [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

Debt Conversion, Original Debt, Amount

$ 940,000

Interest on Convertible Debt, Accrued and Converted

$ 68,319

Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares

50,439,751

Advances [Member] | Minimum [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Monthly Interest Expense, Debt

$ 500

Advances [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Monthly Interest Expense, Debt

$ 500

Upon Effectiveness of Registration Statement [Member] | Southridge Partners II, LP [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares) | shares

500,000

500,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.0169

First Draw Down Notice [Member] | Southridge Partners II, LP [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares) | shares

500,000

500,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.0161

Series D Preferred Stock [Member] | Securities Pledged as Collateral [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Preferred Stock, Shares Issued (in Shares) | shares

50

Series D Preferred Stock [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Preferred Stock, Shares Issued (in Shares) | shares

930

Minimum [Member] | Solar Panels and Inverters [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

15 years

15 years

Minimum [Member] | Installation [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

5 years

Minimum [Member] | Defective Products [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

5 years

Maximum [Member] | Solar Panels and Inverters [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

25 years

25 years

Maximum [Member] | Installation [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

10 years

Maximum [Member] | Defective Products [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

25 years

Maximum [Member] | Southridge Partners II, LP [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Additional Take-Down Request, Amount

$ 125,000

Common Stock, Value, Subscriptions

$ 5,000,000

Maximum [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Line of Credit Facility, Administrative Fee, Amount

$ 500

Common Stock, Subscription Period

18 months

Patents [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Finite-Lived Intangible Assets, Remaining Amortization Period

9 years 9 months

10 years

Finite-Lived Intangible Assets, Net

$ 1,100,000

Finite-Lived Intangible Assets, Accumulated Amortization

$ 314,000

Finite-Lived Intangible Asset, Useful Life

17 years

Amortization of Intangible Assets

$ 113,000

$ 113,000

Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months

113,000

Other Finite-Lived Intangible Assets, Gross

$ 141,000

Warrants in Connection with December 19, 2013 Convertible Note [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Class of Warrant or Right, Issued During Period (in Shares) | shares

6,250,000

Warrants in Connection with Feb. 25, 2014 Convertible Note [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Class of Warrant or Right, Issued During Period (in Shares) | shares

5,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

Warrants in Connection with March 18, 2014 Convertible Note [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Class of Warrant or Right, Term of Warrants or Rights

5 years

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares

7,500,000

7,500,000

Warrants in Connection with December 2013 Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

149.10%

149.10%

Fair Value Assumptions, Risk Free Interest Rate

0.70%

0.70%

Fair Value Assumptions, Expected Term

4 years 36 days

4 years 36 days

Debt Instrument, Unamortized Discount

$ 109,000

$ 109,000

Warrants in Connection with February 2014 Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

169.10%

Fair Value Assumptions, Risk Free Interest Rate

0.70%

Fair Value Assumptions, Expected Term

4 years 36 days

Debt Instrument, Unamortized Discount

$ 101,000

Warrants in Connection with March 2014 Convertible Debt [Member

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

168.80%

Fair Value Assumptions, Risk Free Interest Rate

0.80%

Fair Value Assumptions, Expected Term

4 years 36 days

Debt Instrument, Unamortized Discount

$ 154,000

$ 154,000

$ 154,000

Convertible Debt [Member] | Subsequent Event [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Term

1 year

Convertible Debt [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Class of Warrant or Right, Issued During Period (in Shares) | shares

5,000,000

6,250,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares

$ 0.02

0.02

$ 0.02

$ 0.02

$ 0.02

$ 0.02

$ 0.02

Class of Warrant or Right, Term of Warrants or Rights

5 years

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares

7,500,000

7,500,000

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

$ 0.02

$ 0.02

Debt Instrument, Convertible, Threshold Consecutive Trading Days

20 days

Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share) | $ / shares

$ 0.04

Line of Credit Facility, Repayment of Principle and Accrued Interest, Total, Percent

120.00%

120.00%

Derivative Asset, Fair Value, Gross Liability

$ 123,000

Embedded Derivative, Fair Value of Embedded Derivative Liability

178,000

$ 178,000

$ 178,000

178,000

Embedded Derivative, Gain (Loss) on Embedded Derivative, Net

$ 41,000

$ 51,000

Debt Conversion, Original Debt, Amount

520,000

Interest on Convertible Debt, Accrued and Converted

$ 47,134

Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares

34,565,577

ASC Recap LLC [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Agreement with Party to Sell Prior Debt Owed to Creditors Amount of Prior Debt Owed

$ 3,700,000

Market Value of Outstanding Debt Principal Percent

25.00%

Litigation Settlement, Amount

$ 250,000

$ 250,000

Extinguishment of Debt, Amount

1,027,705

Discounted Stock Issuance Price

250.00%

Gains (Losses) on Extinguishment of Debt

$ 769,148

Subsequent Event [Member] | Southridge Partners II, LP [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Proceeds from Issuance of Common Stock

$ 929,000

$ 94,000

$ 55,000

Stock Issued During Period, Shares, New Issues (in Shares) | shares

67,813,489

14,000,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.0137

Subsequent Event [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Proceeds from Issuance of Common Stock

$ 780,000

Stock Issued During Period, Shares, New Issues (in Shares) | shares

53,781,201

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.013

Material and Workmanship [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Warranty Period

5 years

5 years

Product Warranty Accrual, Current

345,000

$ 366,000

$ 371,000

345,000

Installation [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Standard Product Warranty Accrual, Preexisting, Increase (Decrease)

(324,000)

Southridge Partners II, LP [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

Commmon Stock, Equity Purchase Agreement, Committment To Be Purchased, Value

$ 5,000,000

$ 5,000,000

Common Stock, Subscription Period

18 years

Common Stock, Shares Subscribed but Unissued (in Shares) | shares

3,200,000

35,000,000

Initial Take-Down Request, Amount

$ 300,000

Proceeds from Issuance of Common Stock

$ 100,000

$ 200,000

Additional Take-Down Request, Amount

$ 52,000

$ 125,000

$ 100,000

$ 100,000

Stock Issued During Period, Shares, New Issues (in Shares) | shares

12,541,806

500,000

44,079,800

500,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

Debt Issuance Costs, Commitment Fee, Number of Securities (in Shares) | shares

1,000,000

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs

16,500

Cash

$ 135,000

62,000

Restructuring and Related Cost, Number of Positions Eliminated

12

Restructuring Charges

$ 0

$ 3,000,000

Debt Instrument, Face Amount

$ 650,000

$ 520,000

$ 650,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares

$ 0.49

$ 0.23

$ 0.23

$ 0.49

Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

$ 0.02

Debt Instrument, Convertible, Threshold Consecutive Trading Days

20 days

Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share) | $ / shares

$ 0.04

Derivative Asset, Fair Value, Gross Liability

$ 243,889

$ 243,889

$ 243,889

Embedded Derivative, Fair Value of Embedded Derivative Liability

$ 177,927

$ 129,598

$ 177,927

Embedded Derivative, Gain (Loss) on Embedded Derivative, Net

(50,809)

65,962

Line of Credit Facility, Initiation Date

Sep. 30, 2013

Line of Credit Facility, Expiration Period

1 year

Line of Credit Facility, Maximum Borrowing Capacity

$ 500,000

Line of Credit Facility, Collateral Fees, Amount

$ 5,000

Line of Credit Facility, Administrative Fee, Percentage

0.50%

Line of Credit Facility, Administrative Fee, Amount

$ 500

Prepayment Fee, Percent

0.50%

Long-term Line of Credit

$ 500,000

$ 500,000

$ 350,000

500,000

Proceeds from Lines of Credit

$ 50,000

$ 100,000

$ 50,000

$ 100,000

$ 100,000

Finite-Lived Intangible Assets, Net

1,244,712

$ 1,144,342

1,131,327

1,244,712

Amortization of Intangible Assets

29,358

28,347

113,385

113,071

Product Warranty Accrual, Current

1,312,918

$ 934,088

938,466

1,312,918

Standard Product Warranty Accrual, Preexisting, Increase (Decrease)

(324,349)

Advertising Expense

15,000

16,000

Research and Development Expense

$ 178,000

243,000

Number of Operating Segments

2

2

Common Stock, Subscription Period

18 months

18 months

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs

$ 36,618

40,602

Debt Settlement Price

25.00%

Gains (Losses) on Extinguishment of Debt

$ 769,148

$ 769,148

Cash Equivalents, at Carrying Value

$ 0

$ 0

$ 0

Note 2 - Summary of Significa51

Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary	12 Months Ended
	Dec. 31, 2014
Minimum [Member] | Office Equipment [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary [Line Items]
Property and Equipment	2 years
Minimum [Member] | Vehicles [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary [Line Items]
Property and Equipment	3 years
Maximum [Member] | Office Equipment [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary [Line Items]
Property and Equipment	5 years
Maximum [Member] | Vehicles [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary [Line Items]
Property and Equipment	5 years
Leasehold Improvements [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives Summary [Line Items]
Property and Equipment	2 years

Note 2 - Summary of Significa52

Note 2 - Summary of Significant Accounting Policies (Details) - Liability for Manufacturing Warranty - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Liability for Manufacturing Warranty [Abstract]
Warranty balance	$ 938,466	$ 1,312,918	$ 1,312,918	$ 1,372,342
Reduction for labor payments and claims made under the warranty	(13,998)	(75,966)	(75,966)	(79,134)
Accruals related to warranties issued during the period	9,620	25,863	25,863	19,710
Adjustment to warranty liability for discontinued operations			(324,349)
Warranty balance	$ 934,088	$ 938,466	$ 938,466	$ 1,312,918

Note 2 - Summary of Significa53

Note 2 - Summary of Significant Accounting Policies (Details) - Computation of Basic and Diluted Net Loss Per Share - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Numerator:
Net loss	$ (825,176)	$ (69,942)	$ (1,852,301)	$ (2,830,047)
Preferred deemed dividend and preferred stock dividend			(18,927)	(1,028,609)
Less: Net loss allocated to participating securities	8	960	6,005	12,503
	$ (825,168)	$ (83,436)	$ (1,865,223)	$ (3,846,153)
Denominator:
Weighted-average shares outstanding (in Shares)	328,001,069	132,940,312	204,471,018	69,477,915
Weighted-average unvested restricted shares outstanding (in Shares)	3,322	1,512,311	(656,121)	(306,958)
Denominator for basic net loss per share (in Shares)	327,997,747	131,428,001	203,814,897	69,170,957
Basic net loss per share attributable to common stockholders (in Dollars per share)	$ 0	$ 0	$ (0.01)	$ (0.06)

Note 2 - Summary of Significa54

Note 2 - Summary of Significant Accounting Policies (Details) - Antidilutive Securities - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities		37,034,483	5,368,233
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities		7,186	1,890,952
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	22,148,045	22,148,045	9,648,045
Preferred Stock - Convertible [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities			68,353,582

Note 3 - Discontinued Operati55

Note 3 - Discontinued Operations (Details) - USD ($)	Jan. 15, 2013	Dec. 31, 2014	Mar. 31, 2011	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2010
Discontinued Operations and Disposal Groups [Abstract]
Restructuring Charges	$ 0					$ 3,000,000
Severance Costs						765,000
Inventory Write-down				$ 0		948,000
Impairment of Leasehold						307,000
Goodwill, Impairment Loss						299,000
Impairment of Long-Lived Assets to be Disposed of						290,000
Other Asset Impairment Charges						367,000
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax						$ (6,500,000)
Standard Product Warranty Accrual, Preexisting, Increase (Decrease)					$ (324,349)
Escrow Deposit			$ 200,000
Escrow Deposit Disbursements			$ 40,000
Escrow Deposit Returned		$ 110,000			$ 110,000

Note 4 - Accounts Receivable (D

Note 4 - Accounts Receivable (Details) - Accounts Receivable - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable [Abstract]
Trade accounts	$ 104,005	$ 154,172	$ 575,375
Less: Allowance for bad debts	(21,972)	(24,882)	(2,899)
Less: Allowance for returns	(19,647)	(10,834)	(4,953)
	$ 62,386	$ 118,456	$ 567,523

Note 4 - Accounts Receivable 57

Note 4 - Accounts Receivable (Details) - Allowance for Doubtful Accounts - USD ($)	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Allowance for Doubtful Accounts [Abstract]
Balance at beginning of period	$ 2,899	$ 108,750	$ 24,882	$ 2,899	$ 2,899
Provisions, net	36,763	92,224	2,909	$ (4,492)	36,763	$ 92,224
Balance at end of period	24,882	2,899	21,972		24,882	$ 2,899
Write-off/recovery	$ (14,780)	$ (198,075)	$ 5,819		$ (14,780)

Note 5 - Inventory (Details)

Note 5 - Inventory (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2010
Inventory Disclosure [Abstract]
Inventory Write-down	$ 0	$ 948,000

Note 5 - Inventory (Details) -

Note 5 - Inventory (Details) - Inventory Schedule - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Inventory Schedule [Abstract]
Finished goods	$ 631,616	$ 669,706	$ 654,970
Work in process	70,329	58,666	131,666
	$ 701,945	$ 728,372	$ 786,636

Note 6 - Prepaid Expenses and60

Note 6 - Prepaid Expenses and Other Current Assets (Details) - USD ($)	1 Months Ended		12 Months Ended
	Dec. 31, 2014	Mar. 31, 2011	Dec. 31, 2014	Mar. 31, 2015
Other Assets [Member]
Note 6 - Prepaid Expenses and Other Current Assets (Details) [Line Items]
Escrow Deposit				$ 90,000
Escrow Deposit		$ 200,000
Escrow Deposit Disbursements		$ 40,000
Escrow Deposit Returned	$ 110,000		$ 110,000

Note 6 - Prepaid Expenses and61

Note 6 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Prepaid Expenses and Other Current Assets [Abstract]
Prepaid insurance		$ 116,243	$ 152,812
Prepaid - other		46,471	68,906
Vendor deposits		117,352	95,792
	$ 315,377	$ 280,066	$ 317,510

Note 7 - Property and Equipme62

Note 7 - Property and Equipment, Net (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]
Depreciation	$ 349	$ 4,920	$ 13,155	$ 33,023

Note 7 - Property and Equipme63

Note 7 - Property and Equipment, Net (Details) - Property and Equipment, Net - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 436,051	$ 436,051	$ 436,051
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	123,278	123,278	123,278
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,992	17,992	17,992
Property and equipment, gross	577,321	577,321	577,321
Less: Accumulated depreciation and amortization	(576,971)	(576,622)	(563,467)
	$ 350	$ 699	$ 13,854

Note 8 - Accrued Liabilities (D

Note 8 - Accrued Liabilities (Details) - Accrued Liabilities - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accrued Liabilities [Abstract]
Accrued salaries, wages, benefits and bonus	$ 63,876	$ 45,586	$ 45,456
Sales tax payable	3,646	662	4,409
Customer deposit payable	33,604	41,265	580
Accrued interest	22,256	5,683	6,288
Other accrued liabilities	20,361	11,033	32,997
	$ 204,793	$ 104,229	$ 89,730

Note 9 - Convertible Notes Pa65

Note 9 - Convertible Notes Payable and Credit Facility (Details) - USD ($)

Feb. 27, 2015

Mar. 18, 2014

Nov. 20, 2013

Oct. 21, 2013

Mar. 31, 2014

Mar. 18, 2014

Feb. 28, 2014

Feb. 25, 2014

Dec. 31, 2013

Dec. 19, 2013

Nov. 20, 2013

Oct. 31, 2013

Oct. 21, 2013

Sep. 30, 2013

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 19, 2013

Jul. 01, 2014

Jun. 02, 2014

May. 02, 2014

Apr. 02, 2014

Mar. 02, 2014

Feb. 02, 2014

Jan. 27, 2014

Jan. 02, 2014

Dec. 02, 2013

Nov. 25, 2013

Nov. 02, 2013

Aug. 30, 2013

Minimum [Member] | Advances [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Monthly Interest Expense, Debt

$ 500

Maximum [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line of Credit Facility, Administrative Fee, Amount

500

Warrants in Connection with December 2013 Convertible Debt [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

149.10%

149.10%

Fair Value Assumptions, Risk Free Interest Rate

0.70%

0.70%

Fair Value Assumptions, Expected Term

4 years 36 days

4 years 36 days

Debt Instrument, Unamortized Discount

$ 109,000

$ 109,000

Warrants in Connection with February 2014 Convertible Debt [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

169.10%

Fair Value Assumptions, Risk Free Interest Rate

0.70%

Fair Value Assumptions, Expected Term

4 years 36 days

Debt Instrument, Unamortized Discount

$ 101,000

Warrants in Connection with March 2014 Convertible Debt [Member

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Fair Value Assumptions, Expected Volatility Rate

168.80%

Fair Value Assumptions, Risk Free Interest Rate

0.80%

Fair Value Assumptions, Expected Term

4 years 36 days

Debt Instrument, Unamortized Discount

$ 154,000

$ 154,000

Convertible Debt [Member] | Convertible Notes Maturing on August 29, 2015 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

Convertible Debt [Member] | Convertible Notes Maturing on November 25, 2015 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

Convertible Debt [Member] | Convertible Notes Maturing on December 19, 2015 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 250,000

$ 250,000

Convertible Debt [Member] | Convertible Notes Maturing on January 27, 2016 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 100,000

Convertible Debt [Member] | Convertible Notes Maturing on February 25, 2016 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 200,000

Convertible Debt [Member] | Convertible Notes Maturing on March 18, 2016 [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 300,000

$ 300,000

Convertible Debt [Member] | Adjustment to the Fair Value of Embedded Derivatives [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Derivative Asset, Fair Value, Gross Liability

$ 178,000

Convertible Debt [Member] | Subsequent Event [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Term

1 year

Convertible Debt [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Class of Warrant or Right, Issued During Period (in Shares)

5,000,000

6,250,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.02

$ 0.02

$ 0.02

$ 0.02

$ 0.02

Class of Warrant or Right, Term of Warrants or Rights

5 years

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

7,500,000

7,500,000

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.02

$ 0.02

$ 0.02

Debt Instrument, Convertible, Threshold Consecutive Trading Days

20 days

Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share)

$ 0.04

Debt Conversion, Original Debt, Amount

$ 520,000

Interest on Convertible Debt, Accrued and Converted

$ 47,134

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

34,565,577

Line of Credit Facility, Repayment of Principle and Accrued Interest, Total, Percent

120.00%

120.00%

Derivative Asset, Fair Value, Gross Liability

$ 123,000

Embedded Derivative, Gain (Loss) on Embedded Derivative, Net

$ 41,000

51,000

Interest Payable, Current

7,707

28,284

7,707

Accounts Receivable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

$ 200,000

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

80.00%

Raw Materials [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

50.00%

Finished Goods [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

65.00%

Cash [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

95.00%

Aggregate, Cash, Raw Material, and Finished Goods [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

$ 300,000

Cash [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Line Of Credit Facility, Maximum Borrowing Capacity, Percentage

95.00%

Matures November 30, 2014 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures December 31, 2014 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures January 31, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures February 28, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures October 31, 2014 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 30,000

Matures Between October 31, 2014 And February 28, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

150,000

Matures March 31, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures April 30, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures May 31, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 20,000

Matures Between February 28, 2015 And May 31, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 60,000

$ 60,000

Matures June 30, 2015 [Member] | Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Face Amount

$ 10,000

Convertible Notes Payable [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.02

$ 0.02

Debt Conversion, Original Debt, Amount

940,000

Interest on Convertible Debt, Accrued and Converted

$ 68,319

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

50,439,751

Convertible Debt [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.01

Debt Instrument, Term

1 year

Convertible Notes Payable

$ 500,000

Interest Payable, Current

10,000

Debt Instrument, Convertible, Beneficial Conversion Feature

$ 275,000

Beneficial Coversion Feature Amortization Period

12 months

Amortization of Debt Discount (Premium)

$ 23,000

Advances [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Monthly Interest Expense, Debt

$ 500

Securities Pledged as Collateral [Member] | Series D Preferred Stock [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Preferred Stock, Shares Issued (in Shares)

50

Series D Preferred Stock [Member]

Note 9 - Convertible Notes Payable and Credit Facility (Details) [Line Items]

Preferred Stock, Shares Issued (in Shares)

930

Convertible Notes Payable

$ 200,000

Debt Instrument, Face Amount

$ 650,000

$ 520,000

$ 650,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.49

$ 0.23

$ 0.23

$ 0.49

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.02

$ 0.02

Debt Instrument, Convertible, Threshold Consecutive Trading Days

20 days

Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share)

$ 0.04

Derivative Asset, Fair Value, Gross Liability

$ 243,889

$ 243,889

Embedded Derivative, Gain (Loss) on Embedded Derivative, Net

$ (50,809)

$ 65,962

Line of Credit Facility, Initiation Date

Sep. 30, 2013

Line of Credit Facility, Maximum Borrowing Capacity

$ 500,000

Line of Credit Facility, Collateral Fees, Amount

$ 5,000

Line of Credit Facility, Administrative Fee, Percentage

0.50%

Line of Credit Facility, Administrative Fee, Amount

$ 500

Prepayment Fee, Percent

0.50%

Long-term Line of Credit

$ 500,000

$ 500,000

$ 350,000

500,000

Proceeds from Lines of Credit

$ 50,000

$ 100,000

$ 50,000

$ 100,000

$ 100,000

Convertible Notes Payable

$ 442,084

373,499

442,084

Interest Payable, Current

$ 6,288

$ 22,256

$ 5,683

$ 6,288

Share Price (in Dollars per share)

$ 0.0155

Debt Instrument, Convertible, Beneficial Conversion Feature

275,000

Amortization of Debt Discount (Premium)

$ 22,985

Note 9 - Convertible Notes Pa66

Note 9 - Convertible Notes Payable and Credit Facility (Details) - Convertible Notes Payable - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Financial Advisory Services Fees [Member]
Note 9 - Convertible Notes Payable and Credit Facility (Details) - Convertible Notes Payable [Line Items]
Convertible notes payable		$ 10,000	$ 60,000
Less: Derivative liability		(93,376)	(243,889)
Convertible Debt [Member]
Note 9 - Convertible Notes Payable and Credit Facility (Details) - Convertible Notes Payable [Line Items]
Accrued interest		28,284	7,707
Convertible notes payable		520,000	650,000
Less: Derivative liability		(129,598)	(177,927)
Less: Relative fair value of warrants		(170,767)	(53,623)
Accreted interest		79,358	21,889
Accrued interest	$ 22,256	5,683	6,288
Convertible notes payable, net		373,499	442,084
Less current portion		(30,000)	(60,000)
		$ 343,499	$ 382,084

Note 10 - Long-term Debt (Detai

Note 10 - Long-term Debt (Details)	Dec. 31, 2014USD ($)
Convertible Debt [Member]
Note 10 - Long-term Debt (Details) [Line Items]
Long-term Debt, Gross	$ 500,000

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity (Details) - USD ($)	May. 12, 2015	Apr. 20, 2015	Apr. 06, 2015	Jan. 20, 2015	Jan. 16, 2015	Dec. 10, 2014	Mar. 31, 2014	Mar. 26, 2014	Jan. 23, 2014	Apr. 20, 2015	Apr. 30, 2014	Apr. 17, 2014	Apr. 16, 2014	Apr. 16, 2014	Mar. 31, 2014	Feb. 26, 2014	Mar. 31, 2015	Apr. 10, 2015	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Oct. 25, 2014	Aug. 11, 2014	Jul. 08, 2014	Jun. 18, 2014	Jun. 04, 2014	Mar. 21, 2014	May. 13, 2013	Jan. 24, 2013	Apr. 13, 2011
Maximum [Member] | Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Value, Subscriptions (in Dollars)						$ 5,000,000
Maximum [Member] | Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Additional Take-Down Request, Amount (in Dollars)																								$ 125,000
Common Stock, Value, Subscriptions (in Dollars)						$ 5,000,000
Maximum [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Subscription Period						18 months
Settled [Member] | ASC Recap LLC [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, Other											8,079,800	8,079,800
Shares Issued, Price Per Share (in Dollars per share)											$ 0.031
Settled Litigation [Member] | ASC Recap LLC [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, Other												8,079,800
ASC Recap LLC [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Litigation Settlement, Amount (in Dollars)												$ 250,000				$ 250,000
Subsequent Event [Member] | Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, New Issues	67,813,489									14,000,000
Proceeds from Issuance of Common Stock (in Dollars)	$ 929,000	$ 94,000	$ 55,000
Shares Issued, Price Per Share (in Dollars per share)	$ 0.0137
Subsequent Event [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, New Issues																		53,781,201
Proceeds from Issuance of Common Stock (in Dollars)																		$ 780,000
Shares Issued, Price Per Share (in Dollars per share)																		$ 0.013
Upon Effectiveness of Registration Statement [Member] | Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, New Issues					500,000															500,000
Shares Issued, Price Per Share (in Dollars per share)					$ 0.0169
First Draw Down Notice [Member] | Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Stock Issued During Period, Shares, New Issues				500,000																500,000
Shares Issued, Price Per Share (in Dollars per share)				$ 0.0161
Series A Preferred Stock [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Preferred Stock, Shares Authorized																			2,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																			$ 0.001
Series B Preferred Stock [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Preferred Stock, Shares Authorized																			4,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)																			$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Shares Outstanding																				0	467
Preferred Stock, Dividend Rate, Percentage																			4.00%
Series C Preferred Stock [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Temporary Equity, Shares Authorized																			1,175
Temporary Equity, Par or Stated Value Per Share (in Dollars per share)																			$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Shares Outstanding																												260	720
Series D Preferred Stock [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Temporary Equity, Shares Authorized																			1,180
Temporary Equity, Par or Stated Value Per Share (in Dollars per share)																			$ 0.001	$ 0.001	$ 0.001
Southridge Partners II, LP [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Shares Subscribed but Unissued																							3,200,000				35,000,000
Initial Take-Down Request, Amount (in Dollars)								$ 300,000
Stock Issued During Period, Shares, New Issues								12,541,806			500,000		44,079,800		500,000
Proceeds from Issuance of Common Stock (in Dollars)							$ 100,000							$ 200,000
Additional Take-Down Request, Amount (in Dollars)																						$ 52,000		$ 125,000	$ 100,000	$ 100,000
Shares Issued, Price Per Share (in Dollars per share)													$ 0.02	$ 0.02
Debt Issuance Costs, Placement Fee, Number of Securities													1,000,000	1,000,000			1,000,000
Common Stock, Subscription Period						18 years
Debt Issuance Costs, Commitment Fee, Number of Securities						1,000,000
Debt Issuance Costs, Commitment Fee, Amount (in Dollars)						$ 17,900
Commmon Stock, Equity Purchase Agreement, Committment To Be Purchased, Value (in Dollars)						$ 5,000,000			$ 5,000,000
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars)																	$ 16,500
Shares of Capital Stock Authorized under Certificate of Incorporation																	501,000,000			501,000,000
Common Stock, Shares Authorized																	500,000,000			500,000,000	500,000,000									500,000,000
Preferred Stock, Shares Authorized																	1,000,000			1,000,000
Preferred Stock, Shares Outstanding																			0
Common Stock, Subscription Period						18 months			18 months
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars)																				$ 36,618	$ 40,602

Note 12 - Convertible Redeema69

Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details)	May. 13, 2013USD ($)$ / sharesshares	May. 13, 2013USD ($)$ / sharesshares	Mar. 21, 2013USD ($)shares	Feb. 15, 2013USD ($)$ / sharesshares	Jan. 24, 2013USD ($)$ / sharesshares	Aug. 30, 2013USD ($)$ / sharesshares	Jan. 24, 2013USD ($)$ / sharesshares	Mar. 31, 2014USD ($)	Sep. 30, 2013USD ($)shares	Dec. 31, 2014USD ($)shares	Dec. 31, 2013USD ($)shares	Feb. 27, 2015$ / shares	Sep. 30, 2014shares
Maximum [Member] | Series D Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Securities Purchase Agreement, Maximum Multiplication Number	3.34	3.34		1.67
Additional Financing [Member] | Series C Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Convertible Preferred Stock, Conversion Price (in Dollars per share) | $ / shares	$ 0.03	$ 0.03			$ 0.05	$ 0.02	$ 0.05
Additional Financing [Member] | Series D Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Convertible Preferred Stock, Conversion Price (in Dollars per share) | $ / shares						0.02
Securities Pledged as Collateral [Member] | Series D Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Preferred Stock, Shares Issued									50
Debt Instrument, Collateral Fee (in Dollars) | $									$ 50,000
Series C Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Preferred Stock, Number of Shares Issued During Period					75
Proceeds from Issuance of Preferred Stock and Preference Stock (in Dollars) | $					$ 75,000
Share Price (in Dollars per share) | $ / shares					$ 0.05		$ 0.05
Convertible Preferred Stock, Shares Issued upon Conversion					1,500,000		1,500,000			4,333,350
Preferred Stock, Shares Outstanding	260	260			720		720
Convertible Preferred Stock, Conversion Price (in Dollars per share) | $ / shares	$ 0.05	$ 0.05			$ 0.08	$ 0.03	$ 0.08
Preferred Stock, Shares Issued	260	260			720	147	720
Convertible Preferred Deemed Dividends (in Dollars) | $						$ 36,000	$ 270,000
Redeemable Preferred Stock Dividends (in Dollars) | $		$ 104,000
Conversion of Stock, Shares Converted										87
Series D Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Preferred Stock, Number of Shares Issued During Period	583		167	150
Proceeds from Issuance of Preferred Stock and Preference Stock (in Dollars) | $	$ 175,000		$ 100,000	$ 150,000
Convertible Preferred Stock, Shares Issued upon Conversion										43,000,000
Convertible Preferred Stock, Conversion Price (in Dollars per share) | $ / shares	$ 0.03	$ 0.03				$ 0.10
Preferred Stock, Shares Issued						930
Convertible Preferred Deemed Dividends (in Dollars) | $						$ 465,000
Securities Purchase Agreement, Maximum Number of Shares Issued				1,180
Preferred Stock, Stated Value (in Dollars per share) | $ / shares				$ 1,000
Securities Purchase Agreement, Maximum Aggregate Proceeds from Issuance of Preferred Stock (in Dollars) | $				$ 1,000,000
Convertible Notes Payable (in Dollars) | $						$ 200,000
Conversion of Stock, Shares Converted										860
Series B Preferred Stock [Member]
Note 12 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion										21,020,015
Preferred Stock, Shares Outstanding										0	467
Preferred Stock, Shares Issued										0	467
Conversion of Stock, Shares Converted										467
Share Price (in Dollars per share) | $ / shares												$ 0.0155
Preferred Stock, Shares Outstanding													0
Convertible Preferred Deemed Dividends (in Dollars) | $											$ (875,304)
Redeemable Preferred Stock Dividends (in Dollars) | $								$ 14,454			875,304
Convertible Notes Payable (in Dollars) | $										$ 373,499	$ 442,084
Line of Credit Facility, Maximum Borrowing Capacity (in Dollars) | $									$ 500,000

Note 13 - Stock Option and In70

Note 13 - Stock Option and Incentive Plan (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 19, 2013	Dec. 31, 2012
Restricted Stock [Member] | Expire Over One Year [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			1 year
Restricted Stock [Member] | Expire Over Four Years [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			4 years
Restricted Stock [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	4 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 1,000	$ 1,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			73 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 23,000	13,000	$ 64,000	$ 19,000
Excess Tax Benefit from Share-based Compensation, Financing Activities	$ 0	0	$ 0	$ 0
Employee Stock Option [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	4 years 109 days		255 days	1 year
Excess Tax Benefit from Share-based Compensation, Financing Activities	$ 0		$ 0	$ 0
Financial Advisory Services Fees [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Notes Issued		90,000
The 2006 Stock Incentive Plan [Member]
Note 13 - Stock Option and Incentive Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)					50,000,000	50,000,000	3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)					45,593,221
Restriction Period on Restricted Stock Grants, Expiration Rate, Per Quarter Over One Year			25.00%
Restriction Period On Restricted Stock Grants Expiration Rate Per Year Over Four Years	25.00%		25.00%
Options Vesting And Exercisability Rate Per Quarter Over One Year			25.00%
Term of Options			5 years
Allocated Share-based Compensation Expense	$ 68,600	$ 166,000	$ 224,000	$ 110,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 479,000		$ 514,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$ 0.02	$ 0.02
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	0	0	30,456,250	6,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	4 years 36 days		4 years 146 days	4 years 255 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 23,000	$ 13,000	$ 91,000	$ 81,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 0		$ 0	$ 0
Term of Warrants	5 years

Note 13 - Stock Option and In71

Note 13 - Stock Option and Incentive Plan (Details) - Summary of Restricted Stock Activity - Restricted Stock [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Note 13 - Stock Option and Incentive Plan (Details) - Summary of Restricted Stock Activity [Line Items]
Outstanding and not vested beginning balance as of January 1, 2013	7,186	1,890,952	48,073
Outstanding and not vested beginning balance as of January 1, 2013	$ 2.16	$ 0.05	$ 2.50
Granted, number of restricted shares			2,500,000
Granted, weighted-average grant date fair value			$ 0.03
Forfeited/cancelled, number of restricted shares			(21,798)
Forfeited/cancelled, weighted-average grant date fair value			$ 2.46
Released/vested, number of restricted shares	(7,186)	(1,883,766)	(635,323)
Released/vested, weighted-average grant date fair value	$ 2.16	$ 0.04	$ 0.08
Outstanding and not vested beginning balance, number of restricted shares		7,186	1,890,952
Outstanding and not vested beginning balance, weighted-average grant date fair value		$ 2.16	$ 0.05

Note 13 - Stock Option and In72

Note 13 - Stock Option and Incentive Plan (Details) - Stock Option Activity - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Stock Option Activity [Abstract]
Outstanding balance, number of shares subject to option	37,034,483	6,618,233	6,618,233	679,744
Outstanding balance, weighted-average exercise price	$ 0.03	$ 0.11	$ 0.11	$ 2.82
Exercisable at end of year	7,321,779		5,934,303	2,330,650
Exercisable at end of year	$ 0.07		$ 0.09	$ 0.28
Outstanding and expected to vest			36,916,502	6,191,212
Outstanding and expected to vest			$ 0.03	$ 0.11
Granted during the year	0	0	30,456,250	6,400,000
Granted during the year			$ 0.02	$ 0.03
Forfeited/cancelled/expired during the year			(40,000)	(461,511)
Forfeited/cancelled/expired during the year			$ 5.15	$ 3.29
Outstanding balance, number of shares subject to option	37,034,483		37,034,483	6,618,233
Outstanding balance, weighted-average exercise price	$ 0.03		$ 0.03	$ 0.11

Note 13 - Stock Option and In73

Note 13 - Stock Option and Incentive Plan (Details) - Valuation Assumptions of Stock Options	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Valuation Assumptions of Stock Options [Abstract]
Weighted-average volatility	185.00%	105.50%
Expected dividends	0.00%	0.00%
Expected life (in years)	3 years 6 months	2 years
Weighted-average risk-free interest rate	1.10%	0.30%

Note 13 - Stock Option and In74

Note 13 - Stock Option and Incentive Plan (Details) - Non-vested Stock Option Activity - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Non-vested Stock Option Activity [Abstract]
Non-vested stock options outstanding	31,066,430	4,287,583	4,287,583
Weighted-average grant date fair value of options outstanding	$ 0.02	$ 0.02	$ 0.02
Granted	0	0	30,456,250	6,400,000
Granted			$ 0.02	$ 0.02
Forfeited/cancelled			(40,000)
Forfeited/cancelled			$ 3.04
Released/vested			(3,637,403)
Released/vested			$ 0.02
Non-vested stock options outstanding			31,066,430	4,287,583
Weighted-average grant date fair value of options outstanding			$ 0.02	$ 0.02

Note 13 - Stock Option and In75

Note 13 - Stock Option and Incentive Plan (Details) - Options Outstanding - Dec. 31, 2014 - $ / shares	Total
Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price, upper range	$ 0.0192
Number Outstanding (in Shares)	12,450,000
Weighted-Average Remaining Contractual Life (in years)	4 years 219 days
Weighted-Average Exercise Price	$ 0.02
Number Outstanding (in Shares)	358,320
Weighted-Average Exercise Price	$ 0.02
Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price, lower range	0.020
Exercise price, upper range	$ 0.023
Number Outstanding (in Shares)	18,000,000
Weighted-Average Remaining Contractual Life (in years)	4 years 219 days
Weighted-Average Exercise Price	$ 0.02
Number Outstanding (in Shares)	1,125,000
Weighted-Average Exercise Price	$ 0.02
Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price, upper range	$ 0.0296
Number Outstanding (in Shares)	6,400,000
Weighted-Average Remaining Contractual Life (in years)	3 years 292 days
Weighted-Average Exercise Price	$ 0.0296
Number Outstanding (in Shares)	4,266,500
Weighted-Average Exercise Price	$ 0.0296
Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price, lower range	0.11
Exercise price, upper range	$ 5.32
Number Outstanding (in Shares)	184,483
Weighted-Average Remaining Contractual Life (in years)	1 year 109 days
Weighted-Average Exercise Price	$ 1.95
Number Outstanding (in Shares)	184,483
Weighted-Average Exercise Price	$ 1.95
Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price, lower range	0.0192
Exercise price, upper range	$ 5.32
Number Outstanding (in Shares)	37,034,483
Weighted-Average Remaining Contractual Life (in years)	4 years 146 days
Weighted-Average Exercise Price	$ 0.03
Number Outstanding (in Shares)	5,934,303
Weighted-Average Exercise Price	$ 0.09

Note 14 - Stock Warrants and 76

Note 14 - Stock Warrants and Warrant Liability (Details) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 31, 2009	Mar. 31, 2015	Dec. 31, 2014	Mar. 18, 2014	Feb. 25, 2014	Dec. 31, 2013	Dec. 19, 2013
Minimum [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Term of Warrants		4 years 6 months	4 years 6 months
Maximum [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Term of Warrants		5 years	5 years
Series E Warrants [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Class of Warrant or Right, Issued During Period (in Shares)	334,822
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 5.36
Fair Value Assumptions, Risk Free Interest Rate	2.69%
Fair Value Assumptions, Expected Term	5 years
Fair Value Assumptions, Expected Volatility Rate	112.00%
Fair Value Assumptions, Expected Dividend Rate	0.00%
Warrants Issued During Period, Value (in Dollars)	$ 1,000,000
Derivative Liability (in Dollars)	$ 1,000,000					$ 0
Convertible Notes Maturing on December 19, 2015 [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)			$ 0.02
Debt Instrument, Face Amount (in Dollars)							$ 250,000
Term of Warrants		5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		6,250,000	6,250,000
Convertible Notes Maturing on February 25, 2016 [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)			$ 0.02
Debt Instrument, Face Amount (in Dollars)					$ 200,000
Term of Warrants		5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		5,000,000	5,000,000
Convertible Notes Maturing on March 19, 2016 [Member
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.02	$ 0.02
Debt Instrument, Face Amount (in Dollars)				$ 300,000
Term of Warrants		5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		7,500,000	7,500,000
Convertible Notes Maturing on December 19, 2013 [Member]
Note 14 - Stock Warrants and Warrant Liability (Details) [Line Items]
Debt Instrument, Face Amount (in Dollars)							$ 250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.23	$ 0.23			$ 0.49
Derivative Liability (in Dollars)			$ 129,598			$ 177,927
Debt Instrument, Face Amount (in Dollars)			$ 520,000			$ 650,000
Term of Warrants		5 years

Note 14 - Stock Warrants and 77

Note 14 - Stock Warrants and Warrant Liability (Details) - Warrant Activity - 12 months ended Dec. 31, 2014 - $ / shares	Total
Warrant Activity [Abstract]
Warrants for number of shares	22,148,045
Weighted-average exercise price	$ 0.23
Issued	12,500,000
Issued	$ 0.02

Note 15 - Fair Value Measurem78

Note 15 - Fair Value Measurement (Details) - USD ($)	1 Months Ended			3 Months Ended		12 Months Ended
	Dec. 19, 2013	Nov. 25, 2013	Aug. 30, 2013	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 19, 2013	Feb. 27, 2015
Minimum [Member] | Beneficial Conversion Feature [Member] | Monte Carlo Simulation [Member]
Note 15 - Fair Value Measurement (Details) [Line Items]
Share Price (in Dollars per share)				$ 0.011
Fair Value Assumptions, Expected Volatility Rate				94.40%
Maximum [Member] | Beneficial Conversion Feature [Member] | Monte Carlo Simulation [Member]
Note 15 - Fair Value Measurement (Details) [Line Items]
Share Price (in Dollars per share)				$ 0.036
Fair Value Assumptions, Expected Volatility Rate				99.70%
Proceeds from Convertible Debt	$ 250,000	$ 200,000	$ 200,000		$ 600,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$ 0.02							$ 0.02
Debt Instrument, Convertible, Threshold Consecutive Trading Days								20 days
Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share)								$ 0.04
Derivative Asset, Fair Value, Gross Liability	$ 243,889							$ 243,889
Net Income (Loss) Available to Common Stockholders, Basic				$ (825,176)	$ (84,396)	$ (1,871,228)	$ (3,858,656)
Net Income (Loss), Impact of 10 Percent Lower in Closing Stock Price						15,000
Net Income (Loss), Impact of 10 Percent Higher in Closing Stock Price						(26,000)
Net Income Loss, Impact of 10 Percent Lower in Volatility Assumption						7,000
Net Income (Loss), Impact of 10 Percent Higher in Volatility Assumption						$ (13,000)
Share Price (in Dollars per share)									$ 0.0155

Note 15 - Fair Value Measurem79

Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value - USD ($)	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Inputs, Level 1 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	$ 0
	0	$ 0
Fair Value, Inputs, Level 2 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	0
	0	0
Fair Value, Inputs, Level 3 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	129,598	177,927
	129,598	177,927
Fair value of derivative liability – embedded conversion feature	129,598	177,927
	$ 129,598	$ 177,927

Note 15 - Fair Value Measurem80

Note 15 - Fair Value Measurement (Details) - Changes in Level 3 Liabilities Measured at Fair Value on Recurring Basis - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accrued and Other Long-term Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	$ 129,598	$ 177,927
Issuances		122,630
Total realized and unrealized gains or losses	(41,265)	(50,809)
Transfers out of level 3 upon exercise or conversion	(88,333)	(221,768)
Balance		129,598
Common Stock Warrant Liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	129,598	177,927
Issuances		122,630
Total realized and unrealized gains or losses	(41,265)	(50,809)
Transfers out of level 3 upon exercise or conversion	$ (88,333)	(221,768)
Balance		$ 129,598

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Domestic Tax Authority [Member]
Note 16 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Tax Credit Carryforwards, Research			$ 361,000
State and Local Jurisdiction [Member]
Note 16 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Tax Credit Carryforwards, Research			231,000
Income Tax Expense (Benefit)	$ 0	$ 0	$ 0	$ 0
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			34.00%
Valuation Allowance as Percentage of Deferred Tax Asset	100.00%		100.00%
Deferred Tax Assets, Operating Loss Carryforwards, Domestic			$ 75,200,000
Deferred Tax Assets, Operating Loss Carryforwards, State and Local			73,100,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount			$ 650,000	1,100,000
Change in Control Ownership Threshold			50.00%
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense			$ 0
Unrecognized Tax Benefits that Would Impact Effective Tax Rate			$ 128,000	$ 128,000

Note 16 - Income Taxes (Detai82

Note 16 - Income Taxes (Details) - Effective Income Tax Reconciliation - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Effective Income Tax Reconciliation [Abstract]
Tax at federal statutory rate			$ (740,000)	$ (967,000)
State taxes, net of federal benefit			(117,000)	(160,000)
Research and development credits				(12,000)
Fair market value of warrants & derivatives			17,000	(22,000)
Stock-based compensation			51,000	29,000
Other permanent items			10,000	1,000
Valuation allowance			779,000	1,131,000
Income tax provision	$ 0	$ 0	$ 0	$ 0

Note 16 - Income Taxes (Detai83

Note 16 - Income Taxes (Details) - Deferred Tax Assets and Liabilities - USD ($)	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Net operating loss and credit carryforwards	$ 30,227,000	$ 29,431,000
Stock-based compensation	1,199,000	1,193,000
Stock-based compensation	422,000	558,000
Basis difference for fixed assets and intangibles	158,000	174,000
Total gross deferred tax assets	32,006,000	31,356,000
Valuation allowance	(32,006,000)	(31,356,000)
Net deferred tax assets	$ 0	$ 0

Note 16 - Income Taxes (Detai84

Note 16 - Income Taxes (Details) - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits	12 Months Ended
	Dec. 31, 2013USD ($)
Aggregate Changes in Balance of Gross Unrecognized Tax Benefits [Abstract]
Balance, beginning of year	$ 140,000
Balance, end of year	147,000
Additions for tax positions related to prior years	$ 7,000

Note 17 - Commitments and Con85

Note 17 - Commitments and Contingencies (Details) - USD ($)	Feb. 09, 2015	Dec. 31, 2014	Feb. 28, 2014
Executive Offices and Warehouse Premises in San Jose, CA [Member]
Note 17 - Commitments and Contingencies (Details) [Line Items]
Operating Lease Monthly Rent		$ 10,500	$ 7,800
Snell & Wilmer LLP [Member]
Note 17 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value	$ 808,202

Note 18 - Concentration of Ri86

Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 30, 2012	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Mar. 15, 2013
Suntech America [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) [Line Items]
Loss Contingency, Estimate of Possible Loss					$ 946,438
Loss Contingency Accrual		$ 946,438	$ 946,438
Liabilities, Total [Member] | Supplier Concentration Risk [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) [Line Items]
Concentration Risk, Percentage		30.00%	39.00%	25.00%
Supplier Concentration Risk [Member]
Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) [Line Items]
Accounts Payable		$ 68,000	$ 0	$ 1,000,000
Stock Issued During Period, Shares, Purchase of Assets (in Shares)	1,900,000
Stock Issued During Period, Value, Purchase of Assets	$ 1,045,000

Note 18 - Concentration of Ri87

Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) - Percentages of Sales to Largest Customers - Sales Revenue, Goods, Net [Member] - Customer Concentration Risk [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Smart Energy Today [Member]
Concentration Risk [Line Items]
Percentage of sales	34.90%		13.30%	13.50%
WDC Solar, Inc. [Member]
Concentration Risk [Line Items]
Percentage of sales			12.00%	14.70%
JCF Wholesale [Member]
Concentration Risk [Line Items]
Percentage of sales			8.70%	10.60%
Lowe's Companies, Inc. [Member]
Concentration Risk [Line Items]
Percentage of sales			5.90%	6.90%
Sustainable Environmental Enterprises [Member]
Concentration Risk [Line Items]
Percentage of sales		11.70%	1.30%	52.80%

Note 18 - Concentration of Ri88

Note 18 - Concentration of Risk in Customer and Supplier Relationships (Details) - Percentage of Gross Accounts Receivable - Accounts Receivable [Member] - Customer Concentration Risk [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
WDC Solar, Inc. [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	62.40%	40.10%	40.10%
Lowe's Companies, Inc. [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	11.60%	16.80%	16.80%
Sustainable Environmental Enterprises [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable		6.50%		86.70%
Smart Energy Today [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable			6.50%

Note 19 - Employee Benefit Pl89

Note 19 - Employee Benefit Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	10.00%
Pension and Other Postretirement Defined Benefit Plans, Liabilities	$ 0	$ 0

Note 20 - Subsequent Events (De

Note 20 - Subsequent Events (Details)

May. 12, 2015USD ($)$ / sharesshares

Apr. 20, 2015USD ($)

Apr. 17, 2015USD ($)ft²

Apr. 06, 2015USD ($)

Feb. 09, 2015USD ($)

Dec. 10, 2014USD ($)

Mar. 31, 2014USD ($)

Mar. 26, 2014shares

Jan. 23, 2014

Apr. 20, 2015shares

Apr. 30, 2014shares

Apr. 16, 2014$ / sharesshares

Apr. 16, 2014USD ($)$ / shares

Mar. 31, 2014shares

Apr. 10, 2015USD ($)$ / sharesshares

Mar. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Dec. 31, 2013USD ($)

Maximum [Member] | Southridge Partners II, LP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Common Stock, Value, Subscriptions

$ 5,000,000

Maximum [Member] | Southridge Partners II, LP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Common Stock, Value, Subscriptions

$ 5,000,000

Common Stock, Subscription Period

18 months

Maximum [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Common Stock, Subscription Period

18 months

Subsequent Event [Member] | Office Space [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Area of Real Estate Property (in Square Feet) | ft²

1,500

Subsequent Event [Member] | Warehouse Storage Space [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Area of Real Estate Property (in Square Feet) | ft²

2,000

Subsequent Event [Member] | Southridge Partners II, LP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares) | shares

67,813,489

14,000,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.0137

Proceeds from Issuance of Common Stock

$ 929,000

$ 94,000

$ 55,000

Subsequent Event [Member] | Snell & Wilmer LLP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Loss Contingency, Damages Sought, Value

$ 808,202

Subsequent Event [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares) | shares

53,781,201

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.013

Proceeds from Issuance of Common Stock

$ 780,000

Operating Lease Monthly Rent

$ 4,250

Lessee Leasing Arrangements, Operating Leases, Term of Contract

12 months

Southridge Partners II, LP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Common Stock, Subscription Period

18 years

Stock Issued During Period, Shares, New Issues (in Shares) | shares

12,541,806

500,000

44,079,800

500,000

Shares Issued, Price Per Share (in Dollars per share) | $ / shares

$ 0.02

$ 0.02

Proceeds from Issuance of Common Stock

$ 100,000

$ 200,000

Snell & Wilmer LLP [Member]

Note 20 - Subsequent Events (Details) [Line Items]

Loss Contingency, Damages Sought, Value

$ 808,202

Accounts Payable, Current

$ 808,202

Accounts Payable, Current

$ 3,220,948

$ 3,345,361

$ 4,199,511

Common Stock, Subscription Period

18 months

18 months

Note 2 - Significant Accounting

Note 2 - Significant Accounting Policies (Details) - Liability for Manufacturing Warranty - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Discontinued Operations [Member]
Product Warranty Liability [Line Items]
Adjustment to warranty liability for discontinued operations		$ (324,349)
Warranty balance	$ 938,466	1,312,918	$ 1,312,918	$ 1,372,342
Reduction for labor payments and claims made under the warranty	(13,998)	(75,966)	(75,966)	(79,134)
Adjustment to warranty liability for discontinued operations			(324,349)
Accruals related to warranties issued during the period	9,620	25,863	25,863	19,710
Warranty balance	$ 934,088	$ 938,466	$ 938,466	$ 1,312,918

Note 3 - Segment Reporting (Det

Note 3 - Segment Reporting (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Segment Reporting [Abstract]
Number of Operating Segments	2	2

Note 3 - Segment Reporting (D93

Note 3 - Segment Reporting (Details) - Segment Revenue, Operating Profit, and Assets - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Distribution [Member]
Segment Reporting Information [Line Items]
Revenue	$ 166,136	$ 142,482
Gross profit (loss)	(9,975)	7,094
Assets	2,482,508	2,560,940
Installation [Member]
Segment Reporting Information [Line Items]
Revenue	108,505
Gross profit (loss)	(1,766)
Assets	20,997
Revenue	274,641	142,482	$ 1,288,985	$ 1,124,836
Gross profit (loss)	(11,741)	7,094	97,595	3,224
Assets	$ 2,558,782	$ 2,560,940	$ 2,560,940	$ 3,465,405

Note 5 - Accounts Receivable (D

Note 5 - Accounts Receivable (Details) - Accounts Receivable - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable [Abstract]
Trade accounts	$ 104,005	$ 154,172	$ 575,375
Less: Allowance for bad debts	(21,972)	(24,882)	(2,899)
Less: Allowance for returns	(19,647)	(10,834)	(4,953)
	$ 62,386	$ 118,456	$ 567,523

Note 5 - Accounts Receivable 95

Note 5 - Accounts Receivable (Details) - Allowance for Doubtful Accounts - USD ($)	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Allowance for Doubtful Accounts [Abstract]
Balance at beginning of period	$ 2,899	$ 108,750	$ 24,882	$ 2,899	$ 2,899
Provisions, net	36,763	92,224	2,909	$ (4,492)	36,763	$ 92,224
Write-off/recovery	(14,780)	(198,075)	5,819		(14,780)
Balance at end of period	$ 24,882	$ 2,899	$ 21,972		$ 24,882	$ 2,899

Note 6 - Inventory (Details) -

Note 6 - Inventory (Details) - Inventory Schedule - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Inventory Schedule [Abstract]
Finished goods	$ 631,616	$ 669,706	$ 654,970
Work in process	70,329	58,666	131,666
	$ 701,945	$ 728,372	$ 786,636

Note 7 - Property and Equipme97

Note 7 - Property and Equipment, Net (Details) - Property and Equipment, Net - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 436,051	$ 436,051	$ 436,051
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	123,278	123,278	123,278
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,992	17,992	17,992
Property and equipment, gross	577,321	577,321	577,321
Less: Accumulated depreciation and amortization	(576,971)	(576,622)	(563,467)
	$ 350	$ 699	$ 13,854

Note 8 - Accrued Liabilities 98

Note 8 - Accrued Liabilities (Details) - Accrued Liabilities - USD ($)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accrued Liabilities [Abstract]
Accrued salaries, wages, benefits and bonus	$ 63,876	$ 45,586	$ 45,456
Sales tax payable	3,646	662	4,409
Accrued accounting and legal fees	61,050
Customer deposit payable	33,604	41,265	580
Accrued interest	22,256	5,683	6,288
Other accrued liabilities	20,361	11,033	32,997
	$ 204,793	$ 104,229	$ 89,730

Note 11 - Stock Option Plan and

Note 11 - Stock Option Plan and Stock Incentive Plan (Details) - Summary of Restricted Stock Activity - Restricted Stock [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Stock Option Plan and Stock Incentive Plan (Details) - Summary of Restricted Stock Activity [Line Items]
Outstanding and not vested beginning balance as of January 1, 2015		7,186	1,890,952	48,073
Outstanding and not vested beginning balance as of January 1, 2015		$ 2.16	$ 0.05	$ 2.50
Released/vested	(7,186)	(1,883,766)	(635,323)
Released/vested	$ 2.16	$ 0.04	$ 0.08

Note 11 - Stock Option Plan 100

Note 11 - Stock Option Plan and Stock Incentive Plan (Details) - Stock Option Activity - $ / shares	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stock Option Activity [Abstract]
Exercisable as of March 31, 2015	7,321,779	5,934,303	2,330,650
Exercisable as of March 31, 2015	$ 0.07	$ 0.09	$ 0.28

Note 12 - Stock Warrants and Wa

Note 12 - Stock Warrants and Warrant Liability (Details) - Warrant Activity - $ / shares	Mar. 31, 2015	Dec. 31, 2013
Warrant Activity [Abstract]
Warrants for number of shares	22,148,045
Weighted-average exercise price	$ 0.23
Warrants for number of shares	22,148,045	9,648,045
Weighted-average exercise price	$ 0.23	$ 0.49

Note 13 - Earnings Per Share (D

Note 13 - Earnings Per Share (Details) - Computation of Earnings Per Share - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Numerator:
Net loss	$ (825,176)	$ (69,942)	$ (1,852,301)	$ (2,830,047)
Preferred deemed dividend and preferred stock dividend
Less: Net loss allocated to participating securities	8	960	6,005	12,503
	$ (825,168)	$ (83,436)	$ (1,865,223)	$ (3,846,153)
Denominator:
Weighted-average shares outstanding	328,001,069	132,940,312	204,471,018	69,477,915
Weighted-average unvested restricted shares outstanding	(3,322)	(1,512,311)	656,121	306,958
Denominator for basic net loss per share	327,997,747	131,428,001	203,814,897	69,170,957
Basic net loss per share attributable to common stockholders	$ 0	$ 0	$ (0.01)	$ (0.06)

Note 13 - Earnings Per Share103

Note 13 - Earnings Per Share (Details) - Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	37,034,483	37,034,483
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities		7,186	1,890,952
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	22,148,045	22,148,045	9,648,045

Note 14 - Concentration of Risk

Note 14 - Concentration of Risk (Details) - Percentages of Sales to Largest Customers - Sales Revenue, Goods, Net [Member] - Customer Concentration Risk [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Smart Energy Today [Member]
Concentration Risk [Line Items]
Percentage of sales	34.90%		13.30%	13.50%
Heclo Electric [Member]
Concentration Risk [Line Items]
Percentage of sales	12.70%	22.90%
Verengo Solar [Member]
Concentration Risk [Line Items]
Percentage of sales	13.90%
Sustainable Environmental Enterprises [Member]
Concentration Risk [Line Items]
Percentage of sales		11.70%	1.30%	52.80%
Shoreline Electric [Member]
Concentration Risk [Line Items]
Percentage of sales		31.90%

Note 14 - Concentration of R105

Note 14 - Concentration of Risk (Details) - Percentage of Gross Accounts Receivable - Accounts Receivable [Member] - Customer Concentration Risk [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
WDC Solar, Inc. [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	62.40%	40.10%	40.10%
Lowe's Companies, Inc. [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	11.60%	16.80%	16.80%
Greg Teegarden [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	11.40%
Sustainable Environmental Enterprises [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable		6.50%		86.70%

Note 15 - Fair Value Measure106

Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value - USD ($)	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Inputs, Level 1 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	$ 0
Total	0	$ 0
Fair Value, Inputs, Level 2 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	0
Total	0	0
Fair Value, Inputs, Level 3 [Member]
Note 15 - Fair Value Measurement (Details) - Assets and Liabilities Measured at Fair Value [Line Items]
Fair value of derivative liability – embedded conversion feature	129,598	177,927
Total	129,598	177,927
Fair value of derivative liability – embedded conversion feature	129,598	177,927
Total	$ 129,598	$ 177,927

Note 15 - Fair Value Measure107

Note 15 - Fair Value Measurement (Details) - Changes in Level 3 Liabilities Measured at Fair Value on Recurring Basis - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accrued and Other Long-term Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	$ 129,598	$ 177,927
Conversions	(88,333)	(221,768)
Total realized and unrealized gains or losses	(41,265)	(50,809)
Balance		129,598
Common Stock Warrant Liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	129,598	177,927
Conversions	(88,333)	(221,768)
Total realized and unrealized gains or losses	$ (41,265)	(50,809)
Balance		$ 129,598

Uncategorized Items - west-2015

Label	Element	Value
Unrecognized Tax Benefits	us-gaap_UnrecognizedTaxBenefits	$ 147,000